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Abstract 

Ketone bodies, namely beta-hydroxybutyrate (βHB), acetoacetate (AcAc) and acetone, are 
produced in the liver during physiological states and manipulations that result in reduced 
carbohydrate availability. Exogenous ketone supplements, namely ketone esters and ketone 
salts, have been developed with the aim of achieving acute nutritional ketosis i.e. βHB 
concentrations > 0.5 mM. We investigated whether exogenous ketone supplements had an 
effect on the metabolic response to exercise, physical and cognitive performance in athletes.   
 A literature review was undertaken to examine the relationship between elevated 
ketone bodies, achieved via intravenous fusion of ketone bodies or fasting, and metabolism 
both at rest and during exercise1. The review focused on seminal work performed in the 
1970s and 1980s and identified a number of metabolic effects that may have relevance to 
improve performance and recovery in athletic populations.   
 Study 1 investigated the effect of a commercially-available ketone salt product 
formulation on the metabolic response to a graded exercise session in trained endurance 
athletes2. We observed an elevation in βHB concentrations (0.4-0.5 mM), a reduction in 
plasma glucose concentrations, but no effect on plasma lactate concentrations or exercise 
efficiency.  
 Study 2 investigated the effect of co-ingestion with carbohydrate of a ketone ester 
supplement in the form of a (R)-3-hydroxybutyl (R)-3-hydroxybutyrate ketone mono ester on 
	 v	
physical and cognitive performance in team sport athletes in response to a simulated soccer 
task3. Ingestion of the ketone ester had no effect on 15 m sprint times during the simulated 
task, or on reaction time or sustained attention performed afterwards. Compared to 
carbohydrate alone, we observed a preservation in executive function, measured by a decision 
making task, but a possible impairment in performance in a short high intensity intermittent 
performance test in the ketone ester condition.  
 Study 3 investigated the effect in trained runners of co-ingestion with carbohydrate of 
a (R)-3-hydroxybutyl (R)-3-hydroxybutyrate ketone mono ester on the metabolic response to 
submaximal exercise, and performance in 10 km time trial and cognitive tasks. We observed 
no effect on endurance performance or cognitive performance with the ketone ester compared 
to the carbohydrate alone condition.  
 Future research should focus on exploring the optimal dosage and timing of 
exogenous ketone supplements around exercise to confer performance benefits, if any. It 
remains to be confirmed which exercise modalities may benefit from exogenous ketone 
supplementation.  
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Introduction 
	
 Ketone bodies (KB), namely β-hydroxybutyrate (βHB), acetoacetate (AcAc) and 
acetone, are produced in the liver during physiological states and nutritional manipulations 
that result in reduced carbohydrate availability, including fasting, starvation and ketogenic 
diets (Robinson & Williamson, 1980; Laffel, 1999). The practical relevance for athletic 
seeking performance gains generated from these states are negligible (Burke, 2015). This led 
to the exploration of exogenous ketone supplements as means to achieve acute nutritional 
ketosis to raise ketone body concentrations without reducing carbohydrate availability. The 
use of exogenous ketone supplements in professional sport was rumoured as long ago as 
2012, while their use was more recently confirmed in professional cycling (Abraham, 2015; 
Pinckaers et al., 2016). Since then several original research articles have been published 
investigating the effect of various exogenous ketone supplements on the metabolic response 
to exercise and physical and cognitive performance (Cox et al. 2016; Leckey et al. 2017; 
O’Malley et al. 2017; Rodger et al. 2017; Waldman et al. 2017; Holdsworth et al. 2017; 
Vandoorne et al. 2017). While interest has peaked only in the last few years, the work on 
ketones provided exogenously, either through injections or infusions goes back to the 1940s 
where their potential to alter whole body and local tissue metabolism was first realised. These 
data remained largely isolated until recently. The purpose of this introductory chapter is to 
explore the historical development of exogenous ketone supplements, and the current interest 
in these supplements for athletic performance. Chapter 2 will provide an extensive review of 
the physiology and metabolism of ketone bodies at rest, during exercise and in response to 
training. 
 
 
	 3	
History and development of exogenous ketone supplements 
 During the 1940s, a series of experiments identified bHB and AcAc as two of sixteen 
metabolites with the ability to increase the metabolic efficiency of animal sperm (Lardy & 
Phillips, 1945; Lardy et al., 1945). Simultaneously, bHB and AcAc injections were 
administered to study their effects on glucose metabolism in animal models (Nath & 
Brahmachari, 1944; Nath & Brahmachari 1946; Nath & Brahmachari, 1948; Tidwell & 
Axelrod, 1948; Tidwell & Nagler, 1952; Chari & Wertheimer, 1953). The blood glucose 
response to KB administration was divergent in these works. In a set of experiments 
administering bHB and AcAc injections to rabbits and guinea pigs, progressive 
hyperglycaemia was observed and it was hypothesised that KB cause a hypersecretion of 
insulin and damage of the pancreatic islet cells (Nath & Brahmachari, 1944; Nath & 
Brahmachari, 1946; Nath & Brahmachari, 1948). Conversely, hypoglycaemia was observed 
in rats following AcAc administration and glucose tolerance was unaltered following 
simultaneous AcAc/glucose administration. A “sugar sparing action of ketone bodies” was 
suggested, associated with decreased glycogenolysis and lower blood glucose concentrations 
(Tidwell & Axelrod, 1948; Tidwell & Nagler, 1952). Furthermore, KB inhibit glycolysis and 
increase the conversion of glucose to glycogen as demonstrated in rat heart skeletal muscle in 
vitro (Maizels et al., 1977), perfused heart model in dogs (Laughlin et al., 1994), and reduce 
hepatic glucose output when combined with somatostatin in type 2 diabetic patients (Henry et 
al., 1990).  
 The describing of KB for exogenous delivery in the novel form of ketone esters 
occurred some 40 years ago, and outlined a speculated primary role in parenteral nutrition 
(Brunengraber, 1997). The use of KB, whether as esters of AcAc or bHB, as a source of 
parenteral nutrition was devised as an alternative to carbohydrate to deliver more energy at a 
lower osmolality, avoid the pathophysiological side effects that accompany intravenous 
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glucose infusion, and avoid the catabolism of protein that accompanies instances of critical 
illness and trauma in humans (Birkhahn, 1983). Initially, glycerol monobutyrate was used 
due to its structural similarity to bHB with no toxic effects being observed in rats during 
infusion (Birkhahn et al., 1977). Monoacetoacetin, a monoester of glycerol and AcAc was 
also a viable intravenous substrate for rats. Body weight gains were observed and nitrogen 
balance in growing mice was maintained with 71% of energy needs met with 
monoacetoacetin infused over 7 d compared to isocaloric carbohydrate infusion, with total 
KB concentrations elevated to 0.4-1.2 mM in various animal models (Birkhahn et al., 1979; 
Birkhahn, 1983). To further increase total KB concentrations and the amount of energy per 
osmol provided parenterally, triesters of glycerol and acetoacetate were developed but were 
not completely water-soluble and therefore unsuitable for intravenous infusion (Brunengraber, 
1997). The solution to this was to use bHB, improving the water-solubility of the compounds. 
Glycerol bHB mono- and triesters maintained nitrogen balance and body weight similar to 
that of isocaloric carbohydrate infusion when providing 50% of energy needs in rats over 7 d 
(Birkhahn et al., 1997). As well as glycerol, 1,3-butanediol (BD) can be bound via an 
esterification reaction to bHB or AcAc. BD is converted to D-bHB in the liver via of alcohol 
and aldehyde dehydrogenase (Kies et al., 1973), elevating circulating bHB concentrations 
and having metabolic effects such as protein sparing in burned rats (Maiz et al., 1985). 
These data on the metabolic action of ketone esters remained largely isolated until the 
last 5 years, but KB infusion studies in humans from the late 1960s to 1980s contribute 
significantly to knowledge on the role of KB during exercise (Hagenfeldt & Wahren, 1968; 
Hagenfeldt & Wahren, 1971; Fery et al., 1974; Sherwin et al., 1975; Balasse et al., 1978; 
Fery & Balasse, 1983; Fery & Balasse, 1986; Fery & Balasse, 1988). KB disposal into 
skeletal muscle is elevated as much as fivefold during exercise; reflected by a decrease in 
circulating KB concentrations at the onset of exercise. bHB is the primary KB extracted from 
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circulation and a net production of AcAc is observed. This drop in bHB is accompanied by 
an increase in the metabolic clearance rate (MCR) and oxidation of KB in skeletal muscle 
(Fery & Balasse, 1986). MCR is a measure of the ability of tissues to remove ketones form 
the blood, analogous to arteriovenous difference per unit time, but when measured during 
exercise is taken to represent an index of the ability of exercise to stimulate the capacity of 
working muscle to extract and utilise ketones (Fery & Balasse, 1983; Balasse & Fery, 1989). 
Taken together, the earlier work on KB and their potential role in parenteral nutrition 
informed the development and safety of ketone esters, whereas the infusion work in humans 
undertaking exercise informed the role that KB may play as an alternative fuel source for 
skeletal muscle (Chapter 2).  
 
Methods of exogenous ketone supplementation producing acute nutritional ketosis 
 Investigating effects of ketosis on skeletal muscle metabolism has been typically 
achieved by endogenous ketosis using fasting of various durations (Balasse & Fery, 1989), or 
by exogenous ketosis produced by either ketone salt ingestion (Johnson & Walton, 1972), or 
infusion of AcAc or βHB (Fery & Balasse, 1988; Mikkelsen et al., 2015). Endogenous 
ketosis may also be achieved by carbohydrate (CHO) restriction, particularly by ketogenic 
diets (Paoli et al., 2013). The practical relevance for athletes seeking performance gains of 
metabolic responses generated from prolonged fasting is negligible, whereas benefits of 
ketogenic dieting for performance with a high intensity component are equivocal (Burke, 
2015). This has led to the exploration of exogenous ketone ingestion as a means to achieve 
acute nutritional ketosis. Importantly, because endogenous ketosis results in concomitant 
elevations in free fatty acids (FFA) and alterations in glucose, insulin and counter-regulatory 
hormones, isolating the metabolic effects specific to KB has proved challenging. Therefore, 
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exogenous ketone supplementation is a means to address these questions and explore 
potential for performance and therapeutic benefits. 
Oral administration of KB in their free acid form is expensive and ineffective at 
producing ketosis, so buffering the free acid form with sodium/potassium/calcium salts has 
been explored and are commercially available. These too are relatively ineffective at 
increasing βHB concentrations, but may be improved by co-ingestion with medium chain 
triglycerides (C:8, C:10), at least in rats (Kesl et al., 2016). However, ingestion of large 
quantities of ketone salts (KS) is impractical due to resulting gastrointestinal distress, and 
potentially undesirable consequences of cation overload or acidosis (Veech, 2004). 
The development of ketone esters provides an alternative method to increase βHB 
concentrations, and are well-tolerated in rodents and humans (Clarke et al., 2012; Cox et al., 
2016; Kesl et al., 2016). Two prominent ketone esters in the published literature are the R,S-
1,3-butanediol acetoacetate diester (KDE) (Kesl et al., 2016; Leckey et al., 2017), originally 
developed by Dr. Henri Brunengraber (Case Western Reserve University) as a metabolic 
therapy for parenteral and enteral nutrition (Desrochers et al., 1995), and the (R)-3-
hydroxybutyl (R)-3-hydroxybutyrate ketone monoester (KME) (Clarke et al., 2012; Cox et al., 
2016), originally developed by Dr. Richard Veech (National Institutes for Health) and Dr. 
Kieran Clarke (University of Oxford) to improve the physical and cognitive performance in 
warfighters (Ford and Glymour, 2014). 
Acute ingestion of either ester can result in short-term (~0.5 to 6 h) nutritional ketosis 
indicated by βHB concentrations >0.5 mM (Clarke et al., 2012; Leckey et al., 2017). For 
KME, ingestion at a dose 573 mg.kg-1 body mass (BM) resulted in βHB concentrations of 
~3.0 mM after 10 minutes and rising to ~6.0 mM 30 min after ingestion (Cox et al., 2016). 
Ingestion of two 250 mg.kg-1 body mass KDE at 50 and 30 min prior to a 31.2 km cycling 
time trial, respectively, elevates serum βHB concentrations to ~0.4 mM. Whole blood βHB 
	 7	
concentrations reached ~0.6 mM during the time trial and peaked at ~1.4 mM during a 1 h 
recovery period (Leckey et al., 2017). Acute nutritional ketosis is therefore achieved without 
the impracticality of prolonged fasting or ketogenic dieting. 
 
Endogenous versus exogenous ketosis for athletic performance  
 The link between increasing muscle glycogen stores and enhanced exercise capacity 
is well-established, accomplished by increasing intake of dietary carbohydrates in the days 
prior to exercise or through exogenous carbohydrate feeding during exercise (Bergström et al., 
1967; Coyle et al., 1986; Jeukendrup, 2004). Accordingly, sports nutrition guidelines 
recommend high carbohydrate intakes in preparation for and during competition to maximise 
muscle glycogen stores and improve performance (Burke et al., 2004). Despite this, low 
carbohydrate, high fat ketogenic diets are recommended in some quarters as a means to take 
advantage of the body’s large fat reserves, namely adipose tissue and intramuscular 
triglycerides (IMTG), as a source of fuel during exercise (Volek et al., 2015). A period of 
“keto-adaptation” is often cited as necessary gain full benefit of a high fat diet (LCHF) for 
athletic performance. LCHF (<50g carbohydrate.day-1) is associated with a preservation of 
submaximal exercise capacity (~60% V̇O2peak), a reduction in RER reflecting an increasing in 
fat utilisation during exercise and an elevation of circulating bHB to ~0.5-2.5 mM, depending 
on the length of the LCHF (Phinney et al., 1980; Phinney et al., 1983; Volek et al., 2016; 
McSwiney et al., 2018). Furthermore, muscle glycogen stores are maintained during 20 
months of LCHF (~70% fat) despite elevated bHB concentrations, possibly explaining the 
preservation of exercise capacity and the ability to synthesise muscle glycogen from 
gluconeogenic substrates (Volek et al., 2016). These dietary approaches can be considered as 
“endogenous ketosis”, but are proposed to impair high intensity exercise performance 
through an attenuation of pyruvate dehydrogenase activity (PDH), a key glycolytic enzyme 
	 8	
(Burke, 2015). This performance impairment was demonstrated as a reduction in 1 km sprint 
power output following 6 d adaptation to a LCHF (~68% fat), while 100 km time trial 
performance was maintained (Stellingwerff et al., 2006; Havemann et al., 2006). Of note is 
the brief (<1 wk) adaptation period to the LCHF, which proponents of the diet say is too short 
to fully adapt to endogenous ketosis as an alternative fuelling strategy (Volek et al., 2015). 
However, while 3 wk adaptation to a LCHF improves maximal aerobic capacity (V̇O2peak) in 
a group of Australian elite race walkers, it conversely impairs gains in performance in 
response to a 3 wk intense training camp in elite race walkers (Burke et al., 2017). 
“Exogenous ketosis”, also known as the aforementioned acute nutritional ketosis, can 
be produced through ingestion of a ketone ester or ketone salt (Clarke et al., 2012; Cox et al., 
2016; Stubbs et al., 2017) but does not require a LCHF to elevate bHB concentrations, and 
results in a similar increase in bHB concentrations to endogenous ketosis. Elevations in bHB 
concentrations are achieved with concomitant exogenous ketone supplement and 
carbohydrate intake, regardless of prior feeding status (Stubbs et al., 2017; Myette-Côté et al., 
2018). Exogenous ketone ingestion aims to circumvent the impairment of high intensity 
exercise performance in athletes by elevating bHB concentrations without the impractical but 
necessary low carbohydrate intake implemented during endogenous ketosis. However, 
similarly to endogenous ketosis, rats supplemented for 5 d with exogenous ketones exhibit a 
reduction in cardiac PDH activity versus rats fed a high carbohydrate diet (Murray et al., 
2016), but this inhibition remains to be directly confirmed either in human skeletal muscle, or 
in response to a single bolus ingestion. Nevertheless, given the effects of acute ingestion of 
KME to reduce glycolytic flux during exercise (Cox et al., 2016), it is likely that some of 
these effects are being mediated via inhibition of PDH. 
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Ketogenic supplements 
 Ketones esters and KS are exogenous ketone supplements orally ingested with the 
aim of elevating circulating bHB concentrations. bHB has two enantiomers, designated D- 
and L-, or R- and S-, respectively. Currently-available commercial bHB assays and handheld 
point-of-care monitors determine the concentration of the D- enantiomer. D-bHB is the 
circulating and primary form of bHB (Tsai et al., 2006), and L-bHB is not a substrate for 
mitochondrial 3-hydroxybutyrate dehydrogenase, a key enzyme in the ketolytic pathway, and 
thus is not metabolised to AcAc (Scofield et al., 1982). The constituent parts of ketone esters 
and KS are different and this alters the metabolic response to the respective ketogenic 
supplements after acute ingestion. Ketone esters, namely KME and KDE, are D-bHB and 
AcAc molecules respectively, attached via an ester bond either to another ketone body or a 
ketone body precursor such as BD. KS are a racemic mixture of D/L-bHB or non-racemic D-
bHB molecules attached to a sodium/calcium/potassium mineral salt (Figure 1.1). All 
investigations in to the efficacy of elevating bHB concentrations using KS have used 
commercially-available supplements containing a racemic mixture of bHB, typically 
containing 50% of the D- and L-enantiomers (Stubbs et al., 2017; O'Malley et al., 2017; 
Rodger et al., 2017; Fischer et al., 2018; Waldman et al., 2018).  KME has a chiralic purity of 
99%, meaning it exclusively contains the D-bHB isomer, whereas commercially-available 
KS have a purity of 50%, making them less effective at elevating the metabolically-active D-
bHB enantiomer (Stubbs et al., 2017). One serving of KME (DeltaG, HVMN Ketone, 
HVMN, United States) provides 25g D-bHB, whereas one serving of KS (KetoCana, 
KetoSports, United States) provides 11.7 g bHB comprising of 50% each of the D- and L-
bHB enantiomers. 
In addition to the ingestion of KB-containing formulations, medium chain 
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triglycerides are ketogenic agents and may be coingested with KS to augment the bHB 
response to KS ingestion (Kesl et al., 2016). Briefly, medium chain triglycerides are fatty 
acids 6 to 12 carbons in length and are transported to the liver directly via the portal vein and 
oxidised rapidly (Bach & Babayan, 1982). Acute ingestion of 25 g medium chain triglyceride 
prior to exercise elevates bHB to ~0.5 mM, lowering blood glucose concentrations but has no 
effect on glycogen utilisation during 60 min cycling at 60% V̇O2peak (Decombaz et al., 1983). 
Simultaneous carbohydrate and medium chain triglyceride ingestion increases the rate of 
medium chain triglyceride oxidation compared to medium chain triglyceride ingestion alone 
(Jeukendrup et al., 1995), with the latter impairing performance in a cycling time trial due to 
a high incidence of gastrointestinal distress (Jeukendrup et al., 1998). However, this 
impairment in performance was not observed with concomitant carbohydrate and medium 
chain triglyceride ingestion (Jeukendrup et al., 1998).  
The original article on the effect of a (R)-3-hydroxybutyl (R)-3-hydroxybutyrate 
ketone monoester (KME) on cycling time trial performance remains the only report of a 
performance benefit of an exogenous ketone supplement (Cox et al., 2016). Ingestion of 573 
mg.kg-1 body mass of KME improved 30 min maximal distance time trial performance by 
~2%, whereas 31.2 km cycling time trial performance was impaired by ~2% with ingestion of 
the R,S-1,3-butanediol acetoacetate diester (Leckey et al., 2017). Racemic ketone salts have 
no performance benefit for short duration, high intensity efforts (O’Malley et al., 2017; 
Rodger et al., 2017; Waldman et al., 2018). At the time of commencing our experimental 
work, the Cell Metabolism report (Cox et al., 2016) was the only published work in the area 
and informed the dosing and timing strategies employed in studies 1, 2 and 3 of this thesis.  
 Given the increasing interest but relative lack of scientific research on exogenous 
ketone supplements, there is a need to investigate whether ketogenic supplements alter the 
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metabolic response to various exercise challenges and improve athletic performance. With 
these gaps in knowledge in mind, three human intervention studies were undertaken to 
investigate whether administration of bHB in the form of KS or ketone esters altered the 
metabolic response to exercise and/or improved physical and cognitive performance in 
response to various exercise challenges in trained athletes.  
	
	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. 1 Chemical structures of ketogenic supplements	
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A,	racemic	ketone	salts.	B,	the (R)-3-hydroxybutyl (R)-3-hydroxybutyrate ketone monoester. 
C, R,S-1,3-butanediol acetoacetate diester. 	
	
Aims of the Thesis 
	
• During pilot testing, discover the optimal dose and timing of racemic ketone ingestion 
to maximise peak βHB concentrations after acute ingestion of racemic ketone salts. 
• Use this dose and timing information to investigate the effect of racemic ketone salts 
on the metabolic response to a graded exercise session in trained cyclists. 
Specifically, are the βHB concentrations achieved similar to those of the (R)-3-
hydroxybutyl (R)-3-hydroxybutyrate ketone monoester and will they cause the 
characteristic reduction in plasma glucose and attenuate the exercise induced rise in 
plasma lactate concentrations.  
• Investigate whether carbohydrate plus the (R)-3-hydroxybutyl (R)-3-hydroxybutyrate 
ketone monoester has an ergogenic effect on short duration, high intensity exercise 
performance during a 75 min soccer simulation protocol and a subsequent intermittent 
run to volitional exhaustion in team sport athletes compared to carbohydrate ingestion 
alone. It is of interest to whether the metabolic effects of (R)-3-hydroxybutyl (R)-3-
hydroxybutyrate ketone monoester ingestion, namely a reduction in plasma glucose 
and an attenuation in the exercise-induced rise in plasma lactate, are observed in this 
intermittent sporting context. 
• Investigate whether ingestion of carbohydrate plus the (R)-3-hydroxybutyl (R)-3-
hydroxybutyrate ketone monoester has an ergogenic effect on 10 km self-paced, 
treadmill based time trial performance following a 1 h pre load at 65% V̇O2peak 
compared to carbohydrate alone.  
• Investigate whether ingestion of carbohydrate plus the (R)-3-hydroxybutyl (R)-3-
hydroxybutyrate ketone monoester improves cognitive performance in intermittent 
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and endurance contexts compared to carbohydrate ingestion alone. Reaction time, 
decision-making and sustained attention will be measured. 
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Chapter 2 
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Sections from this literature review are included in the published Journal of Physiology 
article (Appendix A): Evans M, Cogan KE, Egan B (2017) Metabolism of ketone bodies 
during exercise and training: physiological basis for exogenous supplementation. Journal of 
Physiology 595(9):2857–71. 
 
 
 
Figure 2.1 Overview of ketogenesis, ketolysis and the metabolic and ergogenic potential 
of exogenous ketones. 
Endogenous ketogenesis and exogenous ketone ingestion result in an increase in circulating βHB. βHB enters 
the muscle where it alters the metabolic response to exercise and may result in improved recovery and 
adaptation from exercise training or improved physical performance. 
 
Introduction 
Over the past century, exercise physiologists have appreciated the role of 
carbohydrate and fat in energy provision to exercising skeletal muscle. Much of the work 
examining the metabolic response during exercise and the impact of exercise on metabolic 
regulation and adaptive responses to training has focussed on the relative contribution of 
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these fuels (Egan & Zierath, 2013). Optimising training and nutrition strategies by 
manipulating the relative intakes of these macronutrients is central to supporting elite sports 
performance (Cermak & van Loon, 2013; Bartlett et al., 2015; Burke, 2015). An alternative 
fuel source to CHO and fat are ketone bodies (KB), namely acetoacetate (AcAc), acetone, 
and β-hydroxybutyrate (βHB), which are produced in the liver during physiological states and 
nutritional manipulations that result in reduced CHO availability, most commonly during 
prolonged fasting, starvation, and ketogenic [very low CHO (~5%), low protein (~15%), high 
fat (~80%)] diets (Robinson & Williamson, 1980; Laffel, 1999). This relative glucose 
deprivation and concomitant elevation in circulating free-fatty acids results in the production 
of KB to replace glucose as the primary fuel for peripheral tissues such as the brain, heart and 
skeletal muscle in these states.  
Aside from a role as an alternative fuel source, KB exert a range of metabolic effects 
including attenuating glucose utilisation in peripheral tissues, anti-lipolytic effects on adipose 
tissue, and potential attenuation of proteolysis in skeletal muscle (Figure 2.1) (Robinson & 
Williamson, 1980). KB are utilised by working muscle during exercise (Fery & Balasse, 
1986; Fery & Balasse, 1988), and the capacity to uptake and oxidise KB during exercise is 
higher in exercise-trained skeletal muscle (Winder et al., 1975). Despite these observations, 
in addition to a glucose sparing action (Maizels et al., 1977) and potential to lower the 
exercise-induced rise in plasma lactate concentrations (Fery & Balasse, 1988), the potential 
performance benefits of KB when provided as an exogenous fuel source had until recently 
received little attention, but had been postulated (Cox & Clarke, 2014; Pinckaers et al., 2016). 
Since then several articles have been published investigating the effect of various exogenous 
ketone supplements on the metabolic response to exercise and physical and cognitive 
performance (Cox et al. 2016; Leckey et al. 2017; O’Malley et al. 2017; Rodger et al. 2017; 
Holdsworth et al. 2017; Vandoorne et al. 2017; Waldman et al., 2018). Apart from a role as 
	 17	
an alternative fuel source, KB may act as signalling molecules to regulate gene expression 
and adaptive responses (Shimazu et al., 2013; Zou et al., 2016). Moreover, therapeutic roles 
for KB have long been proposed in a variety of disease states including aberrant glucose 
metabolism, genetic myopathies, hypoxic states and neurodegenerative pathologies (Veech, 
2004). For therapeutic effects, exogenous ketones are ingested in the form of βHB salts or 
ketone esters to produce acute (~0.5 to 6 h) nutritional ketosis (Clarke et al., 2012; Kesl et al., 
2016), but a surge in interest in KB as a performance aid for athletes arose when ketone ester 
supplementation was confirmed in professional cycling (Abraham, 2015; Pinckaers et al., 
2016).  
 
Exercise metabolism and biochemistry 
 
Overview 
 
Skeletal muscle has the capacity to alter the rate of energy production in response to 
movement, powered by actin-myosin crossbridge cycling contraction (Podolsky and 
Schoenberg, 1983). Exercise causes skeletal muscle to rapidly increase its rate of ATP 
hydrolysis, providing an immediate source of energy for muscular work by increasing ATP 
turnover more than 100-fold compared to resting values (Gaitanos et al., 1993). Metabolic 
pathways that drive ATP production are activated during exercise that help to maintain ATP 
stores, facilitating the continuation of muscular work. Skeletal muscle is the primary site of 
carbohydrate and lipid metabolism for energy production, illustrated by a greater than 30-fold 
demand increase in intramuscular oxygen consumption during strenuous exercise and an 
approximate 70- to 100- fold increase in tricarboxylic acid cycle flux under similar conditions 
(Anderson and Saltin, 1985; Gibala et al., 1998). The relative contribution of CHO and lipid 
to total energy provision during exercise is dependent on the modality, the frequency, 
intensity, and duration of individual exercise sessions (Egan and Zierath, 2013). 
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Substrate utilisation during exercise  
 
 The relative contribution of different metabolic pathways to energy provision is 
dependent on the relative intensity and power output of the exercise bout. Power output 
determines the ATP demand while intensity determines the relative contributions of CHO, 
lipid and other fuel sources. Isotope tracer methodology has provided us with a detailed view 
of the impact of these factors on substrate utilisation during exercise (Romijn et al., 1993; van 
Loon et al., 2001). At low to moderate intensities of exercise (<65% V̇O2peak), the primary 
source of fuel for skeletal muscle is glucose, derived from hepatic glycogenolysis, and free 
fatty acids, liberated from adipose tissue. These responses are dependent on various hormonal 
responses, including adrenaline, noradrenaline, insulin, and glucagon) (Kjaer, 2006). As 
exercise intensity increase (>65 V̇O2peak), the contribution of CHO increases while the use of 
FFA declines. This trend continues up to maximal intensities, where the vast majority of 
energy is being provided by muscle glycogen (Van Loon et al., 2001). Conversely to exercise 
intensity, as exercise duration increase (> 60 min) lipid oxidation increases (Romijn et al., 
1993) (Figure 2.2). Muscle glycogen, the predominant fuel during moderate to intense 
exercise, is converted to glucose in a process known as glycogenolysis. This process is under 
the control of the enzyme glycogen phosphorylase, regulated by allosteric modulation by 
AMP and IMP (Hargreaves, 2006). The end of product of glycogenolysis is glucose 
molecules that are converted to glucose-6-phosphate and subsequently pyruvate in the 
cytoplasm before crossing the mitochondrial membrane, converted to acetyl Co-A and 
incorporated in to the tricarboxylic acid cycle to produce ATP. As the duration of exercise 
increases, or the intensity of exercise decreases, the contribution of lipids to fuel provision 
increases. FFA, liberated from adipose tissue and intramuscular trigycerides are the two 
sources of lipids that muscle can oxidise during exercise. Lipids, in the form of triglycerides, 
are stored in adipose tissue and sequentially broken down to glycerol and three fatty acids by 
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the enzymes adipose triglyceride lipase, hormone sensitive lipase and monoacylglycerol 
lipase under the control of the hormone insulin and the catecholamines. Each fatty acid 
passes out of the adipocyte in to the blood and are transported across the plasma membrane of 
the muscle cell via fatty acid transports, including fatty acid binding protein, fatty acid 
transport protein and fatty acid translocase. Fatty acids are transported across the carnitine 
shuttle and undergo β-oxidation in the mitochondria in the mitochondria to produce acetyl 
CoA, which enters the tricarboxylic acid cycle to produce ATP and fuel muscular work 
(Figure 2.3).  
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Figure 2. 2	The effect of exercise intensity and exercise duration on substrate 
metabolism during acute exercise 
(A) Substrate contribution to exercise of increasing intensity. Up to 30%VO2max, oxidation of lipid sources 
(mostly plasma FFAs) accounts for themajority of energy provision. As exercise intensity increases, absolute 
CHOoxidation rate and relative contribution to energy provision increases. The lipidoxidation rate increases up 
to60%–70% VO2max, after which it declines asintensity increases. In relative terms, the contribution of lipid 
oxidation toenergy provision decreases proportionally with increasing exercise intensity,as reflected by a steady 
rise in RER.(B) Substrate contribution to exercise at a fixed intensity (e.g., 65%VO2max) foran extended 
duration. An initial rise in RER occurs at the onset of exercise,reflecting the increase in relative contribution of 
CHO to energy provisioncompared to resting metabolism. Thereafter, a small but steady decline in RERis 
observed with extended duration of exercise, reflecting the declining relativecontribution of CHO to energy 
provision as a function of the increasing relativecontribution of lipid. 
 
 
Figure 2. 3 Energy provision in skeletal muscle during exercise 
ATP hydrolysis, catalyzed by myosin ATPase, powers skeletal muscle contraction. Metabolic pathways of ATP 
generation in skeletal muscle include (1) the ATP-phosphagen system wherein the degradation of PCr by 
creatine kinase (CK) produces free Cr and Pi, which is transferred to ADP to re-form ATP; the adenylatekinase 
(AK) (myokinase) reaction catalyzes the formation of ATP and AMP from two ADP molecules; (2) anaerobic 
glycolysis, where glucose-6-phosphate derivedfrom muscle glycogen (GLY) (catalyzed by glycogen 
phosphorylase, PHOS) or circulating blood glucose (GLU) (catalyzed by hexokinase, HK), is catabolized 
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topyruvate (PYR), which is reduced to lactate (LAC) by lactate dehydrogenase (LDH), and produces ATP by 
substrate level phosphorylation; (3) processesofcarbohydrate (glycolysis) and lipid (b-oxidation) metabolism 
producing acetyl-CoA (Ac-CoA), which enters the tricarboxylic acid (TCA) cycle in the mitochondria,coupled 
to oxidative phosphorylation in the electron transport chain (ETC). The two main metabolic pathways, i.e., 
glycolysis and oxidative phosphorylation, arelinked by the enzyme complex pyruvate dehydrogenase (PDH). 
GLUT4 facilitates glucose uptake to the sarcoplasm, which may undergo glycolysis or during rest/inactivity, be 
stored as glycogen via glycogen synthase (GS). Fatty acyl translocase (FAT/CD36) facilitates long-chain fatty 
acid transport at the sarcolemma, and,in concert with fatty acid binding protein (FABPpm) and carnitine 
palmitoyltransferase 1 (CPT1), across the mitochondrial membrane. FFAs entering the cell maybe oxidized 
viab-oxidation or be diverted for storage as IMTG via esterification by monoacylglycerol acyltransferase 
(MGAT) and diacylglycerol acyltransferase(DGAT). Liberation of FFAs from IMTG stores via lipolysis in 
skeletal muscle during exercise occurs via the activities of HSL and ATGL. All pathways of ATPgeneration are 
active during exercise, but the relative contribution of each is determined by the intensity and duration of 
contraction, as a function of the relativepower (rate of ATP production) and capacity (potential amount of ATP 
produced). CS, citrate synthase; Cyt c, cytochromec; PFK, phosphofructokinase 
 
 
Overview of ketone body metabolism 
Ketone bodies in circulation  
Plasma KB concentrations reflects the balance between hepatic production 
(“ketogenesis”) and peripheral breakdown and utilisation (“ketolysis”) in extra-hepatic 
tissues, both of which are under various levels of control as detailed in previous reviews 
(Robinson & Williamson, 1980; Laffel, 1999). Ketogenesis is an evolutionarily-conserved 
adaptive response playing a critical role in survival during an energy crisis by providing a 
substrate for the brain, which cannot utilise FFA as a fuel source. AcAc, acetone, and βHB 
comprise the KB, although βHB is not technically a ketone because the ketone moiety has 
been reduced to a hydroxyl group. AcAc and βHB are short-chain, four carbon organic acids 
that act as FFA-derived circulating substrates to provide energy to extra-hepatic tissues, 
whereas the contribution of acetone, readily generated by the spontaneous decarboxylation of 
AcAc, to energy provision is negligible. Plasma KB concentrations are <0.1 mM in the 
postprandial state, whereas hyperketonemia is accepted as KB concentrations exceeding 0.2 
mM (Robinson & Williamson, 1980). Various states of CHO restriction, depletion and 
dysregulation produce hyperketonemia to different degrees (Figure 2.4). 
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Figure 2.4 Changes in bHB concentrations under various physiological states.  
Plasma [KB] is <0.1 mM in the postprandial state when consuming high CHO or high protein meals, and rises 
upward after an overnight fast, and with ketogenic dieting, prolonged fasting, starvation, and pathological states 
of ketoacidosis. 
 
Ketogenesis 
	
The primary substrate for ketogenesis are FFA liberated from adipose tissue. 
Ketogenic amino acids, namely leucine, lysine, phenylalanine, isoleucine, tryptophan, and 
tyrosine also serve ketogenesis, but are likely to contribute to less than 5% of circulating KB 
(Thomas et al., 1982). The rise in FFA is consequent to the stimulation of lipolysis as a result 
of declines in plasma glucose and insulin that are characteristic of reduced CHO availability. 
Factors stimulating ketogenesis include an elevated glucagon-to-insulin ratio and decline in 
hepatic glycogen concentration, while reduced blood flow to the liver or elevations in [KB] 
suppress ketogenesis (Robinson & Williamson, 1980; Laffel, 1999). Ketogenesis involves a 
series of sequential reactions beginning with acetyl CoA (Ac-CoA) and acetoacetyl CoA 
(AcAc-CoA), and ending with the liberation of AcAc (Figure 2.5). Some AcAc is exported, 
but the majority is reduced to βHB in an NAD+/NADH-coupled near equilibrium reaction 
catalysed by 3-hydroxybutyrate dehydrogenase (BDH), in which the equilibrium constant 
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favours βHB formation. These KB are transported into the circulation via the solute ligand 
carrier (SLC) protein 16A (SLC16A) family of monocarboxylate transporters (MCTs) in 
mitochondrial and sarcolemmal membranes. 
 
Ketolysis in extra-hepatic tissues 
	
In peripheral tissues, KB, primarily in the form of βHB, enter the mitochondrial 
matrix again via MCT1-mediated transport. βHB is re-oxidised to AcAc via BDH after which 
sequential reactions result in the generation of two molecules of Ac-CoA (Figure 2.5). These 
are incorporated into the TCA cycle via citrate synthase for terminal oxidation and 
production of ATP, which in skeletal muscle contributes to fuelling muscular work (Fery & 
Balasse, 1986, 1988). Succinyl-CoA:3-oxoacid CoA transferase (OXCT) is essential for 
ketolysis in extra-hepatic tissues, with very low abundance in hepatocytes explaining the lack 
of ketolytic activity in these cells (Robinson & Williamson, 1980).  
Activity of OXCT is highest in heart and kidney, followed by skeletal muscle and the 
brain (Robinson & Williamson, 1980), but because skeletal muscle accounts for ~40% of 
body mass in adult humans, this organ accounts for the highest fraction of total KB 
metabolism at rest (Balasse & Fery, 1989; Laffel, 1999). Beginning almost 50 years ago, 
models using various durations of fasting, and combined with primed constant infusion of 
radiolabelled either AcAc or βHB tracers and arteriovenous difference measures to quantify 
KB turnover, established that skeletal muscle is a major site of ketolysis at rest (Hagenfeldt & 
Wahren, 1968; Owen & Reichard, 1971; Wahren et al., 1984; Elia et al., 1990; Mikkelsen et 
al., 2015). Skeletal muscle has a high affinity to KB, but because of low circulating 
concentrations under normal conditions, the contribution to energy provision in muscle is less 
than 5%, and FFA are the main source of energy provision in the post-absorptive state. The 
relationship between ketone oxidation and KB concentrations is curvilinear such that 
	 24	
contribution to energy provision in skeletal muscle rises to ~10% after an overnight fast 
(Hagenfeldt & Wahren, 1968; Owen & Reichard, 1971), 20% to 50% after 72 h of fasting 
(Owen & Reichard, 1971; Elia et al., 1990), but declines to ~15% after 24 days of starvation 
(Owen & Reichard, 1971). Thus, skeletal muscle demonstrates saturation kinetics for the KB 
concentration-oxidation relationship, with saturation likely between 1 and 2 mM as 
demonstrated by fasting of various durations (compiled in (Balasse & Fery, 1989)) or step-
wise βHB infusion (Mikkelsen et al., 2015).  
 
Measurement of bHB 
 The majority of studies on acute exogenous ketone ingestion use handheld point-of-
care meters with appropriate reagent strips to measure whole blood bHB concentrations 
(Precision Neo handheld monitor, Freestyle Optium handheld monitor, Precision Xtra 
handheld monitor Abbott Laboratories, Witney, UK; Glucomen Lx plus-meter, Menarini 
Diagnostics, Firenze, Italy) (O'Malley et al., 2017; Rodger et al., 2017; Stubbs et al., 2017; 
Myette-Côté et al., 2018; Stubbs et al., 2018; Waldman et al., 2018; Leckey et al., 2017). 
Ketone body reagent strips use a bHB dehydrogenase enzyme-based amperometric strip to 
establish whole blood bHB (Ceriotti et al., 2014). The use of handheld monitors is preferable 
to urinary ketone measurement due to the inability of nitroprusside, present in the urinary 
sticks, to react with bHB, the predominant ketone body in circulation (Guimont et al., 2015). 
Other studies have used laboratory methods, including reagent/colorimetric kits for 
measurement of plasma bHB (Randox, Daytona; Sigma Aldrich; ABX Pentra, France) (Cox 
et al., 2016; Leckey et al., 2017; Vandoorne et al., 2017). The Optium Freestyle handheld 
monitor (Abbott Laboratories, Berkshire, UK) overestimates bHB concentrations but falls 
within the coefficient of variation (10%) with a laboratory method (Guimont et al., 2015), but 
this overestimation increases with higher bHB concentrations (>5.0mM) (Ceriotti et al., 
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2014). Confounding factors for bHB measurement with handheld monitors include high 
haematocrit and ascorbic acid concentrations, both of which cause overestimation of bHB 
with the Freestyle Optium monitors (Ceriotti et al., 2014; Dhatariya, 2016). Furthermore, 
bHB concentrations were overestimated by ~0.4-0.5 mM during exercise using a handheld 
monitors compared to direct assay-based laboratory methods (Leckey et al., 2017). These 
reports suggest elevations in bHB concentrations via exogenous ketone ingestion must be 
critically evaluated based on the measurement method and any confounding factors that could 
affect such methods.  
 
 
Figure 2.5 Metabolic pathways of ketone body metabolism in liver and skeletal muscle 
During ketogenesis, FFA are converted to fatty acyl CoA, enter hepatic mitochondria via MCT transport and 
undergo b-oxidation to acetyl CoA. Sequential reactions lead to the reduction of the central ketone body, AcAc, 
to bHB. In the muscle bHB is reoxidised to AcAc. Two molecules of acetyl-CoA are formed during the process 
of ketolysis 
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Effect of aerobic exercise training on enzymes of ketogenesis and ketolysis 
Adaptations to exercise training reduce perturbations to homeostasis during 
subsequent bouts of exercise, and thereby enhance resistance to fatigue. Central to these 
effects are enhanced respiratory capacity and contractile parameters, and importantly 
adaptations that contribute towards maximising delivery and utilisation of circulating 
substrates (Egan & Zierath, 2013). Therefore, if KB make a meaningful contribution to 
energy provision during exercise, it is pertinent to explore analogous regulation in skeletal 
muscle. Training-induced changes in expression and activities of enzymes of ketolysis in 
skeletal muscle have not been described in humans, but differences in KB metabolism during 
and after exercise between trained and untrained individuals have been reported (Johnson et 
al., 1969; Johnson & Walton, 1972; Rennie et al., 1974; Rennie & Johnson, 1974). The 
general pattern is for attenuation in trained individuals of the post-exercise rise in KB 
concentrations, but this is influenced by nutritional manipulation and relative exercise 
intensity, the latter of which has often been poorly controlled (see later sections). 
Nevertheless, circulating concentrations reflect the balance between ketogenesis and 
ketolysis, these differences may be explained by the factors influencing one or both. For 
ketogenesis, data are limited but suggest that in exercise-trained rodents enzymatic activity of 
BDH or ACAT (Winder et al., 1974), or HMGCS (Askew et al., 1975) is unaltered in liver, 
and, in fact, the overall activity of the ketogenic pathway may be lower (El Midaoui et al., 
2006) compared to untrained rodents. In these rodent models of intense aerobic exercise 
training, the activities of the ketolytic enzymes BDH, OXCT and ACAT are higher in trained 
skeletal muscle (Winder et al., 1974; Askew et al., 1975; Winder et al., 1975; Beattie & 
Winder, 1984). This coincides with two- to three-fold higher ex vivo rates of βHB and AcAc 
oxidation in gastrocnemius muscle homogenates presented with concentrations of both βHB 
and AcAc at 0.1 and 0.5 mM (Winder et al., 1973; Winder et al., 1975).  
	 27	
In terms of muscle fibre type, enzymatic activities of BDH, OXCT and ACAT are all 
highest in type I fibres, intermediate in type IIA fibres, and lowest in type IIB fibres of rats 
(Winder et al., 1974). BDH is essentially undetectable in type IIB muscle fibres, and across 
the fibre types BDH activity is much lower than activities of OXCT and ACAT (Winder et al., 
1974). Although OXCT is essential for ketolysis, BDH activity is, therefore, potentially rate-
limiting in skeletal muscle. When rats performed 12 weeks of treadmill running, compared to 
sedentary rats BDH activity was almost three-fold higher in type I fibres, but six-fold higher 
in type IIA fibres of trained skeletal muscle, resulting in concentrations comparable to the 
type I fibres (Winder et al., 1974). OXCT activity was 26% higher in type I, and 
approximately two-fold higher in type IIA and IIB fibres, whereas ACAT activity was 40% 
to 45% higher in all three fibre types in trained skeletal muscle (Winder et al., 1974). 
Similarly, in skeletal muscle from mice with 8 weeks of access to running wheels, the 
difference compared to sedentary mice was greater for BDH mRNA expression (~two-fold 
higher than sedentary) compared to differences in OXCT and ACAT mRNA expression (~30% 
to 50% higher) (Svensson et al., 2016). These changes in ketolytic enzymes are localised to 
the working muscle given the absence of change after training in the heart (Askew et al., 
1975), kidney and brain (Winder et al., 1974). 
In terms of KB transport into skeletal muscle, similarly to the ketolytic enzymes, 
MCT1 protein expression is highest in type I fibres, lowly expressed in type II fibres, and 
correlates well with muscle oxidative capacity (Bonen, 2001). Elevated MCT1 protein 
expression after exercise training is well-established for human skeletal muscle, and increases 
occur in an intensity-dependent manner (Thomas et al., 2012). Using a rodent perfused 
hindlimb model, the capacity for uptake of KB in skeletal muscle at 1 mM each of βHB and 
AcAc was higher in an aerobically-trained group of rats, with uptake of total KB, AcAc and 
βHB 33%, 27% and 53% higher, respectively, compared to untrained rats (Ohmori et al., 
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1990). Similarly, βHB clearance during a βHB tolerance test is higher in mice given 8 weeks 
of running wheel access, or with enhanced oxidative capacity consequent to skeletal muscle 
overexpression of PGC-1α, a transcriptional co-activator and master regulator of 
mitochondrial biogenesis in adaptive responses such as exercise training (Svensson et al., 
2016). In both conditions, this coincides with elevated expression of MCT1 and the ketolytic 
enzymes in skeletal muscle. Therefore, the uptake and utilisation of KB in skeletal muscle is 
likely to be greatest in those individuals that are highly trained with a high proportion of type 
I muscle fibres and a high oxidative capacity in skeletal muscle. 
 
Ketone body metabolism during exercise 
The existing literature on fuel selection during exercise has focused almost 
exclusively on utilisation of CHO and fat, but skeletal muscle has the ability to resynthesize 
ATP from other substrates including protein, lactate, and KB (Fery & Balasse, 1986; Mazzeo 
et al., 1986; Fery & Balasse, 1988; Wagenmakers et al., 1991). With increasing exercise 
intensity, the contribution of substrates to energy provisions shifts from blood-borne FFA and 
glucose to increased reliance on intramuscular fuel stores, namely intramuscular triglyceride 
and muscle glycogen, such that at moderate to high intensities (>75%VOpeak) of exercise, 
muscle glycogen is the main source of energy provision (van Loon et al., 2001). This pattern 
is readily altered by nutritional manipulation such as CHO loading and acute CHO ingestion 
resulting in increased CHO utilisation (Bosch et al., 1996), glycogen depletion resulting in 
increased contribution of protein to energy provision (Wagenmakers et al., 1991), and 
habitual high fat consumption resulting in increased contribution of fat to energy provision 
(Volek et al., 2016). Clearly, skeletal muscle is a major site of ketolysis under fasting 
conditions, but central to the rationale for exogenous ketone supplementation must be that 
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ketolysis increases during exercise, makes a meaningful contribution to energy provision, and 
can alter patterns of substrate utilisation.  
 The pioneering work of Hagenfeldt, Wahren and colleagues (Hagenfeldt & Wahren, 
1968; Hagenfeldt & Wahren, 1971; Wahren et al., 1984) and Fery, Balasse and colleagues 
(Balasse et al., 1978; Fery & Balasse, 1983; Fery & Balasse, 1986; Fery & Balasse, 1988) 
established that KB disposal into human skeletal muscle is elevated as much as five-fold 
during exercise. This is generally reflected by a drop in KB concentrations soon after the 
onset of exercise, primarily βHB, concomitant with increases in KB oxidation in skeletal 
muscle and elevated metabolic clearance rate (MCR). MCR is a measure of the ability of 
tissues to remove ketones from the blood, analogous to arteriovenous difference per unit time, 
but measured during exercise is taken to represent an index of the ability of exercise to 
stimulate the capacity of working muscles to extract and utilise ketones (Fery & Balasse, 
1983; Balasse & Fery, 1989). Because the stoichiometry of KB oxidation yields respiratory 
quotients of 1.00 and 0.89 for AcAc and βHB, respectively (Frayn, 1983), calculation of 
oxidation rates for KB from whole-body gas exchange data has not been routinely performed 
using methods that determine the relative contribution of CHO and fat oxidation. However, a 
recent attempt has been made (Cox et al., 2016) based on methods and assumptions described 
for KB utilisation during ketogenesis (Frayn, 1983). Previous to this, oxidation rates for KB 
have historically been derived from arteriovenous differences of radiolabelled KB across 
working muscles with rates calculated as a fraction of O2 consumption or CO2 production 
(Hagenfeldt & Wahren, 1968; Balasse et al., 1978).  
Like CHO and fat utilisation, KB metabolism during exercise is influenced by a 
variety of factors including metabolic status (Wahren et al., 1984; Fery & Balasse, 1986), 
training status (Johnson & Walton, 1972; Rennie et al., 1974; Beattie & Winder, 1985), and 
the intensity of exercise (Cox et al., 2016). Given the aforementioned fibre type-specific 
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differences for activities of ketolytic enzymes, the muscle fibre type profile of the working 
muscle is also likely to be an important determinant of ketolysis during exercise. However, 
the most important determinant of KB metabolism during exercise is the degree of ketonemia, 
and the method by which this is achieved i.e. of endogenous or exogenous origin. 
 
Ketone body metabolism during exercise under conditions of endogenous ketosis 
Like KB metabolism in resting skeletal muscle, the relationship between 
concentration and oxidation or MCR is curvilinear (Balasse & Fery, 1989). At low ketonemia 
(<1.0 mM) such as that produced by an overnight fast, resting MCR is as much as four-fold 
greater than during prolonged fasting (Fery & Balasse, 1983). During prolonged exercise of 
low-to-moderate intensity after an overnight fast, MCR increases by 50% to 75% (Fery & 
Balasse, 1983; Fery & Balasse, 1986), which indicates that working muscle has an increased 
capacity to extract ketones from blood compared to rest. However, when ketonemia exceeds 
2.5 mM such as that achieved by greater than 72 h of fasting, the exercise-induced rise in 
MCR is abolished (Fery & Balasse, 1986). Therefore, when ketosis is achieved by prolonged 
(>72 h) fasting there is a negligible contribution of KB oxidation to energy provision 
(Hagenfeldt & Wahren, 1971; Fery & Balasse, 1986), but after an overnight fast, the 
contribution ranges from 2 to 10% (Balasse et al., 1978; Fery & Balasse, 1983; Wahren et al., 
1984). Under these conditions, the majority of energy provision in working muscle is from 
CHO and fat as classically described (van Loon et al., 2001). Moreover, unlike CHO and fat, 
there is progressive attenuation of the oxidation of KB with rising ketonemia, and thus the 
mobilisation of KB is not the factor limiting oxidation in skeletal muscle. This attenuation of 
exercise-stimulated MCR suggests either that above a threshold concentration the capacity 
for skeletal muscle to oxidise KB becomes saturated, and/or that hyperketonemia itself is a 
self-inhibitory factor (Balasse & Fery, 1989). Mechanistically, this is likely mediated either 
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through the inhibition of OXCT by elevated AcAc, and/or via FFA-mediated inhibition of 
ketolysis (Robinson & Williamson, 1980). This regulation is critical in the starvation 
response because the capacity of the liver to produce KB closely matches the requirements of 
the brain to utilise KB as an energy source (Robinson & Williamson, 1980). Therefore, 
excessive oxidation by working muscle would threaten survival, whereas it’s inhibition 
spares circulating substrate for the brain (Hagenfeldt & Wahren, 1971; Fery & Balasse, 1983). 
 
Ketone body metabolism during exercise under conditions of exogenous ketosis 
	
The aforementioned self-inhibitory effect of rising ketonemia underscores a key 
methodological issue when considering KB metabolism in skeletal muscle, namely the 
method of achieving ketosis. While fasting of various durations is a widely used model of 
ketosis, acute nutritional ketosis relevant to sports performance would be achieved with 
replete glycogen stores, and in the absence of prolonged elevations in FFA and KB 
concentrations that would likely impair KB oxidation rates through these mechanisms. To our 
knowledge, only two studies have addressed this convincingly by examining effects of 
exercise on KB metabolism without interference from the various hormonal and metabolic 
perturbations associated with prolonged fasting or diabetes (Fery & Balasse, 1988; Cox et al., 
2016). 
In the former study (Fery & Balasse, 1988), infusion of sodium AcAc after an 
overnight fast achieved KB concentrations of ~6 mM (βHB ~3.5 mM, AcAc ~2.5 mM) at the 
onset of 2 h of exercise at ~52%V̇O2peak. Notably, AcAc did not change during exercise 
whereas βHB declined throughout exercise to be reduced by ~2 mM at the end of exercise. 
This coincided with a progressive rise in MCR throughout exercise peaking at ~75% higher 
than rest at the end of exercise. In contrast, this effect was abolished with similar ketonemia 
in three to five day fasted participants. Importantly, although the inhibition of KB oxidation 
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by hyperketonemia is present during exogenous ketosis, an “auto-amplification” was noted 
that is not present in fasting ketosis i.e. the initial rise in MCR induced by exercise causes a 
reduction in concentration which, in turn, provokes a further rise in MCR and so on. 
Additionally, the threshold concentration at which hyperketonemia inhibits MCR was higher 
in exogenous ketosis than in fasting ketosis. However, in terms of contribution to energy 
provision, this ultimately only resulted in a 2% contribution over the 2 h exercise bout. 
Nevertheless, plasma lactate concentrations did not rise during exercise after AcAc infusion 
compared to a ~1 mM rise in the fasted participants, which suggests that despite a modest 
contribution to energy provision, exogenous ketosis can impact on metabolic processes 
during exercise.  
 
Metabolic effects of ingesting ketone salts and ketone esters at rest and during exercise 
Ketone salts at rest 
	 Ingestion of 1.6 and 3.2 mM.kg-1 body mass in the form of a sodium/potassium 
racemic KS elevates whole blood bHB concentrations to ~0.8 mM and 1.0 ± 0.1 mM, 
respectively with concentrations peaking between 60-90 min (Stubbs et al., 2017). Similarly, 
ingestion of 0.5 g.kg-1 body mass sodium/calcium KS, providing ~0.31 g.kg-1 body mass bHB 
elevates plasma bHB concentrations to 0.60 ± 0.30 mM after 2.5 h, after which 
concentrations returned to baseline over 3 h (Fischer et al., 2018). Elevations in bHB 
concentrations via KS ingestion coincide with decreases in plasma FFA, triglycerides and 
glucose, and an elevation in plasma insulin, which may be accounted for by the small amount 
of carbohydrate used to sweeten the KS (Stubbs et al., 2017). KS ingestion does not alter 
blood pH or plasma lactate, but reduces plasma potassium concentrations and increases 
sodium and chloride concentrations (Fischer et al., 2018). L-bHB concentrations are elevated 
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to ~2.0 mM with the ingestion of KS (Stubbs et al., 2017), suggesting racemic KS products 
are more effective at raising the L-enantiomer than the D-enantiomer of  bHB. 
	
Ketone salts during exercise 
	
	 Acute ingestion of one serving KS elevates whole blood bHB concentrations between 
0.5-0.8 mM (O'Malley et al., 2017; Rodger et al., 2017; Waldman et al., 2018). Given the 
lower dosage employed and the discrepancy in bHB measurement between handheld 
monitors and laboratory methods, it is a salient question whether these measurements in 
whole blood are accurate.  Serving sizes have ranged from 11.38 g bHB to 23.4 g D/L-bHB. 
This modest elevation in bHB concentrations is accompanied by an ~10% decrease in plasma 
glucose during sub maximal exercise (O'Malley et al., 2017), however, this decrease is not 
always observed (Rodger et al., 2017; Waldman et al., 2018). During submaximal exercise, 
plasma lactate is not affected by acute KS ingestion (Rodger et al., 2017; O'Malley et al., 
2017; Waldman et al., 2018). Ingestion of KS lowers RER during exercise (O'Malley et al., 
2017) given the respiratory quotient of AcAc is 1.00, similar to that of CHO it would be 
expected to rise when compared to a non-caloric placebo, so more work is needed as to 
whether training status or a larger dose may have a further effect on RER during exercise. 
Studies using the manufacturers recommended dose of KS do not report incidences of 
gastrointestinal distress. However, given the modest elevation in bHB concentrations during 
exercise with these dosages, increasing the dose is required to achieve bHB >1.0 mM, which 
may cause gastrointestinal distress, possibly due to acute hyperosmotic load.  
 Increases in heart rate (HR) have been observed with bHB infusions (Gormsen et al., 
2017; Svart et al., 2018) but this is not observed with KS ingestion (Waldman et al., 2018). It 
is likely the sodium load in KS is causing this elevation in HR as it is not observed with 
either acute KME or KDE supplementation. Acute sodium ingestion can elevate blood 
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pressure (Farquhar et al., 2005), and a similar sodium load delivered as sodium bicarbonate 
results in an elevation in HR of ~10 bpm during moderate intensity activity (Kahle et al., 
2013). 
 
Ketone esters at rest 
	
 In the fasted state, ingestion of 573 mg.kg-1 body mass KME elevates plasma bHB 
concentrations to 3.5 ± 0.3 mM at 10 min, reaching ~6.0 and ~6.5 mM after 40 and 70 min, 
respectively (Cox et al., 2016). Ingestion of 482 mg.kg-1 KME elevates blood bHB 
concentrations to ~3.2 mM after 30 min, thereafter concentrations decrease during a 2 h oral 
glucose tolerance test (Myette-Côté et al., 2018). Whole blood bHB concentrations peaked at 
2.8 ± 0.2 mM 60 min following the ingestion of 282 mg.kg-1 KME and at ~1.5 mM 20 min 
following ingestion of 141 mg.kg-1 (Stubbs et al., 2017). These results demonstrate a dose 
response in bHB concentrations following KME ingestion, with elevating concentrations 
following increasing dosages in the fasted state. Feeding status alters the bHB response to 
KME ingestion, as a prior breakfast (600 kcal; macronutrient ratio carbohydrate: protein: fat 
of 2:1:1) attenuates the elevation in whole blood bHB by ~1.0 mM (Fed: ~2.0 mM; Fasted 
~3.0 mM), reducing the bHB area under the curve by 27% following 395 mg.kg-1 body mass 
KME (Stubbs et al., 2017). Conversely, ingestion of 500 mg.kg-1 body mass KDE elevates 
serum bHB to ~0.4 mM 60 min after ingestion of the initial bolus (Leckey et al., 2017), a 
major difference between the two ketone esters. The AcAc response to KME and KDE 
ingestion are similar, with concentrations elevated to ~0.3 mM 60 min after KDE ingestion 
(Leckey et al., 2017) and ~0.7 mM after KME ingestion (Stubbs et al., 2017).  The elevation 
in bHB concentrations with KME coincides with decreases in plasma glucose, FFA and 
triglycerides (Cox et al., 2016; Stubbs et al., 2017; Myette-Côté et al., 2018). 
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A secondary mechanism for the glucose lowering effect of ketone esters has been 
proposed (Myette-Côté et al., 2018); ingestion of KME resulted in a 44% reduction in FFA 
AUC over the course of a 2 h oral glucose tolerance test, with the authors suggesting the anti-
lipolytic action of KB may be responsible for this increase insulin sensitivity. The 
insulinotropic effects of KB in humans are evident (Balasse et al., 1970; Miles et al., 1981) 
but is frequently not observed (Balasse & Ooms, 1968; Balasse & Neef, 1975; Balasse, 1979; 
Fery & Balasse, 1980; Beylot et al., 1986; Nair et al., 1988; Mikkelsen et al., 2015); it is 
suggested that the insulinotropic action of ketone bodies occur under conditions where the 
ketone body concentration is raised above 2.0 mM, and when this rise occurs abruptly 
(Balasse & Fery, 1989). Given the elevation in circulating bHB observed with KME 
ingestion, it may have an insulinotropic effect. In the context of ketone ester ingestion, 
insulinotropic is defined as an increase in circulating insulin concentrations with exogenous 
ketone supplement plus nutrient condition being greater than nutrient alone. In the fasted 
state, ingestion of KME causes a small elevation in insulin (Stubbs et al., 2017; Stubbs et al., 
2018), but is ~20% to 40% of the response to isocaloric carbohydrate ingestion. When KME 
is coingested with carbohydrate, there is no difference in circulating insulin concentrations 
compared to carbohydrate alone (Stubbs et al., 2017; Myette-Côté et al., 2018; Cox et al., 
2016).  
 Ingestion of 1.9 kcal.kg-1 body mass of KME (102-210 kcal; 21-43 g bHB) elevated 
whole blood bHB concentrations to 3.3 ± 0.2 mM after 1 h while attenuating the rise in 
circulating insulin and ghrelin compared to an isocaloric dextrose drink. This attenuation in 
plasma ghrelin resulted in a decrease in feelings of hunger, desire to eat and increased levels 
of fullness, suggesting KME may aid dietary strategies aimed at weight loss (Stubbs et al., 
2018) 
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Ketone esters during exercise 
	
 Many of the responses seen at rest with exogenous ketone ingestion are prevalent 
during exercise. In one of a series of experiments, ingestion of 573 mg.kg-1 body mass KME 
prior to 45 min cycling at 40% and 75% peak power output (Wmax) elevated bHB 
concentrations to ~4.0 mM and ~3.0 mM respectively and bHB contributed 18% and 16% 
towards total oxygen consumption. The exercise induced rise in plasma lactate was 
attenuated by ~50% during 1 h cycling at 75% Wmax compared to isocaloric carbohydrate 
ingestion (Cox et al., 2016).  
 The glucose lowering effect of ketone esters during exercise is well-demonstrated 
(Cox et al., 2016; Leckey et al., 2017; Vandoorne et al., 2017; Myette-Côté et al., 2018). This 
effect is caused by reduced hepatic gluconeogenesis (Mikkelsen et al., 2015) and occurs 
independently of differences in circulating insulin between conditions (Vandoorne et al., 
2017; Myette-Côté et al., 2018).  
 Ketone ester ingestion prior to exercise attenuates the exercise induced increase in 
plasma lactate (Cox et al., 2016; Leckey et al., 2017). One of the main proposed benefits of 
exogenous ketones is a ‘glycogen sparing’ mechanism that will confer an advantage during 
periods of competition that are high intensity in nature and carbohydrate dependent 
(Pinckaers et al., 2016). Carbohydrate utilisation is reduced during submaximal exercise with 
KME ingestion in the fasted state (Cox et al., 2016), and it remains to be seen whether this 
sparing of carbohydrate can be overcome later in exercise or whether it will impair 
performance if the exercise duration is sufficiently extended. When compared to the effect of 
KS ingestion on plasma lactate, bHB concentrations between ~1.0 to 2.0 mM may be 
required to elicit an attenuation in plasma lactate concentrations.  
 The exercise-induced rise in FFA and glycerol is blunted with KME ingestion during 
60 min cycling at 75%Wmax compared to isocaloric fat and carbohydrate ingestion. Plasma 
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insulin is elevated to ~7 mU.L-1 following KME ingestion but remains lower than isocaloric 
carbohydrate ingestion. KME increases the contribution of IMTG to total energy provision 
during exercise and results in a preservation of muscle glycogen (Cox et al., 2016).  
 
Ketone body metabolism after exercise: post-exercise ketosis 
Despite the aforementioned decline in KB concentrations at the onset of exercise, this 
pertains to situations where exercise has begun during hyperketonemia (Balasse et al., 1978; 
Fery & Balasse, 1983; Fery & Balasse, 1988; Cox et al., 2016). In the post-absorptive state, 
the pattern generally observed is for KB concentrations to rise gradually during prolonged 
exercise up to 0.2 to 0.4 mM, after which time post-exercise ketosis (PEK) of 0.3 to 2.0 mM 
is observed for several hours into recovery (Koeslag, 1982). Explained in terms of plasma 
kinetics, at cessation of exercise, the rate of appearance of KB increases coincident with a 
decrease in MCR relative to rates present during exercise. MCR remains above resting values 
for several hours after exercise, but ketogenesis exceeds ketolysis during this period. 
On a mechanistic level, regulation likely resides at several sites including malonyl 
CoA-mediated regulation of fat transport into hepatocytes via CPT-1 in addition to 
availability of Ac-CoA for ketogenesis, and oxaloacetate for the TCA cycle as classically 
described for ketogenic regulation. Because oxaloacetate is a product of pyruvate formed 
during glycolysis, reductions in glycolytic flux with low glycogen content after intense 
exercise result in oxaloacetate moving to cytoplasm for preferential use in gluconeogenesis, 
which allows diversion of Ac-CoA towards ketogenesis during the post-exercise period rather 
than citrate synthesis for the TCA cycle. Additionally, the actions of insulin and glucagon 
exert a strong influence through activation and inhibition, respectively, of Ac-CoA 
carboxylase (ACC), which catalyses the synthesis of malonyl CoA from Ac-CoA. When liver 
glycogen becomes depleted and glucagon:insulin ratio is elevated, the synthesis of malonyl 
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CoA is reduced, thereby relieving the inhibition of fat transport into hepatocytes, and 
resulting in elevated concentrations of Ac-CoA. These regulatory mechanisms are acutely 
sensitive to nutrient manipulations before and after exercise and to aerobic exercise training, 
given their respective influences on substrate availability and utilisation during exercise. 
Modulation of post-exercise ketosis by aerobic exercise training and nutrition 
intervention 
An attenuation of, or abolished, post-exercise ketosis has been consistently observed 
in rodents and humans in response to aerobic exercise in trained versus untrained individuals 
(Johnson et al., 1969; Johnson & Walton, 1972; Rennie et al., 1974), or after a period of 
exercise training (Rennie & Johnson, 1974; Beattie & Winder, 1984, 1985; Adams & 
Koeslag, 1988; Adams & Koeslag, 1989; Ohmori et al., 1990). The aforementioned enhanced 
ketolytic capacity and downregulation of ketogenic capacity by training may play a role in 
these observations, but the majority of this work has been performed in comparisons with the 
absolute exercise intensity and duration being the same for comparisons (reviewed in 
(Koeslag, 1982)). This is problematic because the relative exercise intensity is the key 
determinant of the metabolic and hormonal response to acute exercise e.g. catecholamine 
responses, FFA mobilisation, glycogen utilisation among others. When trained and untrained 
participants have performed exercise at a similar relative intensity, PEK is blunted but not 
abolished in trained individuals (Rennie et al., 1974). Moreover, in rodents when exercise is 
completed to exhaustion, i.e. the trained rats exercise for longer than untrained, βHB 
concentrations are ~two-fold higher at the exercise cessation in the trained group (Askew et 
al., 1975). These divergent findings are likely due to the degree of liver glycogen depletion 
that occurs (Adams & Koeslag, 1988), inasmuch as higher concentrations of resting liver 
glycogen and attenuated rates of depletion are a consequence of training (Baldwin et al., 
1975).  
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Therefore, PEK is strongly influenced by nutrition manipulation. High CHO feeding 
prior to exercise attenuates PEK regardless of training status (Rennie & Johnson, 1974; 
Askew et al., 1975; Koeslag et al., 1980), and CHO restriction increases PEK (Impey et al., 
2016). Glucose ingestion at 2 h into recovery (Koeslag et al., 1982; Carlin et al., 1987) and 
alanine during recovery (Koeslag et al., 1980; Koeslag et al., 1985; Carlin et al., 1987) 
attenuate PEK 
, but the glucose effect is not seen when glucose is ingested immediately after 
exercise. Alanine ingestion increases mitochondrial oxaloacetate concentrations in liver, 
thereby allowing condensation with Ac-CoA and diversion away from ketogenesis. This 
suggests that the early PEK response is determined by the extent of liver glycogen depletion 
and reduced glycolytic flux, whereas several hours into recovery is under regulation by 
insulin and FFA concentrations related to nutrition intake. 
 
Metabolic consequences of post-exercise ketosis during recovery: a role for exogenous 
ketones as a recovery aid? 
The physiological role for PEK is likely to favour the replenishment of muscle 
glycogen, consistent with classically described metabolic actions of ketosis in the sparing of 
protein and CHO stores during times of low CHO availability. During the post-exercise 
recovery period, in contrast to the reliance on CHO metabolism during exercise, muscle 
glycogen resynthesis has a high metabolic priority and is facilitated by an increase in fat 
oxidation and sparing of CHO sources for energy provision (Kiens & Richter, 1998). A 
priority for muscle glycogen resynthesis over liver glycogen resynthesis is suggested to occur 
because in ancestral terms, a depleted liver is less of hindrance to intense exertion than 
depleted muscle (Adams & Koeslag, 1988). To this end, the priority for muscle glycogen 
resynthesis is observed even during CHO restriction (Adams & Koeslag, 1989), and is 
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achieved through non-CHO sources such as lactate and alanine being used for hepatic 
gluconeogenesis and redistribution to skeletal muscle (Fournier et al., 2002). The 
contribution of PEK may be via the ability of KB to inhibit glycolysis and increase the 
conversion of glucose to glycogen as demonstrated in rat skeletal muscle in vitro (Maizels et 
al., 1977), and a perfused heart model in dogs (Laughlin et al., 1994). This effect is likely 
mediated by inhibition of PDH and phosphofructokinase (PFK) by elevations in Ac-CoA and 
citrate formation, respectively, as a consequence of metabolism of AcAc in mitochondria 
(Randle et al., 1964; Maizels et al., 1977; Laughlin et al., 1994; Kashiwaya et al., 1997). 
This raises the possibility that an optimal post-exercise recovery milieu exists that 
includes both CHO and ketones to enhance recovery of muscle glycogen. This is not possible 
by conventional nutrition strategies because elevations in glucose, lactate and alanine 
ultimately limit ketogenesis and PEK. The suggestion is that the co-ingestion of KME and 
CHO in a recovery protocol can confer a metabolic advantage.  
 Following exercise, glycogen re-synthesis and stimulation of muscle protein synthesis 
(MPS) are of high importance to improve recovery. Athletes are recommended to follow 
optimal carbohydrate and protein-based fuelling related to the type, timing and amount of 
carbohydrate and protein to facilitate this recovery process and prepare the next bout of 
exercise. Ingestion of carbohydrate at a rate of 1.2 g.kg-1 body mass. h-1 during the first 4 h of 
recovery maximises the rate of muscle glycogen resynthesis; addition of 0.4 g.kg-1 body mass. 
h-1 of protein added to suboptimal carbohydrate doses during recovery increases the rate of 
glycogen resynthesis compared to suboptimal carbohydrate alone  (Beelen et al., 2010). 
When the time between exercise bouts is limited (< 8 h), nutritional strategies to augment 
glycogen resynthesis for subsequent exercise performance are a priority (Burke et al., 2017).  
During recovery from endurance exercise, the general pattern is a gradual rise in ketosis for 
several hours in the range of 0.3 to 2.0 mM, termed post exercise ketosis (Koeslag, 1982). 
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This rise in PEK is attenuated in aerobically-trained individuals when exercise is performed 
at the same absolute intensity, but not when performed at the same relative intensity (Johnson 
et al., 1969; Rennie and Johnson, 1974). Carbohydrate availability abolishes the rise in PEK 
during 3 h recovery following a mixture of high intensity and steady-state exercise, 
demonstrating the influence of circulating nutrients on ketosis (Impey et al., 2016). Similarly, 
alanine ingestion during recovery attenuates PEK (Koeslag et al., 1980; Carlin et al., 1987).  
The physiological role for PEK is likely to favour the replenishment of muscle 
glycogen and enhancing MPS, consistent with the metabolic action of KB as a survival 
mechanism during periods of low carbohydrate availability. Resting muscle glycogen 
concentrations are not lower in ‘fat adapted’ ultra-endurance athletes following a high fat 
(70%) diet for 20 months; during and after 3 h submaximal running, the pattern of glycogen 
utilisation and recovery respectively was not different to a matched group of athletes 
following a high carbohydrate (55%) diet despite a larger contribution of fat towards total 
energy consumption (Volek et al., 2016). This is a pattern repeated in Alaskan sled dogs, who 
despite following a high fat/low carbohydrate diet show no cumulative signs of muscle 
glycogen depletion over several days of exercise or inability to oxidise carbohydrate 
(McKenzie et al., 2005; McKenzie et al., 2008). Glycogen replenishment following 
endurance exercise is facilitated by non-carbohydrate gluconeogenic sources, of which KB 
may be one. In a postabsorptive state, over 90% of gluconeogenesis is accounted for by 
gluconeogenic amino acids (alanine, glutamine), lactate and glycerol (Gerich et al., 2001), 
suggesting the preservation of muscle glycogen stores observed in fat-adapted humans and 
dogs is due to the increase in gluconeogenic substrate availability to the liver, preserving 
circulating glucose concentrations. KB act to inhibit glycolysis in rat skeletal muscle in vitro 
(Maizels et al., 1977), and a perfused heart model in dogs (Laughlin et al., 1994) and infusion 
of bHB stimulates muscle protein synthesis by 10% (Nair et al., 1988). These data would 
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suggest exogenous ketones could play in enhancing muscle glycogen re-synthesis and MPS 
in the recovery period after exercise.  
 In the fasted state, ingestion of 573 mg.kg-1 body mass KME immediately after 
glycogen-depleting exercise alongside a 2 h hyperglycaemic clamp reportedly increases 
muscle glucose uptake by 32%, insulin concentrations two-fold and muscle glycogen 
concentrations by 50% compared to an isocaloric control (glucose only) drink (Holdsworth et 
al., 2017). Participants completed a glycogen-depleting bout of interval cycling lasting 115 ± 
2 min. A 10 mM hyperglycaemic clamp was chosen to replicate circulating glucose 
concentrations during a practically-relevant nutrition intervention and KME or control drinks 
were provided immediately after exercise. Blood bHB concentrations peaked at 5.3 ± 0.5 mM 
during recovery and were 3.3 ± 0.2 mM at the end of the clamp. The stated 50% increase in 
muscle glycogen in the KME condition represents the absolute increase muscle glycogen 
after the clamp regardless of immediate post-exercise muscle glycogen concentrations (KET: 
114 ± 23 mM.kg-1 dry weight (DW); CON: 70 ± 23 mM.kg-1 DW) i.e. muscle glycogen was 
decreased by 30% more in the KET condition than in the CON condition. At the end of the 2 
h recovery phase, muscle glycogen concentrations during KME (132 ± 20 mM.kg-1 DW) 
increased by 86% and during CON (94 ± 15 mM.kg-1 DW) by 74%, representing a 12% 
increase in muscle glycogen re-synthesis with acute KME ingestion, which may be accounted 
for by the increase in caloric intake with KME (5 kcal. g-1). The proposed mechanism for the 
enhanced muscle glycogen re-synthesis is stated to be the doubling of insulin concentrations 
with KME (KME: 31±5 mU.L-1; CON: 16±3 mU.L-1). However, early post-exercise muscle 
glycogen resynthesis appears to independent of circulating insulin, lasting 30-60 min when 
muscle glycogen concentrations are depleted below 150-200 mM.kg-1 DW (Beelen et al., 
2010), as is the case in this study. 
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Conversely, a separate study demonstrated that there is no effect on muscle glycogen 
repletion when 0.50 g.kg-1 body mass KME is ingested immediately after exercise, followed 
by 0.25 g.kg-1 body mass alongside 1.00 g.kg-1 body mass.h-1 carbohydrate and 0.30 g.kg-1 
body mass.h-1 whey protein in the form of a recovery drink during a 5 h hour recovery 
(Vandoorne et al., 2017). This feeding regimen was chosen to elicit maximal rates of MPS 
(Morton et al., 2015) and muscle glycogen re-synthesis during the post-exercise recovery 
period (Burke et al., 2017). Participants were provided with a high carbohydrate (70%) 
breakfast and completed a glycogen-depleting bout of unilateral knee extensions. Whole 
blood bHB concentrations peaked at 4.3 ± 0.5 mM at 4 h of recovery. Unilateral exercise 
depleted muscle glycogen concentrations by ~60% during both PLA and KME, reaching 170 
± 22 mM.kg-1 DW and 183 ± 21 mM.kg-1 DW, respectively. No difference in plasma insulin 
concentrations was observed during the 5 h recovery period, reaching ~25 mU.L-1 at 90 and 
300 min of recovery in KME and PLA conditions and blood glucose was ~1.0 mM lower 
during KME during the final 4 h of recovery. Differences in study design may explain the 
contrasting findings of these two studies, e.g. different exercise modalities in cycling vs. 
unilateral exercise, the different method of elevating plasma glucose availability 
(hyperglycaemic clamp vs. powdered drinks), the different lengths of recovery period, and 
the magnitude of glycogen depletion.  
 Regarding anabolic signalling in skeletal muscle, ingestion of KME alongside optimal 
post-exercise carbohydrate and protein fuelling increased the phosphorylation of proteins 
involved in the mammalian target of rapamycin (mTORC1)-regulated muscle protein 
synthesis cascade. In vivo phosphorylation of S6K1 increased ~two-fold and 4E-BP1 
increased 60% with in the KME condition compared to placebo ingestion. In vitro, the 
addition of bHB + AcAc (4.0 + 1.4 mM, respectively) to 1.5 mM leucine increased S6k1 
phosphorylation ~three-fold and 4E-BP1 by 51% in skeletal muscle cells. Moreover, the 
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addition of bHB + AcAc to 1.5 mM leucine increased the rate of MPS by two-fold compared 
to leucine alone. However, KB were not added to the higher leucine concentration of 5.0 mM, 
which alone stimulated MPS to a higher extent than a combination of bHB, AcAc and 1.5 
mM leucine (Vandoorne et al., 2017). Therefore, it remains to be explored whether AcAc and 
bHB have anabolic effects similar to leucine alone, despite earlier reports of a 10% in MPS 
after bHB infusion in humans (Nair et al., 1988). 
 To examine the anticatabolic effect of KB, infusion of 2.4 mL.kg-1 body mass. h-1 
D/L-bHB increased plasma bHB concentrations to 3.5 mM in a LPS stimulated inflammatory 
model in humans (Thomsen et al., 2018). Compared to FFA, infusion of D/L-bHB reduced 
forearm phenylalanine release by ~70%, reflecting a net decrease in muscle protein loss and 
whole body phenylalanine-to-tyrosine degradation was reduced. The insulin-Akt-mTOR and 
p70 S6K phosphorylation was unaffected by D/L-bHB infusion. These results suggest an 
anti-catabolic effect of bHB at a muscle and whole body level, rather than a direct anabolic 
effect. Direct comparisons between bHB and amino acids and simultaneous administration of 
both substrates is required before any statement can be made about the efficacy of bHB as a 
treatment in muscle wasting/catabolic models.  
 These preliminary data suggest that when undertaking best practice recovery 
guidelines, the addition KME confers no benefit to glycogen re-synthesis, but may enhance 
MPS. However, it remains to be seen whether addition of KS, KDE or KME to suboptimal 
delivery of carbohydrate post exercise may, like protein, aid with glycogen re-synthesis.  
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Figure 2.6 bHB as a metabolic regulator and signalling metabolite 
Effects of elevating bHB through acute nutritional ketosis may be mediated by acute regulation of substrate 
utilisation that may enhance performance, and /or possibly through regulation of recovery and adaptive 
processes related to inflammation, oxidative stressand changes in gene expression. 
 
Effects beyond fuelling: βHB as a HDAC inhibitor 
As investigative techniques in molecular biology evolve, so too does our appreciation 
of how complex integrative signalling networks regulate skeletal muscle adaptation in 
response to stimuli such as nutrient manipulation and exercise training (Egan & Zierath, 
2013). Previously considered relatively inert outside their primary metabolic function, 
numerous substrates and metabolites are emerging as important regulators of intracellular 
signalling and tissue adaptation (Hashimoto et al., 2007; Gao et al., 2009; Morton et al., 2009; 
Roberts et al., 2014). Noteworthy for the present review is the recent identification of AcAc 
as a regulator of skeletal muscle satellite cell proliferation and muscle regeneration (Zou et al., 
2016), and βHB as an inhibitor of HDACs (Shimazu et al., 2013) and the NLRP3 
inflammasome (Youm et al., 2015). The latter observations are a consequence of βHB, in 
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essence, acting as a signalling metabolite to regulate gene expression and metabolic processes 
(Figure 2.6). 
Histone acetyltransferases (HATs) and HDACs are enzymes that facilitate the 
addition or removal, respectively, of acetyl moieties from specific lysine residues on histones 
and target proteins (McKinsey et al., 2001). In general, hyperacetylation of histone tails 
induces transcriptional activation while hypoacetylation is associated with transcriptional 
repression. Class IIa HDACs (HDAC4, -5, -7 and -9) are highly expressed in skeletal muscle 
(McKinsey et al., 2001) and their function is responsive to both aerobic endurance exercise in 
humans (McGee et al., 2009; Egan et al., 2010) and nutritional intervention in rodents (Gao et 
al., 2009; Shimazu et al., 2013). An acute bout of aerobic exercise increases class IIa HDAC 
phosphorylation and subsequent nuclear exclusion, thus inhibiting HDAC-mediated 
repression of specific exercise-responsive genes such as GLUT4 and PGC-1α (McGee & 
Hargreaves, 2004; McGee et al., 2009; Egan et al., 2010). This suggests that compounds that 
inhibit or disrupt HDAC inhibition could be used to mimic or enhance adaptations to exercise. 
Regulation of HDAC activity by nutrients including butyrate and βHB has also been 
established (Gao et al., 2009; Shimazu et al., 2013). Butyrate, a short chain fatty acid formed 
via the fermentation of indigestible dietary fibres by microbial species in the gut, is a potent 
inhibitor of HDAC activity (Gao et al., 2009). Mice supplemented with sodium butyrate are 
resistant to diet-induced obesity, and have elevations in markers of skeletal muscle 
mitochondrial biogenesis analogous to exercise effects (Gao et al., 2009). βHB is structurally 
similar to butyrate, and although not as potent as butyrate, also inhibits HDAC class I and II 
activity in a dose-dependent manner and supressed oxidative stress responses (Shimazu et al., 
2013). Importantly, HDAC inhibition by βHB both in vitro and in vivo is evident at 
physiologically-relevant concentrations of βHB i.e. 1 to 4 mM, which is similar to those 
attained during fasting, PEK and exogenous ketone ingestion (Figure 2.6) (Clarke et al., 2012; 
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Kesl et al., 2016). However, although the inhibitory effects were observed in multiple tissues, 
they remain to be confirmed in skeletal muscle. If confirmed, it will be intriguing to explore 
whether, apart from the aforementioned ergogenic effects, exogenous ketone supplementation 
complements exercise-mediated adaptive changes associated with modulating HDAC 
function.  
 
Effects on physical performance 
Ketone esters 
 The aforementioned work by Cox and colleagues at the University of Oxford remains 
the seminal study demonstrating the potential benefits of exogenous ketones on endurance 
performance (Cox et al., 2016).	 Ingestion of 573 mk.kg-1 body mass KME improved 30 min 
max distance cycling time trial performance by ~2% (411 ± 162 m), following a 1 h pre-load 
at 75% Wmax. This improvement coincided with a ~1.5-2.0 mM reduction in plasma lactate 
and a reduction in plasma glucose. The drinks consumed in these trials were isocaloric, 
meaning performance improved despite receiving less carbohydrate throughout the KME arm 
of the trial (Cox et al., 2016). Since then, several reports on the physical performance effects 
of acute exogenous ketones ingestion have emerged (O'Malley et al., 2017; Rodger et al., 
2017; Leckey et al., 2017; Waldman et al., 2018). These studies all use exogenous ketone 
supplementation, but in different forms, and it is important to distinguish between the 
different forms given that each have different metabolic effects that can potentially alter 
performance.  
 Ingestion of 500 mg.kg-1 body mass KDE impaired performance during an 
ecologically-valid 31.2 km time trial in professional cyclists (Leckey et al., 2017). 
Participants ingested the bolus as two 250 mg.kg-1 body mass aliquots 50 and 30 min prior to 
the time trial, having consumed a high carbohydrate breakfast (2 g.kg-1 body mass) on the 
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morning of each trial. Participants received 200 mg caffeine, a 6% carbohydrate sports drink 
and a caffeine gel during the trial to mimic the real-world practice in professional cycling.  
Performance was impaired by 2 ± 1%, (58.2 s; ES -0.42 small), explained by a 3.7% 
reduction in power output and was accompanied by a high prevalence of gastrointestinal 
distress among participants in the KDE condition. The lower plasma bHB concentrations in 
the KDE study makes it difficult to compare the performance findings with the KME work 
(Cox et al., 2016). Plasma bHB reached ~0.4 mM pre-time trial, suggesting KDE at this dose 
is currently ineffective at achieving nutritional ketosis (>0.5 mM bHB), a problem 
complicated by the reports of high prevalence of gastrointestinal distress.  
 To date, ketone ester work has focused on endurance athletes due to the proposed 
glycogen sparing mechanism of elevated circulating bHB concentrations (Cox et al., 2016). 
Sport nutrition guidelines for team sports promote high dietary carbohydrate intake prior to 
and during competition to maximise muscle glycogen stores with a view to enhancing 
performance (Burke et al., 2006). Therefore, nutritional strategies that could attenuate the 
reduction of muscle glycogen during match play (Mohr et al., 2003) is of value to scientists 
and practitioners. Whether ketone ester ingestion benefits team sport activity, and indeed 
most other sporting contexts, remains to be confirmed.  
 
Ketone salts 
	 There are three reports on exercise performance effects of acute KS ingestion 
(O'Malley et al., 2017; Rodger et al., 2017; Waldman et al., 2018). These studies use a variety 
of doses of KS. Ingestion of two servings of a commercially available KS (KetoForce), 
providing 11.7 g D/L-bHB per serving elevated whole blood bHB concentrations to 0.6 ± 0.2 
mM but did not improve mean power output during 4 min maximal performance test in 
highly trained cyclists (KS: 364 ± 56 W; PLA: 355 ± 46 W) (Rodger et al., 2017). Similarly, 
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ingestion of one serving of KS (PerfectKeto) elevated whole blood bHB concentrations to 
0.53 ± 0.19 mM but had no effect on mean power output (KS: 715 ± 94 W; PLA: 714 ± 93 W) 
or peak power output (KS: 969 ± 157 W; PLA: 955 ± 151 W) during 4x15 s maximal sprints 
on a cycle ergometer (Waldman et al., 2018). Ingestion of 0.3 g.kg-1 body mass KS 
(KetoForce) 50 min prior to exercise elevated blood bHB concentrations to ~0.8 mM and 
lowered mean power output during a 150 kJ time trial (~10 km) (-7%, -16W) and resulted in 
a longer time to finish (KS: 711 ± 137 s; PLA: 665 ± 120 s) (O'Malley et al., 2017). 
Overall, KS only modestly elevate bHB concentrations into the range of 0.3-0.8 mM 
during exercise, all measured by handheld monitors. Given the described overestimation of 
bHB concentrations by handheld monitors compared to gold-standard laboratory-based 
assays, it is likely bHB was lower than described in these works on KS ingestion and exercise 
performance. Secondly, elevation of bHB concentrations is postulated to impair high 
intensity exercise performance through an inhibition of glycolytic flux via inhibition of PDH 
and phosphofructokinase (PFK) by increases in NADH:NAD+, acetyl-CoA:CoA or citrate. 
The performance measures used in these studies were high intensity in nature , which are 
unlikely to benefit from exogenous ketone supplementation.  
 
Effects on cognitive performance 
	 The primary physiological role of KB is to provide glucose-dependent organs with a 
usable source of carbon during periods of low carbohydrate availability. FFA acids are unable 
to cross the blood-brain barrier and must be converted to KB in order to provide energy to the 
brain under these circumstances (Owen et al., 1967). KB account for ~60% of the brain’s 
energy demands after 5-6 weeks of starvation in obese patients (Owen et al., 1967). After 
short term (3.5 d), brain glucose metabolism is reduced to ~70% of control values, measured 
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by positron emission tomography, and coincides with an increase in KB oxidation in 
compensation as an alternative fuel source to glucose (Hasselbalch et al., 1994). 
Elevations in circulating KB concentrations have marked effects on brain energy 
metabolism. Elevating bHB concentrations to 4.0-8.0 mM by means of chronic fasting causes 
a 50% reduction in brain glucose MCR (Zhang et al., 2013). Moreover, infusion of D/L-bHB 
increased plasma D-bHB concentrations to 5.5±0.4 mM (similar to that achieved by 
prolonged fasting) and this coincided with a 14% reduction in cerebral glucose utilisation, a 
30% increase in cerebral blood flow and unchanged oxygen consumption (Svart et al., 2018). 
The authors suggest may reduce oxidative stress, explaining the well-established 
neuroprotective properties of KB (Svart et al., 2018). This work was performed in the elderly, 
with similar results observed in young subjects (Hasselbalch et al., 1996) and is not related to 
the age-related decline in glucose utilisation.  
  Exogenous ketones may also play a role in improving cognition in Alzheimer’s 
Disease (AD) and during mild cognitive impairment (MCI) by helping to overcome the 
characteristic brain energy deficit (Veech, 2004). During AD and MCI, brain glucose uptake 
is impaired while uptake of KB is unchanged and the elevation of KB through oral medium 
chain triglyceride supplementation improves cognitive outcomes in these populations (Reger 
et al., 2004; Krikorian et al., 2012; Cunnane et al., 2016). 
Similarly, glucose uptake and oxidation in the brain is reduced in an exercise 
intensity-dependent manner, as evidenced by a reduction of ~30% when exercising for 35 
min at ~75% compared to 30% V̇O2peak (Kemppainen et al., 2005). Conversely, the uptake 
and oxidation of circulating lactate by the brain increases with increasing exercise intensities 
paralleling the downregulation of carbohydrate oxidation. Under resting conditions the 
uptake and oxidation of lactate is minimal but >4.0 mM the brain goes from a state of lactate 
release to uptake, related to an increase in arterial concentrations (Rasmussen et al., 2011). At 
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higher lactate concentrations, lactate may replace glucose as a source for the brain by up to 
25% (Quistroff et al., 2008; Rasmussen et al., 2011). The point to be made here is that the 
brain can oxidise circulating substrates in an arterial concentration-dependent manner. AD, 
MCI and intense exercise are all characterised by a decrease in brain glucose oxidation that is 
compensated for by other substrates capable of crossing the blood brain barrier. Elevations in 
bHB concentrations via ketogenic supplementation can compensate for the deficit in glucose 
oxidation in AD and MCI (Cunnane et al., 2016), so it is tempting to speculate whether 
exogenous ketones may play a similar role in exercise contexts.  
 These works suggest that elevating circulating KB concentrations reduces the brain’s 
reliance on glucose for fuel provision. Exercise places a high demand on whole body 
carbohydrate stores, and nutritional interventions that ensure normal brain energy 
homeostasis warrant investigation. There is no clear relationship between anaerobic maximal 
bouts of exercise and cognitive processes, while aerobic exercise lasting <90 min exerts a 
selective influence on cognition, including improvements in complex problem solving and 
attentional processes that are involved in response inhibition (Tomporowski, 2003). There is 
a facilitating effect of physical activity and cognitive performance, with the majority of work 
on arousal and reaction time, possibly due to elevated levels of cortical catecholamines. 
Much of this work has been performed using low intensity exercise at 40% to 60% V̇O2peak 
(Davranche et al., 2006), while both acute and chronic physical activity improves executive 
function (Best, 2012). It is important to be cognisant of the selective effects of exercise on 
different aspects on cognitive function being measured in nutritional supplement trials. 
Submaximal exercise of >2 h in duration that depletes energy (carbohydrate) stores and 
dehydrates the athlete is more likely to negatively impact cognitive function (Cian et al., 
2000; Cian et al., 2001). If there is a central effect of KB during exercise, it may be that KB 
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could help to conserve cognitive function during endurance exercise by alleviating the 
reliance on glucose as a fuel source, and attenuating the decline in brain energy stores.  
 Work on ketone ester ingestion, cognitive performance and brain metabolism is 
focused in rodents using KME (Murray et al., 2016; Pawlosky et al., 2017) and KDE 
(Ciarlone et al., 2016; Ari et al., 2016; Kovács et al., 2017). Chronic feeding of 2.6 g.day-1 
KME for 5 days improved decision-making and reduced time to completion of a radial maze 
task by 38% versus rats fed an isocaloric high carbohydrate diet (Murray et al., 2016). 
Concentrations of cortical and hippocampal glycolytic intermediates is lower following 
chronic treatment of KME and cortical citrate synthase concentrations are significantly higher, 
while citrate synthase, isocitrate, alpha-ketoglutarate, succinate, fumarate and acetyl Co-A 
were all elevated after chronic ingestion of KME (Pawlosky et al., 2017). These changes 
coincided with a significantly more energetic ΔG in the hippocampus of KME-fed rats. 
Chronic KDE ingestion decreases audiogenic and chemically-induced seizure activity in mice 
when bHB concentrations are elevated to between 0.8-1.0 mM during 8 wk of treatment.  
(Ciarlone et al., 2016). Furthermore, chronic KDE administration by intra-gastric gavage 
decreases absence epileptic activity when bHB concentrations are elevated to ~1.8 mM at the 
end of 1 wk of treatment  (Kovács et al., 2017). These results are explained by an increase in 
GAD65/67 hippocampal protein expression, which code for GABA, with this elevation being 
antithetic to the reduction in GABA that contributes to seizure activity.  
 The cognitive effects of exogenous ketones are underexplored in humans with only 
one study incorporating cognitive tasks (Waldman et al., 2018). Following acute ingestion of 
KS, participants completed a 5-min reaction test during their warm up and immediately 
following 4x15 s anaerobic Wingate sprints on a cycle ergometer. No effect on reaction time 
was observed after the anaerobic activity despite a higher fatigue index in the KS condition 
(KET: 32.3 ± 13.9 W/s; PLA: 29.2 ± 12.6 W/s). However, a learning/order effect is noted by 
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the authors for hits and misses on the same test with repeated testing (Waldman et al., 2018). 
This protocol may also not have been long enough to cause a reduction in whole body energy 
stores or dehydration to cause substantial decline in cognitive function (Tomporowski, 2003), 
and would seemingly agree that short duration exercise has little impact on cognitive function.  
Like physical performance, this work suggests low concentrations of bHB (<1.0 mM) may 
not effect cognitive performance in this high intensity exercise context. Whether ketone ester 
ingestion has an effect on cognitive performance in endurance and high intensity exercise 
challenges remains to be studied. 
	
State-of-the-art in exogenous ketone supplementation and exercise performance 
Exogenous ketone supplements come in multiple forms; racemic ketone salts, a (R)-3-
hydroxybutyl (R)-3-hydroxybutyrate ketone monoester, and a R,S-1,3-butanediol 
acetoacetate diester. Each of these supplements elevates bHB concentrations but differ in 
their effect on the metabolic response to exercise, and possibly exercise performance. There 
is a strong rationale for the performance-enhancing benefits of exogenous ketone in sport and 
the same is true for performance impairment, much of which would depend on the 
supplement being consumed and the nature of the exercise challenge. The (R)-3-
hydroxybutyl (R)-3-hydroxybutyrate ketone monoester is the only supplement shown to be 
beneficial to endurance performance in cyclists, hypothesised to result from a ‘glycogen 
sparing’ effect. Whether this ergogenic effect will be observed in other sporting contexts, 
namely high intensity intermittent team sports, that rely on a high rate of carbohydrate 
oxidation for sustaining performance, and other modalities of endurance exercise (i.e. running) 
remains to be determined. Given the role of KB in fuel provision to the brain during short and 
long term starvation, the effect of exogenous ketone supplements on aspects of cognitive 
performance, including reaction time, sustained attention, and decision making is of interest. 		
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Abstract 
	
Introduction: Acute ingestion of ketone salts induces nutritional ketosis by elevating β-
hydroxybutyrate (βHB), but few studies have examined the metabolic effects of ingestion 
prior to exercise.  Methods: Nineteen trained cyclists (12 male, 7 female) undertook graded 
exercise (8 min each at 	30%, 40%, 50%, 60%, 70%, and 80% V̇O2peak) on a cycle ergometer 
on two occasions separated by either 7 or 14 days. Trials included ingestion of boluses of 
either (i) plain water (3.8 mL kg body mass−1) (CON) or (ii) βHB salts (0.38 g kg body 
mass−1) in plain water (3.8 mL kg body mass−1) (KET), at both 60 min and 15 min prior to 
exercise. Results: During KET, plasma βHB concentrations increased to 0.33 ± 0.16 mM 
prior to exercise and 0.44 ± 0.15 mM at the end of exercise (both p < .05). Plasma glucose 
was 0.44 ± 0.27 mM lower (p < .01) 30 min after ingestion of KET and remained 	0.2mM 
lower throughout exercise compared to CON (p<.001). Respiratory exchange ratio (RER) 
was higher during KET compared to CON (p < .001) and 0.03–0.04 higher from 30%V̇O2peak 
to 60%V̇O2peak (all p < .05). No differences in plasma lactate, rating of perceived exertion, or 
gross or delta efficiency were observed between trials. Gastrointestinal symptoms were 
reported in 13 out of 19 participants during KET. Discussion: Acute ingestion of βHB salts 
induces nutritional ketosis and alters the metabolic response to exercise in trained cyclists. 
Elevated RER during KET may be indicative of increased ketone body oxidation during 
exercise, but at the plasma βHB concentrations achieved, ingestion of βHB salts does not 
affect lactate appearance, perceived exertion, or muscular efficiency.  
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Introduction 
	
The relationship between energy provision and factors intrinsic and extrinsic to 
exercise is complex, but has traditionally focused on the relative contribution of carbohydrate 
and fat being regulated by the intensity and duration of an exercise challenge (Egan & Zierath, 
2013). Many sports nutrition strategies are based around optimizing carbohydrate provision 
before and during performance (Burke, 2015), but there is increasing interest in alternative 
fuelling strategies, particularly in endurance sports, including low carbohydrate and ketogenic 
diets, and the use of exogenous ketone supplements (Burke, 2015; Evans, Cogan, & Egan, 
2017). 
Ketone bodies [namely β-hydroxybutyrate (βHB) and acetoacetate (AcAc)] are 
produced in the liver during periods of low glucose availability such as during fasting, 
starvation and ketogenic diets (Robinson & Williamson, 1980; Balasse & Fery, 1989; Laffel, 
1999). Although principally acting as an alternative fuel source for the brain when glucose 
concentrations are diminished, ketone bodies are also used by skeletal muscle to provide up 
to 10% of energy during exercise in the fasted state (Franken, Neef & Balasse, 1974; Balasse, 
Fery, & Neef, 1978; Fery & Balasse, 1983; Fery, Wahren, Sato, Ostman, Hagenfeldt, & Felig, 
1984). However, the direct contribution to energy provision may be secondary to the 
potential metabolic action of supplemental ketones. For instance, ketone bodies have wide-
ranging metabolic effects on peripheral tissues such as glucose sparing, anti-lipolytic effects 
and stimulation of muscle protein synthesis (Maizels et al., 1977; Nair et al., 1988; Mikkelsen 
et al., 2015). During moderate intensity exercise, infusion of sodium AcAc after an overnight 
fast attenuates the rise in plasma lactate (Fery & Balasse, 1988), whereas sodium βHB 
infusion similarly alters the metabolic response to very intense exercise in rats (Kamysheva 
& Ostrovskaia, 1980), and ischemic forearm exercise in humans (Lestan et al., 1994). 
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 Despite these observations, the potential performance benefits of ketone bodies have 
been unexplored until the recent emergence of exogenous ketone supplements in the form of 
ketone esters and ketone salts. For instance, acute ingestion of the (R)-3-hydroxybutyl (R)-3-
hydroxybutyrate ketone monoester produced plasma βHB concentrations of ~3 mM during 
exercise, and improved 30 min time-trial performance by 2% in elite cyclists (Cox et al., 
2016). Ketone esters are not commercially-available to date, but ketone salts represent a 
cheaper, more readily-available exogenous ketone supplement. These salts comprise of the 
free acid form of βHB buffered with sodium, potassium, and/or calcium salts, but are less 
effective at elevating plasma βHB concentrations compared to the ketone monoester (Stubbs 
et al., 2017). The effects of acute ketone salt ingestion on short-duration, high intensity 
exercise performance in human has been the subject of two recent reports (O'Malley et al., 
2017; Rodger et al., 2017), both of which did not observe the performance benefits associated 
with the ketone monoester. Given that this is an emerging field of research, and to better 
understand the impact of ketone salt ingestion on responses across a range of exercise 
intensities, the purpose of the present study is investigate the effect of acute ingestion of a 
commercially-available βHB salt formulation on the metabolic and physiological responses 
to a graded submaximal exercise session in young, trained male and female cyclists. We 
hypothesise that ingestion of the βHB salt formulation will alter the metabolic response to 
exercise based on our pilot data collection.  
Methods 
Participants 
Nineteen trained cyclists [12 male, 7 female (Table 3.1)] gave written informed 
consent to participate after written and verbal explanation of the procedures. Ethical approval 
(permit number: LS-15-82-Evans-Egan) was obtained from the University College Dublin 
Research Ethics Committee. All participants were active in regular cycling training (≥6 
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sessions per week) and competition in road, time-trial, and/or triathlon disciplines, and had 
been competing in their respective discipline for at least one calendar year. 
 
Table 3.1 Participant anthropometrics and fitness profile 
 
Whole cohort 
(n = 19) 
Males 
(n = 12) 
Females 
(n = 7) 
Males vs. Females 
P value 
Age (y) 26.8 ± 7.6 25.1 ± 6.2 30.3 ± 8.8 0.148 
Height (m) 174.3 ± 8.9 178.7 ± 7.4 166.7 ± 5.7 0.002 
Body mass (kg) 69.0 ± 9.7 73.8 ± 6.8 60.9 ± 8.5 <0.001 
Body fat (%) 17.6 ± 6.8 13.7 ± 3.9 24.3 ± 5.0 <0.001 
FFM (kg) 57.7 ± 10.5 64.3 ± 5.9 46.4 ± 5.3 <0.001 
Wmax (W) 325 ± 67 368 ± 40 251 ± 23 <0.001 
LT (W) 245 ± 59 278 ± 41 187 ± 36 <0.001 
V̇O2peak (L×min-1) 4.3 ± 8.5 4.8 ± 4.3 3.3 ± 4.3 <0.001 
V̇O2peak (mL×kg-1×min-1) 61.1 ± 7.1 65.5 ± 5.6 54.9 ± 3.6 <0.001 
V̇O2peak (mL×kg FFM-1×min-1) 74.0 ± 5.1 75.2 ± 5.1 71.8 ± 4.7 0.171 
	
Data are presented as mean ± SD. LT, power output at 4 mM lactate threshold; FFM, fat-free mass 
 
Experimental design 
	 Participants visited the laboratory for exercise tests on three separate occasions. All 
tests were performed on the same electronically-braked stationary cycle ergometer (Lode 
Excalibur Sport, Netherlands). Saddle height and handlebar position were adjusted to each 
participant’s preference, but kept consistent for the three visits. Participants performed the 
exercise tests in their own cycling shoes with appropriate pedals provided by the laboratory. 
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Body mass and height were measured using digital scales (SECA, Germany) and a wall-
mounted stadiometer (Holtain, UK), respectively. Body composition was measured using 
dual-energy x-ray absorptiometry (Lunar iDXA, GE Healthcare, UK). 
 During their first visit to the lab, participants performed a submaximal incremental 
exercise test to establish their lactate threshold, after which they performed an incremental 
exercise test to volitional exhaustion to establish their peak oxygen uptake (V̇O2peak). Two 
experimental trials, each comprised of a graded exercise test of six stages (at power outputs 
corresponding to approximately 30%, 40%, 50%, 60%, 70% and 80%V̇O2peak), with each 
stage lasting 8 min (Figure 3.1), were performed during subsequent visits in a randomized 
cross-over design. Each experimental trial was identical with the exception of a drink 
consumed in the hour prior to each exercise test, namely plain water (CON), or βHB salts 
(KET).  
Incremental exercise tests 
	 Assessment of lactate threshold and V̇O2peak was performed in accordance guidelines 
from the British Association of Sport and Exercise Sciences (BASES) (Davison & Wooles, 
2007; Spurway & Jones, 2007). Briefly, for determination of lactate threshold, participants 
completed 4 min stages (3 min of cycling and 1 min of rest), starting at 50 W. The power 
output was increased by 50 W for the next two stages, and 30 W thereafter until a blood 
lactate concentration (Lactate Pro 2, Japan) of 4 mM was exceeded. After a 15 min rest, 
V̇O2peak was determined via an incremental test to exhaustion. Participants began cycling at a 
pre-determined power output based on body mass as per the BASES guidelines, and power 
output was progressively increased by was increased by 20 W.min-1 for males and 15 
W.min-1 for females thereafter until volitional exhaustion.  
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Pre-trial preparation 
	 All experimental trials were performed between 07:00 and 10:00, but on an individual 
basis, participants performed their second trial at the same time ±1 h as their first trial. Pre-
trial preparation was the same for each experimental trial. Participants were asked to abstain 
from alcohol for 48 h and caffeine for at least 12 h, and refrain from strenuous exercise 
training for the day prior to each trial. Each trial took place after a standardized 10 h 
overnight fast. Participants were asked to keep a one-day portion estimate food diary for the 
day corresponding to two days prior to the first trial. They were instructed to repeat this 
pattern of intake before their second trial. On the day immediately prior to both experimental 
trials, participants were provided with a standardized diet (Gourmet Fuel, Ireland), which 
provided 40 kcal.kg body mass-1 at a macronutrient ratio of 40% carbohydrate, 30% protein 
and 30% fat. Male participants performed the two experimental trials separated by 7 or 14 
days. Because the phase of the menstrual cycle influences fuel utilization during exercise 
(Oosthuyse & Bosch, 2010), female participants performed the two experimental trials 
separated by 7 days, but within the early to mid-luteal phase of their menstrual cycle.  
Experimental trials 
	 Experimental trials were performed in a randomized cross-over open-label design, 
and were identical with the exception of the drink consumed in the hour prior to each exercise 
test. The open-label design was chosen because of the difficulty in masking the pungent taste 
of the βHB salts, and considered acceptable because there was no performance element to the 
experimental design. Neither the study participants nor research personnel were blinded to 
allocation of condition, with the exception of the laboratory technician who did undertake 
analysis of the blood samples in a blinded manner.  
 During each trial, a bolus of a given drink was ingested at both 60 min and 15 min 
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prior to the commencement of exercise (Figure 3.1). Each bolus consisted of either (i) plain 
water provided at 3.8 mL.kg body mass-1 (CON), or (ii) βHB salts (KetoCaNa, Prototype 
Nutrition, IL USA) provided at 0.38 g.kg-1 body mass dissolved in 3.8 mL.kg body mass-1 
plain water (KET). Each bolus serving of KET provided ~18.5 g βHB, 2.1 g sodium and 1.8 g 
calcium, which is approximately 60% more βHB than the manufacturer’s guidelines of 11.7 g 
βHB per serving. This timing and dosing strategy was based on our own pilot experiments 
(unpublished data) showing that plasma βHB concentration peaked at 60 min after ingestion 
of a single bolus, and that a greater elevation in plasma βHB concentration could be achieved 
with two smaller doses of βHB salts compared to a single larger dose equivalent to the same 
total amount of βHB salts.  
 Upon arrival at the laboratory, an indwelling catheter was introduced into an 
antecubital vein for serial blood sampling at rest (-60, -30 and 0 min) and during exercise 
(last 30 s of each 8 min stage) (Figure 3.1). The catheter was maintained patent between 
samples with saline (0.9% sodium chloride). The exercise test was graded and consisted of 
six stages at power outputs corresponding to approximately 30%, 40%, 50%, 60%, 70% and 
80%V̇O2peak, with each stage lasting 8 min (Figure 3.1). Expired air was collected 
continuously throughout each exercise test on a breath-by-breath basis (COSMED Quark b2, 
Italy). During the last 30 s of each 8 min stage, HR (Polar, Finland) and RPE (Borg scale) 
were recorded, and a blood sample was collected for measurement of plasma βHB, lactate, 
and glucose concentrations.  
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Figure 3.1 Experimental design schematic 
	
Blood analysis 
	 Blood samples (4 mL) were collected in plastic tubes containing sodium 
fluoride/potassium oxalate (Vacuette Glucose tubes, Greiner-Bio-One, Germany) for 
subsequent analysis. Samples were stored on ice before centrifugation at 3000 g for 10 min at 
4C, after which three aliquots of plasma were separated for storage at -80C until later analysis 
of plasma βHB, lactate, and glucose (RX Daytona, Randox Laboratories, UK; assay codes 
RB1007, LC2389 and GL364 respectively). 
Data analysis 
	 Cardiopulmonary and metabolic parameters. Minute ventilation (VE), V̇O2, carbon 
dioxide production (V̇CO2) and RER were calculated from an average of breath-by-breath 
measurements during the last 30 s of each stage in the incremental exercise tests, and during 
the last 2 min of each stage in main experimental trials. Oxygen pulse (O2 pulse), defined as 
oxygen uptake per heartbeat and expressed in mL.beat-1, was calculated by dividing V̇O2 
(L.min-1) by HR (beats.min-1) during the last 30 s of each stage. 
 Substrate utilization. The rate of energy expenditure (kcal.min-1) during each stage 
was calculated from the average V̇O2 and V̇CO2 values during the last 30 s of each stage 
using equations applied on intensity-dependent basis (Jeukendrup & Wallis, 2005). Rates of 
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carbohydrate and fat oxidation are not reported because of the likely error introduced into 
these calculations by the oxidation of βHB and AcAc, which yield respiratory quotient values 
of 0.89 and 1.00 respectively (Frayn, 1983). Reporting oxidation rates based on RER is 
inaccurate during periods of nutritional ketosis unless appropriate correction factors for CO2 
displacement, and excretion of ketone bodies in urine and expired air are employed (Frayn, 
1983), which were beyond the scope of the current work.  
 Mechanical efficiency. Gross efficiency (GE) was calculated as the ratio of the work 
performed per minute (W converted to kJ.min-1) to the energy expended per minute (kJ.min-1) 
at each stage, expressed as a percentage. Delta efficiency (DE) was calculated as the ratio of 
the change in work performed per minute to the change in energy expended per minute 
between each stage, expressed as a percentage (Gaesser & Brooks, 1975).  
Statistical analysis 
	 Data were evaluated using GraphPad Prism 6 (GraphPad Software, Inc., CA USA), 
and are presented as mean±SD, with the exception of Figure 3.2 where error bars represent 
95% confidence intervals. The experiment was powered based on change in RER as the 
primary outcome, which was chosen as a measure of an altered metabolic response. Based on 
the aforementioned pilot data where a 0.034±0.015 difference in RER between KET and 
CON was observed, n=13 participants would have been required given α=0.05 and 1-β=0.8 
(GPower v3.1). Independent samples t-tests were used to determine differences between male 
and female participants for baseline characteristics. Two-way (condition × intensity) repeated 
measures analysis of variance (ANOVA) was used to determine differences between the two 
experimental trials for variables with serial measurements. When a main effect of condition, 
or an interaction effect between condition and intensity, was indicated, post-hoc testing was 
performed using Holm-Sidak’s multiple comparisons test with multiplicity-adjusted P values 
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to compare KET to CON at respective time points. The data were tested for normality and 
sphericity prior to proceeding with the tests described. In addition, standardised differences in 
the mean were used to assess magnitudes of effects between conditions at respective time 
points. These were calculated using Cohen’s d effect size (ES) and interpreted using 
thresholds of <0.25, >0.25, >0.5 and >1.0 for trivial, small, moderate, and large, respectively 
(Rhea, 2004). Pearson’s product-moment correlation coefficient (r) was used to explore 
correlations between variables. No differences were observed between male and female 
participants for the effect of KET on the metabolic response to exercise compared to water, 
so male and female data are presented as combined (n = 19) data unless otherwise stated. The 
significance level was set at α = 0.05 for all statistical tests. 
 
Results 
	 Plasma βHB, glucose and lactate. Fasting plasma βHB (KET, 0.13±0.10 mM; CON, 
0.12±0.09 mM; ES=.05) and glucose (KET, 4.82±0.46 mM; CON, 4.79 ±0.40 mM; ES=.06) 
concentrations did not differ between trials (Figure 3.2). Ingestion of KET resulted in a rise in 
plasma βHB concentration to 0.28±0.13 mM (P<.001) 30 min after ingestion, and remained 
elevated throughout exercise (P<.001) (Figure 3.2a). The highest plasma βHB concentration 
during KET was observed in the final stage of exercise at 0.44±0.15 mM (P<.001). Plasma 
glucose concentration averaged 0.44±0.27 mM lower 30 min after ingestion of KET 
compared to CON (P=.008; ES=.96). An inverse correlation (r=-0.647, P=.004) was observed 
for the change in plasma βHB and glucose concentrations at this time point. Plasma glucose 
concentrations remained lower at all stages throughout exercise, with effect sizes indicating 
small to moderate effects i.e. 30%V̇O2peak, -0.19±0.36 mM, ES=.39; 40%,V̇O2peak, -0.21±0.43 
mM, ES=.44; 50%V̇O2peak, -0.27±0.40 mM, ES=.66; 60%V̇O2peak, -0.21±0.39 mM, ES=.62; 
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70%V̇O2peak, -0.17±0.54 mM, ES=.33; and 80%V̇O2peak, -0.39±1.24 mM, ES=.34 (Figure 
3.2b). Plasma lactate concentrations were elevated above resting values during the final two 
stages of exercise, but no differences between KET and CON were observed for plasma 
lactate concentrations at any time point (Figure 3.2c). 
 Cardiorespiratory responses to graded exercise and KET ingestion. All 
cardiorespiratory parameters exhibited main effects for exercise intensity (all P<.001). No 
differences in %V̇O2peak, V̇O2, V̇CO2, or VE were observed between conditions (Table 3.2). 
RER was elevated by KET (P<.001 for condition), and was ~0.03 higher for intensities up to 
60%V̇O2peak  (all P<.05), with effect sizes indicating moderate effects at these intensities i.e. 
30%V̇O2peak , 0.038±0.030, P=0.003, ES=.90; 40%,V̇O2peak, 0.035±0.036, P=0.007, ES=.92; 
50%V̇O2peak, 0.028±0.031, P=0.025, ES=.81; and 60%V̇O2peak, 0.027±0.037, P=0.031, 
ES=.78 (Figure 3.2d). The effect of KET on RER was small at 70%V̇O2peak (0.018±0.030, 
P=0.16, ES=.50) and 80%V̇O2peak  (0.012±0.045, P=0.37, ES=.28). HR was also elevated by 
KET (P=.003 for condition), wherein HR averaged ~4 to 8 bpm higher during KET and effect 
sizes indicated small to moderate effects i.e. 30%V̇O2peak, 5.6±4.5 bpm, ES=.48; 40% V̇O2peak, 
8.5±7.1 bpm, ES=.66; 50%V̇O2peak, 7.8±7.1 bpm, ES=.55; 60%V̇O2peak, 3.9±8.6, ES=.26; 
70%V̇O2peak, 4.9±8.2 bpm, ES=.29; and 80%V̇O2peak, 4.4±7.0 bpm, ES=.34 (Figure 3.2e). No 
differences in oxygen pulse, RPE, gross efficiency or delta efficiency were observed between 
conditions (Table 3.2). 
 Gastrointestinal responses. Thirteen out of nineteen (68%) participants reported 
symptoms of gastrointestinal distress in response to KET ingestion. These comprised of 
seven (37%), three (16%), two (11%), and one (5%) of the participants reporting nausea, 
diarrhoea, vomiting and light-headedness, respectively. These symptoms manifested in the 
latter stages of and immediately after the cessation of exercise. No symptoms were reported 
during CON 
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Figure 3.2 Plasma bHB (a), glucose (b) and lactate (c), respiratory exchange ratio (d), 
and HR (e) responses after bHB salt ingestion and water ingestion.  
Data are presented as mean values, with error bars representing 95% confidence intervals. *p < .05 KET vs. CON; 
** p < .01 KET vs. CON; ***p < .001 KET vs. CON; KET, bHB salt ingestion; CON, water ingestion; HR, heart rate; 
RER, respiratory exchange ratio.  
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Table 3.2 Cardiorespiratory responses during graded exercise in  CON or KET.  
	
 Stage 1 Stage 2 Stage 3 Stage 4 Stage 5 Stage 6 
%Wmax       
KET 16±5 28±4 40±4 52±4 64±4 75±4 
CON 16±5 28±4 40±4 52±4 64±4 75±4 
%V̇O2peak       
KET 29±3 39±2 50±3 61±3 74±4 85±4 
CON 29±3 39±2 50±2 61±3 74±4 86±5 
VE (L×min-
1) 
      
KET 30.7±5.5 40.8±5.3 52.6±5.3 66.2±7.7 89.9±10.8 127.6±16.1 
CON 30.0±4.6 40.0±5.0 52.2±5.0 66.3±6.2 89.1±9.6 124.5±23.5 
V̇O2 (L×min-
1) 
      
KET 1.42±216 1.89±151 2.42±152 2.96±210 3.55±257 4.09±299 
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Data are presented as mean ± SD. %Wmax, percentage of maximum power output; %V̇O2peak, percentage or peak oxygen uptake; VE, minute ventilation; V̇O2, rate of oxygen uptake; V̇CO2, rate of 
carbon dioxide production; RPE, rating of perceived exertion. 
CON 1.40±183 1.87±201 2.41±206 2.96±270 3.58±322 4.11±444 
V̇CO2 
(L×min-1) 
      
KET 1.15±195 1.57±172 2.04±183 2.53±243 3.16±293 3.90±360 
CON 1.09±163 1.49±175 1.95±179 2.44±222 3.10±305 3.80±424 
RPE       
KET 7±1 9±1 11±1 13±2 15±1 18±2 
CON 6±1 8±1 11±1 13±1 15±1 17±2 
O2 pulse 
(mL×beat-1) 
      
KET 13±3 15±3 16±3 17±3 19±4 19±4 
CON 14±4 16±4 18±4 18±4 19±4 21±5 
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Discussion 
The aim of the present study was to investigate the effect, if any, of acute ingestion of 
βHB salts on metabolic and physiological responses to a graded exercise session in trained 
cyclists. Ingestion of commercially-available βHB salts resulted in elevated plasma βHB 
concentrations (>0.3 mM) at rest and during exercise. This coincided with elevated RER 
(moderate effects) and HR (small to moderate effects) during submaximal exercise intensities, 
and a lowering of plasma glucose concentrations (small to moderate effects), compared to the 
ingestion of water. However, a range of other parameters including plasma lactate, rating of 
perceived exertion, gross efficiency, and delta efficiency were unaffected by the acute 
ingestion of βHB salts. 
 Exogenous ketone supplements, such as βHB salts, represent a novel method to 
increase the concentration of circulating ketone bodies without implementing restrictive 
dietary practices such as fasting or low carbohydrate, ketogenic diets (Cox & Clarke, 2014; 
Evans et al., 2017). Despite the increasing commercial availability of βHB salts, to date there 
is a paucity of data from humans on the metabolic response to ingestion at rest or during 
exercise. The sodium/potassium βHB mineral salt ingested in the present study resulted in a 
modest elevation (~0.3 to 0.4 mM) in plasma βHB concentrations. These values are similar to 
those observed after a 24 h fast (Balasse & Fery, 1989; Laffel, 1999), and can be considered 
to have produced nutritional ketosis (i.e. >0.2 mM (Robinson & Williamson, 1980). The 
dosing strategy employed involved a bolus ingested both at 60 min and 15 min prior to 
exercise, but plasma βHB concentrations peaked during the last stage of exercise at 
0.44±0.15 mM. This suggests that the supplement was still being released into circulation 
approximately one hour after the ingestion of the second bolus, a time course consistent with 
several recent reports describing βHB salt ingestion at rest (Stubbs et al., 2017), and prior to 
exercise (O'Malley et al., 2017; Rodger et al., 2017). However, these studies reported 
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somewhat higher blood βHB concentrations (~0.6 to 1.0 mM) after ingestion at doses 
providing of two boluses of 11.7 g of βHB (Rodger et al., 2017), ~21 to 27 g of βHB 
(O'Malley et al., 2017), and ~12 g or ~25 g of βHB (Stubbs et al., 2017), compared to the two 
doses of ~18.5 g in the present study. However, unlike the present study, these studies 
measured βHB concentrations in whole blood from finger-prick sampling using handheld 
monitors, which are known to over-estimate blood βHB concentration ranging from 50% to 
three-fold relative to lab-based measures performed on serum (Guimont et al., 2015; Leckey 
et al., 2017).  
 The aim of ingestion of exogenous ketone supplements is to achieve acute nutritional 
ketosis (Cox & Clarke, 2014), and this is readily-achieved by the (R)-3-hydroxybutyl (R)-3-
hydroxybutyrate ketone monoester (Cox et al., 2016). Ingestion of 573 mg.kg-1 body mass of 
that supplement raises plasma βHB concentrations to ~3 mM 10 min after ingestion, which 
rise further to ~6 mM within the next 60 min at rest (Cox et al., 2016). Clearly the βHB salts 
ingested in the present study produce plasma βHB concentrations that are ~10-fold less than 
this. Despite the modest change in plasma βHB concentrations, the acute ingestion of βHB 
salts does exert some metabolic action at rest and during exercise. For instance, a ~10% 
decline in plasma glucose was observed 30 min after the ingestion of βHB salts, with an 
inverse correlation observed between the respective changes in plasma βHB and glucose 
concentrations at this time. This is consistent with the acute infusion of ketone bodies 
producing βHB concentrations of ~0.5 to 1 mM resulting in a decline in plasma glucose of 
~10% (Mikkelsen et al., 2015; Sherwin et al., 1975), and similar results associated with βHB 
salt ingestion (Stubbs et al., 2017). Moreover, a slightly lower plasma glucose concentration 
(~0.2 mM; small to moderate effects) was evident throughout exercise in the present study, 
which confirms other recent reports (Leckey et al., 2017; O'Malley et al., 2017; Rodger et al., 
2017).  
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 Other effects observed during exercise in the present study include elevations in RER 
(moderate effects) and HR (small to moderate effects) during the low-to-moderate intensities 
of exercise. The elevation in RER may be indicative of oxidation of ketone bodies during 
exercise based on the stoichiometry of oxidation of AcAc. Before being oxidized as a fuel 
source in skeletal muscle, βHB is re-oxidized to AcAc through the action of 3-
hydroxybutyrate dehydrogenase (BDH). The respiratory quotient for oxidation of AcAc is 
similar to that glucose at a value of 1.0 (Frayn, 1983). Therefore, a contribution of ketone 
oxidation to energy provision likely explains the elevation in RER during exercise after 
ingestion of βHB salts in the present study. The elevated RER is consistent with a recent 
report of prolonged submaximal exercise in trained male cyclists (Rodger et al., 2017), but 
the opposite of what was reported during graded exercise in recreationally-active men 
(O'Malley et al., 2017). Like the former study, we studied trained cyclists, so whether training 
status is the only explanation for the divergent findings remains to be confirmed. However, 
this would be consistent with our previous suggestion that oxidation of ketone bodies during 
exercise is likely to be greatest in trained participants with a high proportion of type I muscle 
fibres and/or a high oxidative capacity in skeletal muscle (Evans et al., 2017). 
 Calculations of arteriovenous differences of radiolabelled ketone bodies across 
working muscles estimate the contribution of ketone bodies to energy provision of 2% to 10% 
during exercise in the fasted state (Balasse et al., 1978; Fery & Balasse, 1983; Wahren et al., 
1984). This contribution is unlikely to be >10% unless plasma βHB concentrations are 
elevated above 1 mM and exercise is being performed by trained participants (Evans et al., 
2017). In well-trained participants consuming exogenous ketones as a ketone monoester, the 
contribution of ketone bodies to energy provision is greater i.e. 16 to 18% of total oxygen 
consumption (Cox et al., 2016). Therefore, although the elevation in plasma βHB 
concentration in the present study was modest, it is likely that this did result in an increased 
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contribution of ketone bodies to energy provision during exercise.  
Apart from a contribution to energy provision, the principal efficacy of supplemental 
ketones as a performance aid is likely to be secondary effects on metabolism and alterations 
in fuel selection (Evans et al., 2017). For instance, acute infusion of sodium AcAc (Fery & 
Balasse, 1988) or sodium βHB (Lestan et al., 1994) attenuates the exercise-induced rise in 
plasma lactate, an effect also observed after ingestion of the aforementioned ketone 
monoester (Cox et al., 2016). In the latter work, reduced glycolytic flux, glycogen sparing, 
and increased contribution of intramuscular triglyceride to energy provision were observed 
during 2 h of cycling at ~70%V̇O2peak . However, an attenuation of the rise in plasma lactate 
was not observed in the present study, or in other recent studies examining acute ingestion of 
βHB salts (O'Malley et al., 2017; Rodger et al., 2017). Again, this might be explained by the 
relatively lower increase in plasma βHB concentration produced by the βHB salts compared 
to the ketone monoester.  
 An important methodological note is that the βHB salts used in the present study 
provide a racemic mixture of βHB i.e. containing both the D- and L- enantiomers of βHB 
(also designated R- and S- respectively), whereas the βHB assay employed determines the 
concentration of D-βHB. D-βHB is the circulating and primary form of βHB (Tsai et al., 
2006), but intracellular concentrations of L-βHB are sensitive to factors such as aging and 
metabolic health (Hsu et al., 2011). The D- and L- enantiomers of βHB exert divergent 
physiological effects on glucose metabolism in the heart (Tsai et al., 2006) and skeletal 
muscle (Yamada, Zhang, Westerblad, & Katz, 2010), and on longevity (Edwards et al., 2014). 
Recent work has demonstrated that racemic βHB ingested as βHB salts results in elevations 
in L-βHB concentrations of ~2 mM (Stubbs et al., 2017). However, it is doubtful that a 
change in circulating L-βHB concentration, if provided by an exogenous ketone supplement, 
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would have any direct effect on substrate metabolism in skeletal muscle. For instance, L-βHB 
is not a substrate for mitochondrial BDH and thus is not metabolized to AcAc (Scofield et al., 
1982), and its physiological role is most likely in the synthesis of sterols and fatty acids in 
non-muscle tissues (Webber & Edmond, 1977). 
 The small to moderate effects observed for an elevated heart rate of 4 to 8 bpm after 
ingestion of βHB salts compared to water may warrant future investigation. Heart rate during 
exercise was not reported in previous work with βHB infusion, or ketone monoester or βHB 
salt ingestion, but was elevated by 25% under resting conditions after sodium βHB infusion 
compared to saline infusion (Gormsen et al., 2017). This indicates an effect of βHB itself 
rather than sodium load, but occurred at a plasma βHB concentration of ~4 mM in contrast to 
~0.4 mM in the present study. Alternatively, the sodium load delivered by the βHB salts may 
exert some hemodynamic effects. Acute sodium ingestion can transiently elevate blood 
pressure (Farquhar et al., 2005), and sodium bicarbonate ingestion providing a similar dose of 
sodium to the present study results in an elevation in heart rate of ~10 bpm during moderate 
intensity exercise (Kahle et al., 2013). 
 Also notable in the present study was that thirteen out of nineteen (68%) participants 
reported symptoms of gastrointestinal distress after exercise in the βHB salt condition. The 
hypertonic nature of the βHB salts ingested likely caused an intraluminal osmotic load and 
water shift into the intestinal lumen resulting in osmotic diarrhoea. However, gastrointestinal 
distress also is a potential side effect of acute ingestion of ketone esters, with high prevalence 
noted after the ingestion of the ketone diester by elite cyclists (Leckey et al., 2017), and 
increasing incidences occurring with increasing dosages of the ketone monoester, however, 
this may be confounded by the increase in litres per day of the milk based meal replacement 
shake (Clarke et al., 2012). Clearly such issues would be deleterious to exercise performance, 
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and therefore require further exploration, either in terms of optimal dosing strategies, or 
whether repeat exposure to exogenous ketone supplements reduces these symptoms.  
 In conclusion, acute ingestion of a commercially-available βHB salt formulation by 
trained cyclists resulted in a modest increase in plasma βHB concentrations before and during 
graded exercise to concentrations that can be considered acute nutritional ketosis. This 
resulted in alterations in the metabolic and physiological response to exercise as evidenced by 
lowering of plasma glucose concentrations, and elevated RER and heart rate values at low-to-
moderate exercise intensities compared to ingestion of water. However, no effect was 
observed on perceived exertion or muscular efficiency, or on plasma lactate concentrations. 
This is in contrast to previous work using βHB infusion or ingestion of a ketone monoester 
supplement, both of which achieve markedly higher plasma βHB concentrations during 
exercise. This suggests the likelihood that a dose-response effect exists for exogenous ketone 
supplements on metabolic responses and exercise performance. Given the gastrointestinal 
issues observed with the present βHB salts, further work is needed with other methods of 
increasing circulating ketone concentrations including improved free acid or mineral salt 
formulations, before the merit, if any, of ketone salts for performance enhancement in 
athletes is likely to be realised. 
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Evans M, Egan B (2018). Intermittent running and cognitive performance after ketone ester 
ingestion. Medicine & Science in Sports & Exercise 50(11):2330-2338. 
	
Abstract 
	
Introduction: Ingestion of exogenous ketones alters the metabolic response to exercise and 
may improve exercise performance, but has not been explored in variable intensity team sport 
activity, or for effects on cognitive function. Methods: On two occasions in a double-blind, 
randomised crossover design, eleven male team sport athletes performed the Loughborough 
Intermittent Shuttle Test (Part A, 5x15 min intermittent running; Part B, shuttle run to 
exhaustion), with a cognitive test battery before and after. A 6.4% carbohydrate-electrolyte 
solution was consumed before and during exercise either alone (PLA), or with 750 mg.kg-1
 
of 
a ketone ester supplement (KE). Heart rate (HR), rating of perceived exertion (RPE), and 15 
m sprint times were recorded throughout, and serial venous blood samples were assayed for 
plasma glucose, lactate and β- hydroxybutyrate (βHB). Results: KE resulted in plasma βHB 
concentrations of ~1.5 to 2.6 mM during exercise (P<0.001). Plasma glucose and lactate 
concentrations were lower during KE compared to PLA (moderate-to-large effect sizes). HR, 
RPE and 15 m sprint times did not differ between trials. Run time to exhaustion was not 
different (P=0.126, d=0.45) between PLA [(mean (95% CI); 268, (199, 336) sec) and KE 
(229, (178, 280) sec). Incorrect responses in a multi- tasking test increased from pre- to post-
exercise in PLA [1.8 (-0.6, 4.1)] but not KE [0.0 (-1.8, 1.8)] (P=0.017; d=0.70). Discussion: 
Compared to carbohydrate alone, co-ingestion of a ketone ester by team sport athletes 
attenuated the rise in plasma lactate concentrations, but did not improve shuttle run time to 
exhaustion or 15 m sprint times during intermittent running. An attenuation of the decline in 
executive function after exhausting exercise suggests a cognitive benefit after KE ingestion.	
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Introduction  
 Ketone bodies, namely β-hydroxybutyrate (βHB), acetoacetate (AcAc) and acetone, 
are fatty acid metabolites whose production markedly increases in physiological states 
characterised by reduced glucose availability, such as starvation and ketogenic diets 
(Robinson and Williamson, 1980; Balasse & Fery, 1989). Ketone bodies are principally 
produced as a survival mechanism to provide a substrate for the brain, but are also oxidised 
by skeletal muscle and provide up to 10% of energy during exercise in a fasted state (Fery & 
Balasse, 1986). Infusion of ketone bodies exerts a range of metabolic actions, such as 
attenuation of hepatic glucose output, anti-lipolytic effects in adipose tissue, and in skeletal 
muscle, glucose ‘sparing’ and stimulation of protein synthesis (Maizels et al., 1977; Nair et 
al., 1988; Mikkelsen et al., 2015). 
 The effects of ketone bodies on substrate utilisation during exercise, and consequently 
athletic performance, is of increasing interest due to the development of exogenous ketone 
supplements, namely ketone salts and ketone esters (Clarke et al., 2012; Kesl et al., 2016; 
Stubbs et al., 2017). These formulations represent a method of acutely inducing nutritional 
ketosis (plasma βHB >0.5 mM) resulting in a variety of effects on exercise metabolism, 
performance and recovery (Cox et al., 2016; Holdsworth et al., 2017; O'Malley et al., 2017; 
Vandoorne et al., 2017; Rodger et al., 2017; Leckey et al., 2017; Evans et al., 2018; Waldman 
et al., 2018). Ketone salts in their presently-available racemic form produce only modest 
changes (<1.0 mM) in plasma βHB concentrations (Stubbs et al., 2017; O'Malley et al., 2017; 
Rodger et al., 2017; Evans et al., 2018; Waldman et al., 2018). While their pre-exercise 
ingestion can alter the metabolic response to exercise (O'Malley et al., 2017; Evans et al., 
2018), there is no evidence of an ergogenic effect (O'Malley et al., 2017; Rodger et al., 2017). 
Alternatively, exogenous ketone supplements in the form of ketone esters produce markedly 
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greater changes in plasma βHB concentrations than ketone salts in humans (Stubbs et al., 
2017) and rats (Kesl et al., 2016). 
Two ketone esters have been reported in the recent literature: a R,S-1,3-butanediol 
acetoacetate diester (KDE) (Kesl et al., 2016; Leckey et al., 2017) and a (R)-3-hydroxybutyl 
(R)-3-hydroxybutyrate ketone monoester (KME) (Clarke et al., 2012; Stubbs et al., 2017; 
Cox et al., 2016). Both esters were tested in elite endurance athletes with divergent findings 
(Cox et al., 2016; Leckey et al., 2017). Acute ingestion of KME produced plasma βHB 
concentrations of ~3.0 mM after 20 min, and improved 30 min time-trial performance by 2% 
(Cox et al., 2016)). In contrast, acute ingestion of KDE was less effective at raising serum 
βHB concentrations (~0.4 mM) and impaired 31.2 km time-trial performance by 2% (Leckey 
et al., 2017). Consumption of KME increased the estimated contribution of ketone bodies to 
fuel provision during exercise to 16-18% of total energy provision, in addition to marked 
metabolic effects including the attenuation of blood lactate concentrations, ‘sparing’ of 
muscle glycogen, and increased intramuscular triglyceride utilisation (Cox et al., 2016). The 
reduction in glycolytic flux may reflect an impairment of glycogen utilisation rather than 
glycogen sparing (Burke, 2015; Pinckaers et al., 2017; Evans, Cogan and Egan, 2017), a key 
question that requires further investigation. The former is likely to impair performance in 
high intensity sports that demand a high rate of ATP provision from carbohydrate sources 
(Burke, 2015). 
 Team sports such as Australian football, soccer, Gaelic games, rugby union, lacrosse 
and field hockey are high-intensity and intermittent in nature, consisting of repeated periods 
of high intensity activity (sprinting) interspersed with exercise at low-to-moderate intensities 
(walking, jogging) (Spencer et al., 2005; Cummins et al., 2013). Nutrition guidelines for 
soccer, for instance, recommend high intakes of carbohydrate prior to and during competition 
to maximise muscle glycogen stores with the view to enhancing performance (Burke et al., 
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2006). Soccer match play results in a marked reduction in muscle glycogen, and high 
intensity running is attenuated in the last 15 minutes of play (Jacobs et al., 1982; Mohr et al., 
2003). Therefore, nutrition strategies that could spare glycogen and maintain high intensity 
running in the latter parts of matches are of interest to scientists and practitioners, but 
research on exogenous ketone supplements to date has mostly focused on athletes from 
endurance sports (Cox et al., 2016; Rodger et al., 2017; Leckey et al., 2017; Evans et al., 
2017). Moreover, because ketone bodies are the dominant fuel source for the brain in 
ketogenic states (Owen et al., 1967), there is potential for central and/or cognitive effects of 
exogenous ketone supplements, but to date cognitive effects were only explored in short-term 
feeding trials in rats (Ari et al., 2016; Kovacs et al., 2017; Murray et al., 2016), Therefore, the 
aim of the present study was to investigate the effects of acute ingestion of a ketone ester on 
metabolic responses, physical and cognitive performance in team sport athletes in response to 
an intermittent running protocol that simulated soccer match play. We hypothesise that 
ingestion of a ketone ester will have no effect on physical or cognitive performance in 
response to the intermittent running protocol.  
  
Methods 
Participants 
Eleven male team sport athletes (mean±SD: age, 25.4±4.6 y; height 1.80±0.05 cm; 
body mass, 78.6±5.3 kg; V̇O2peak 53.9±2.2 mL×kg-1×min-1) gave written informed consent to 
participate after written and verbal explanation of the procedures. Ethical approval (permit 
number: DCUREC2017_130) was obtained from the Dublin City University Research Ethics 
Committee in accordance with the Declaration of Helsinki. All participants were actively 
training and competing in high-intensity field-based team sports.  
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Experimental design 
Participants visited the laboratory for exercise tests on three separate occasions over a 
14 to 21 day period. During their first visit to the lab, each participant’s maximal oxygen 
consumption (V̇O2peak) and speed at V̇O2peak were determined using a progressive multistage 
shuttle run test (Yo-Yo intermittent recovery test level 1; Yo-Yo IR1) (Bangsbo et al., 2008). 
These data were used to determine jogging (55% V̇O2peak) and cruising (95% V̇O2peak) speeds 
for use during the Loughborough Intermittent Shuttle Test (LIST). The LIST is a validated 
simulation of the physiological and metabolic responses during soccer match play and 
consists of two parts: Part A comprises a fixed period of variable intensity shuttle running 
over 20 m; Part B consists of continuous running, alternating every 20 m between 55% and 
95% V̇O2peak until volitional fatigue (Nicholas et al., 2000). After a 15 min rest after 
completion of the Yo-Yo IR1, participants were familiarised with the LIST protocol by 
completing one 15 min block at their personalised running speeds. Cognitive tests were 
performed before the Yo-Yo IR1 and after familiarisation with the LIST in order to 
familiarise participants with the cognitive test battery. 
Two main experimental trials, each comprising of the LIST (Parts A and B) with 
cognitive tests before and after, were performed during subsequent visits in a double-blinded, 
randomised cross-over design. Both experimental trials included a standardised diet for ~36 h 
prior to the exercise test, and were identical except for the drinks consumed before and during 
the LIST, namely a 6.4% carbohydrate-electrolyte solution, which was either flavoured 
(Symrise, UK) and acted as the control/placebo condition (PLA), or included a ketone ester 
(KE) (Figure 3.1). The primary outcome was endurance capacity measured by run time to 
exhaustion in the LIST Part B, with secondary outcomes including 15 m sprint times during 
the LIST Part A, heart rate (HR), rating of perceived exertion (RPE) and plasma glucose, 
lactate and βHB concentrations. 
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Incremental exercise test and familiarisation 
For determination of V̇O2peak, jogging (55% V̇O2peak) and cruising (95% V̇O2peak) 
during the LIST, participants completed the Yo-Yo IR1. All participants completed a 
standardised 5 min warm-up consisting of progressive shuttle runs at 20%, 40%, 60% and 80% 
V̇O2peak and dynamic stretching (high knees, heel kicks, groin bridges), followed by a period 
of self-selected stretching. The Yo-Yo IR1 consists of 40 m shuttle runs (2x20 m) between 
two sets of cones set 20 m apart. Shuttles progressively increase in speed that is dictated by 
an audio signal (Teambeep Software, UK). Each 40 m shuttle is separated by a 10 s rest 
period. The test was terminated when participants failed to complete the second 20 m shuttle 
on two consecutive occasions or if they reached volitional fatigue. V̇O2peak was calculated as 
V̇O2peak (mL×kg-1×min-1) = Yo-Yo IR1 distance (m) × 0.0084 + 36.4.  
After a 15 min break, participants were familiarised with the LIST by performing one 
block of intermittent activity i.e. 15 min of Part A, were allowed 3 min of rest, and then 
completed the Part B run to exhaustion. Participants completed a battery of cognitive tests 
before the Yo-Yo IR1 and after the intermittent run to fatigue.  
Cognitive test battery 
The battery of cognitive tests (CANTAB Cognition, UK) was administered via a 
touch screen tablet lasting ~25 min. An identical test battery was administered before and 
after each trial. Technical issues, namely with loss of wireless internet access during test 
administration, resulted in the data for the cognitive test battery comprising of n=8 
participants.  
During the reaction time (RTI) task, participants select and hold a button at the 
bottom of the screen and five circles are presented above. In each case, a yellow dot appears 
in one of the five circles, and the participant must react as soon as possible, releasing the 
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button at the bottom of the screen, and selecting the circle in which the dot appeared. Release 
time (msec), reaction time (msec), and number of errors were recorded. 
The multi-tasking test (MTT) is a test of executive function that measures the 
participant’s ability to switch attention between stimuli, and ignore task-irrelevant 
information. White arrows are displayed on a black background, with the arrows located on 
either the left or right side of the screen, and pointing either to the left or to the right. A cue is 
displayed at the same time as the arrows, reading either “SIDE” or “DIRECTION.” When the 
“SIDE” cue is presented, the participant is required to press a button on the left or right of the 
screen corresponding to the side of the screen where the arrow is presented, regardless of the 
direction the arrow is pointing. Conversely, when the “DIRECTION” cue is presented, the 
participant is required to touch a button on the left or right of the screen corresponding to the 
direction the arrow is pointing, regardless of which side of the screen the arrow is presented. 
Reaction time (msec), and number of correct and incorrect responses were recorded.  
The rapid visual information processing task (RVP) is a test of sustained attention. 
The participant is presented with a white box in the center of the screen. Single digits ranging 
from 2 to 9 are presented one at a time in a pseudo-random order inside the box, appearing at 
a rate of 100 digits per minute. The participant is required to detect specific 3-digit sequences, 
including 2-4-6, 4-6-8, and 3-5-7. As soon as a target sequence is detected, the participant is 
required to touch a button on the screen. Response latency (msec), correct responses and false 
alarms were recorded. 
Pre-trial preparation 
All experimental trials were performed between 15:30 and 20:00, but on an individual 
basis, participants performed their second trial at the same time ±1 h as their first trial. Pre-
trial preparation was the same for each experimental trial. Participants were asked to abstain 
from alcohol for 48 h and caffeine for 24 h, and refrain from strenuous exercise training the 
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day prior to each trial. The day prior to experimental trials, participants were provided with a 
standardised diet (Gourmet Fuel, Ireland), which provided 40 kcal×kg body mass-1 at a 
macronutrient ratio of 60% carbohydrate, 20% protein and 20% fat. On the day of 
experimental trials, participants consumed two meals providing 3 g×kg body mass-1 of 
carbohydrate before arriving at the lab. The second meal was consumed 3 h before the 
initiation of the LIST. In addition to the energy content and macronutrient ratio, the food 
itself was identical for both trials. Participants performed the two experimental trials 
separated by either 7 or 14 days.  
Experimental trials 
Experimental trials were performed in a double-blinded, randomised cross-over 
design, and were identical except for the drinks consumed. During each trial, a bolus of a 
given drink was ingested 20 min prior to exercise (drink 1), and during each 3 min seated 
break during Part A (drinks 2 to 6) (Figure 4.1). During PLA, a 6.4% carbohydrate-
electrolyte solution (Lucozade Sport, Lucozade Ribena Suntory Ltd., UK) was provided at a 
rate of ~1.2 g×min-1 of exercise. During KE, a 6.4% carbohydrate-electrolyte solution was 
provided at a rate of ~1.2 g×min-1 combined with 750 mg×kg-1 body mass of a R-βHB (R)1,3-
butanediol ketone ester (KE4, KetoneAid, USA). The ketone ester was mixed directly with 
the carbohydrate-electrolyte solution for ingestion in three boluses (50:25:25) i.e. at 20 min 
prior to exercise (drink 1), and after 30 (drink 3) and 60 min (drink 5) of exercise, 
respectively (Figure 4.1). During PLA, drinks 1, 3 and 5, were flavoured with a bitter 
additive (Symrise, UK) to taste-match with KE, and in both trials, drinks 2, 4, and 6 were 
provided as the unadulterated carbohydrate-electrolyte solution. All drinks were administered 
in opaque drinks bottles. 
  Upon arrival at the laboratory, participants provided a urine sample for assessment of 
hydration status (PalOSMO, VITECH Scientific, Japan), and then proceeded to complete the 
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described battery of cognitive tests. Thereafter, an indwelling catheter (21G Insyte Autoguard; 
Becton Dickinson, USA) was introduced into an antecubital vein for serial venous blood 
sampling at rest (-20 and 0 min), during each 3 min seated rest period between the 15 min 
blocks in Part A, and immediately after the run to exhaustion. Participants were fitted with a 
Bluetooth heart rate monitor (Polar V7, Polar Electro Oy, Finland) for continuous recording 
of HR, and then performed the standardised 10 min warm up followed by self-selected 
stretching. Participants then performed the LIST protocol (Part A: 5x15 min intermittent 
activity; Part B: run to exhaustion) (Nicholas, Nuttall and Williams, 2000). All exercise 
intensities were based on percentages of V̇O2peak determined during the Yo-Yo IR1. The 
repeating order of activity in Part A, which occurs in a continuous manner for each 15 min 
block, comprises of 3 x 20 m at walking speed, 1 x maximal 15 m sprint, 4 sec recovery, 3 x 
20 m jogging speed (55% V̇O2peak) and 3 x 20 m at cruising speed (95% V̇O2peak). Sprint 
times were measured by two sets of wireless infrared photoelectric cells (TC Timing System; 
Brower Timing, USA). 
 Part B consists of single 20 m shuttles alternating between the jogging (55% V̇O2peak) 
and cruising (95% V̇O2peak) speeds. The shuttle run to exhaustion, measured in sec, continued 
until participants were unable to complete two consecutive shuttles at cruising speeds, or 
until volitional fatigue. All speeds were dictated using audio software (Team Beep Software, 
UK). All participants received consistent encouragement during the maximal sprinting of Part 
A, and the run to exhaustion of Part B. 
 Venous blood samples were collected during the 3 min break between each 15 min 
block of Part A, and RPE (Borg scale) was recorded during the same time period. Incidences 
of gastrointestinal (GI) symptoms were recorded by interview after each trial after completion 
of the cognitive test battery. After completion of both experimental trials participants 
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completed an exit interview in which they were asked whether they could identify the KE 
condition, and which trial did they believe that they performed their longest run to exhaustion.  
 
 
Figure 4.1 Schematic of the study protocol. CHO, carbohydrate-electrolyte solution; 
PLA, placebo; RTE, shuttle run to exhaustion 
 
Blood analysis 
Blood was collected in plastic tubes (2 mL) containing sodium heparin (Plus Blood 
Collection Tubes; Becton Dickinson, USA) for subsequent analysis of bHB). A second blood 
sample was collected in plastic tubes (4 mL) containing sodium fluoride (Plus Blood 
Collection Tubes; Becton Dickinson, USA), Samples were stored on ice before centrifugation 
at 3000 g for 10 min at 4 C, after which three aliquots of plasma were separated for storage at 
-80°C until later analysis of plasma βHB, lactate and glucose (RX Daytona, Randox 
Laboratories, UK: assay codes RB1007, LC2389 and GL364 respectively). 
Statistical analysis 
Data were evaluated using Prism 7.0 (GraphPad Software, Inc., CA, USA) and are 
presented as mean (lower, upper 95% confidence interval of the mean), with the exception of 
the participant characteristics, which are described as mean±SD. A paired samples t-test was 
used to determine differences between trials in run time to exhaustion and average HR during 
Part B. Two-way (time x condition) repeated measures analysis of variance (ANOVA) was 
used to determine differences between the two experimental trials for all other with variables 
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with serial measurements. When a main effect of condition, or an interaction effect between 
condition and time was indicated, post-hoc testing was performed with Bonferroni's 
correction with multiplicity-adjusted P values applied to compare KE to PLA at the 
respective time points. The data were tested for normality using the Shapiro-Wilk test prior to 
proceeding with the parametric tests described. For null hypothesis statistical testing, the 
significance level was set at α = 0.05 for all tests. Apart from and independent of the outcome 
of the repeated measures ANOVA, standardized differences in the mean were used to assess 
magnitudes of effects between conditions at respective time points. These effect sizes were 
calculated using Cohen’s d, and interpreted using thresholds of <0.25, >0.25, >0.5, and >1.0 
for trivial, small, moderate, and large, respectively (Rhea, 2004). 
 
Results 
Pre-exercise hydration status 
Hydration status, measured as urine osmolality prior to each trial, did not differ 
between trials [KE, 420 (259, 581) mOsm×kg-1 vs. PLA, 460 (189, 732) mOsm×kg-1; P=0.645, 
d=0.18]. 
Plasma βHB, glucose and lactate concentrations 
Fasting plasma concentrations of βHB [KE, 0.11 (0.09, 0.13) mM; PLA, 0.11 (0.09, 
0.13) mM; P>0.99], glucose [KE, 4.81 (4.62, 5.00) mM; PLA, 4.84 (4.57, 5.01) mM; P>0.99] 
and lactate [KE, 0.86 (0.71, 1.02) mM; PLA 0.96 (0.82, 1.11) mM; P>0.99] concentrations 
did not differ between trials (Figure 4.2). A main effect of time and condition (both P<0.001), 
and time x condition interaction effect (P<0.001) were observed for plasma βHB 
concentrations (Figure 4.2A). Ingestion of KE resulted in a rise in plasma βHB 
concentrations to 1.05 (0.83, 1.26) mM (P<0.001) by the start of exercise. Concentrations 
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continued to rise throughout exercise with the highest concentrations during KE observed at 
cessation of shuttle run to exhaustion at 2.61 (2.03, 3.10) mM (P<0.001). 
A main effect of time (P<0.001) and condition (P=0.020) were observed for plasma 
glucose concentrations (Figure 4.2B). Plasma glucose concentrations were lower during KE 
compared to PLA at each time point with the exception of block 3, but post-hoc pairwise 
comparisons did not reveal significant differences between conditions at any time point. 
However, standardized differences in the mean indicated moderate effect sizes at each of 
these time points. Specifically, plasma glucose concentrations were lower during KE 
compared to PLA by 10.9% [-0.56 (-1.48, 0.35) mM; d=0.52] after block 1, 7.5% [-0.48 (-
1.40, 0.44) mM; d=0.56] after block 2, 11.6% [-0.76 (-1.68, 0.15) mM; d=0.80] after block 4, 
and 8.4% [-0.55 (-1.46, 0.37) mM; d=0.56] after block 5. There was no difference in plasma 
glucose concentration at the end of the shuttle run to exhaustion [KE, 6.49 (6.01, 6.90) mM; 
PLA, 6.46 (5.64, 7.23) mM; P>0.99; d=0.04]. 
A main effect of time and condition (both P<0.001), and time x condition interaction 
effect (P=0.009) were observed for plasma lactate concentrations (Figure 4.2C). Plasma 
lactate concentrations were elevated from block 1 onwards during both conditions but were 
lower during KE compared to PLA at each time point. Post-hoc pairwise comparisons 
revealed significant differences between conditions at block 4 (P=0.037), block 5 (P=0.042) 
and the end of the shuttle run to exhaustion (P<0.001), and effect sizes indicating small, 
moderate and large effects across all time points i.e. block 1: -11.9%, -0.48 mM (-1.46, 0.50), 
d=0.27; block 2: -13.8%, -0.56 (-1.54, 0.42) mM, d=0.33; block 3: -20.2%, -0.73 (-1.71, 0.25) 
mM, d=0.45; block 4: -29.3%; -1.02 (-2.00, -0.04) mM, d=0.58; block 5: -30.1%, -1.00 (-1.98, 
0.02) mM, d=0.63; end of the shuttle run to exhaustion: -21.5%, -1.85 (-2.83, -0.87) mM, 
d=1.00). 
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Figure 4.2 Plasma bHB (A), glucose (B), and lactate (C) responses to ketone ester and 
placebo ingestion.  
Data are presented as mean values, with error bars representing 95% confidence intervals. * P < 0.05 KE vs. PLA; 
***P < 0.001 KE vs. PLA; KE, ketone ester; PLA; placebo 
 
For both HR and RPE, main effects of time were observed (both P<0.001), but the 
absence of main effects of condition or time x condition interaction effects indicates that 
ingestion of KE did not alter the HR or RPE response during any block of Part A of the LIST 
protocol (Figure 4.3). However, the average HR during the shuttle run to exhaustion was 
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lower [-3.9 (-6.4, -1.4) bpm; P=0.007; d=0.42] during KE [170.7 (163.4, 177.9) bpm] 
compared to PLA [174.6 (168.3, 180.8) bpm]. 
 
Figure 4.3 HR (A) and RPE (B) responses to ketone ester and placebo ingestion 
Data are presented as mean values, with error bars representing 95% confidence intervals. KE, ketone ester; PLA; 
placebo. 
 
15 m sprint times and shuttle run time to exhaustion 
A main effect of time was observed for 15 m sprint times during Part A (P<0.001), 
but no main effect of condition or time x condition interaction effect were observed (Figure 
4.4A). There was no statistically significant difference in the shuttle run time to exhaustion 
[KE, 229 (178, 280) sec; PLA, 267 (199, 336) sec; P=0.126] but standardized differences in 
the mean indicated a small effect size for this difference [-38 (-89, 13) sec; d=0.45]. 
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Figure 4.4 Fifteen-meter sprint times (A) and shuttle run time to exhaustion (B) during 
ketone ester and placebo trials 
Data are presented as mean values, with error bars representing 95% CI. KE; ketone ester; PLA; placebo. 
	
Cognitive performance 
A time x condition interaction effect (P=0.021) was observed for the number of 
incorrect responses in the executive function multi-tasking test, which increased from pre- to 
post-exercise in PLA  [1.8 (-0.6, 4.1)], but not in KE [0.0 (-1.8, 1.8)] (P=0.017; d=0.70) 
(Table 4.1). The absence of main effects for time or condition, and time x condition 
interaction effects indicates that there was no difference between conditions in either reaction 
time, or rapid visual information processing assessed by a sustained attention task (Table 4.1).  
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Gastrointestinal symptoms 
Four out of eleven (36%) participants reported symptoms of GI distress during PLA 
and comprised of four (36%), three (27%), three (27%), one (9%) and one (9%) reports of 
belching, cramps, flatulence, boating and nausea, respectively. Nine out of eleven (82%) 
participants reported symptoms of GI distress during KE. These comprised of seven (64%), 
six (55%), four (36%), three (27%), three (27%) and one (9%) of the participants reporting 
nausea, cramps, belching, heartburn, flatulence and vomiting, respectively.  
Identification of KE and best performance trials 
Eight out of eleven (73%) participants correctly identified the trial in which they 
received KE, identifying KE by the awareness of taste and GI symptoms. However, only five 
(45%) of the participants correctly identified the trial in which they performed better in the 
Part B run to exhaustion. Only three participants (27%) stated that they believed KE ingestion 
improved their performance, and two out of those three participants correctly identified their 
KE trial and their best performance. 
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Table 4.1 Cognitive performance measures assessed before and after each trial  
 
Data are presented as mean (95%CI), n=8. Effect size calculated as Cohen’s d. Symbols are ##P < 0.01 for main effect of Time; §P < 0.05 for Condition x Time interaction 
effect; †P < 0.05 for Post vs. Pre; *P < 0.05 for KE vs. PLA. 
Reaction time test (RTI) 
 
Release time 
(msec) 
 
Reaction time 
(msec) 
 Errors 
 Pre Post Post-Pre  Pre Post Post-Pre  Pre Post Post-Pre 
KE 393 (360, 425) 394 (369, 419) 1 (16, 18)  222 (181, 263) 218 (177, 259) -4 (-39, 31)  0.4 (-0.1, 0.8) 0.8 (0.0, 1.5) 0.4 (-0.6, 1.4) 
PLA 404 (371, 436) 397 (368, 427) -6 (-31, 19)  225 (172, 278) 237 (205, 269) 12 (-10, 34)  0.8 (-0.2, 1.7_ 0.6 (-0.6, 1.8) -0.1 (-1.0, 0.7) 
d   -0.28    0.45    -0.46 
            
Multi-tasking test (MTT) 
 
Response latency## 
(msec) 
 Correct responses§  Incorrect responses§ 
 Pre Post Post-Pre  Pre Post Post-Pre*  Pre Post Post-Pre* 
KE 590 (510, 669) 550 (483, 616) -40 (-78, -2)  157.9 (156.4, 159.3) 157.9 (156.0, 159.7) 0.0 (-1.8, 1.8)  2.1 (0.7, 3.6) 2.1 (0.3, 4.0) 0.0 (-1.8, 1.8) 
PLA 589 (526, 652) 543 (499, 587) -46 (-74, -19)  157.8 (155.7, 159.8) 156.0 (152.8, 159.2)† -1.8 (-4.1, 0.6)  2.3 (0.2, 4.3) 4.0 (0.8, 7.2)† 1.8 (-0.6, 4.1) 
d   -0.16    -0.70    0.70 
            
Rapid visual information processing test (RVP) 
 
Response latency 
(ms) 
 Correct responses  False alarms 
 Pre Post Post-Pre  Pre Post Post-Pre  Pre Post Post-Pre 
KE 449 (389, 509) 430 (365, 495) -19 (-65, 26)  44.0 (35.7, 52.3) 44.6 (36.9, 52.3) 0.6 (-2.7, 4.0)  2.0 (0.9, 3.1) 2.3 (0.5, 4.0) 0.3 (-0.9, 1.4) 
PLA 460 (395, 425) 446 (383, 510) -14 (-43, 16)  45.3 (39.0, 51.5) 44.8 (37.4, 52.1) -0.5 (-5.7, 4.7)  2.4 (1.1, 3.6) 2.5 (0.8, 4.2) 0. (-1.2, 1.4) 
d   0.12    -0.21    -0.08 
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Discussion 
The aim of the present study was to investigate the effect, if any, of the acute 
ingestion of a ketone ester on metabolic responses, physical and cognitive performance in 
team sport athletes in response to an intermittent running protocol that simulated soccer play. 
Compared to carbohydrate ingestion alone (PLA), ingestion of the ketone ester with 
carbohydrate (KE) resulted in an elevation in plasma βHB concentration to >1.5 mM after 15 
min of exercise and reached ~2.6 mM by the end of exercise. Metabolic consequences 
included reductions in plasma glucose and lactate concentrations compared to PLA, but no 
differences in HR or RPE were observed between conditions. KE was without benefit to 15 
m sprint times throughout the simulated protocol, or endurance capacity measured by shuttle 
run to exhaustion. However, cognitive performance in a multi-tasking executive function test 
was preserved with KE, but declined during PLA. 
 Recent reports have investigated the effect of acute ingestion of exogenous ketone 
supplements on physical performance in endurance athletes (Cox et al., 2016; Rodger et al., 
2017; Leckey et al., 2017). Ingestion of a βHB ketone monoester (KME) increased distance 
covered in a 30 min cycling time-trial by ~2% (411±162 m) (Cox et al., 2016), whereas in 
contrast, ingestion of an acetoacetate ketone diester (KDE) impaired performance in a 31.2 
km cycling time trial by 2±1% (58.2 sec) (Leckey et al., 2017). The latter effect was 
explained by a reduction in average power output by 3.7%, and coincided with a high 
prevalence of GI distress. Additionally, ingestion of a βHB salt formulation had no effect on 
average power output during a 4 min maximal performance cycling test (Rodger et al., 2017). 
A key distinction between these studies is the form of exogenous ketone supplement ingested. 
Acute ingestion of KME produces plasma βHB concentrations of ~3.0 mM after 20 min, but 
the KDE and racemic ketone salts result in blood βHB concentrations only in the 0.3 to 0.6 
mM range (Rodger et al., 2017; Leckey et al., 2017; Evans et al., 2017). While this 
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concentration range constitutes acute nutritional ketosis and is sufficient to impact the 
metabolic response to exercise (O'Malley et al., 2017; Evans et al., 2018), performance is 
unlikely to be impacted unless circulating βHB concentrations exceed 1.0 mM (Evans, Cogan 
and Egan, 2017). In the present study, the KE condition resulted in an elevation of plasma 
βHB concentrations to >1.5 mM after 15 min of exercise and reached ~2.6 mM by the end of 
exercise, which is broadly similar to previous work (Cox et al., 2016; Stubbs et al., 2017). 
Our participants ingested 750 mg.kg-1 body mass split across three boluses with 50% ingested 
20 min prior to commencing exercise, and the remainder split into aliquots of 25% ingested 
at 30 and 60 min of exercise, respectively. This feeding strategy mimics the previous work 
with KME ingestion and exercise performance, which resulted in plasma βHB concentrations 
of ~2 mM 20 min after ingestion, and ranged from ~2.0 to 3.0 mM throughout 90 min of 
exercise (Cox et al., 2016). In contrast, our participants only achieved these concentrations 65 
min after ingestion of the initial bolus of KE, but these participants ingested KE in the 
postprandial state as opposed to the fasted state in the KME work. Ingestion of KME in the 
post-prandial state can attenuate the Cmax of blood βHB concentrations by 33%, and the 4 h 
βHB AUC by 27% (Stubbs et al., 2017).  
Accordingly, despite the similar changes in circulating βHB concentrations to the 
previous investigation of performance effects using the KME (Cox et al., 2016), the KE 
condition in the present study was without benefit to 15 m sprint times throughout the 75 min 
intermittent running protocol (LIST Part A), or on shuttle run time to exhaustion (LIST Part 
B). The metabolic consequences of KME ingestion were recapitulated herein, namely lower 
plasma glucose and lactate concentrations during KE compared to PLA. A 10% reduction in 
plasma glucose was observed 35 min after ingestion of the initial KE bolus, and was 8 to 12% 
lower (moderate effects) during blocks 1, 2, 4 and 5 of Part A. The glucose-lowering effect of 
exogenous ketones is well-documented whether ingested alone (Cox et al., 2016; Stubbs et al., 
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2017; O'Malley et al., 2017; Evans et al., 2018; Stubbs et al., 2018) or in combination with 
carbohydrate and/or protein (Stubbs et al., 2017; Cox et al., 2016; Vandoorne et al., 2017; 
Leckey et al., 2017; Myette-Côté et al., 2018). While the insulinotropic action of ketone 
bodies is not always observed (Nair et al., 1988; Mikkelsen et al., 2015), it can occur under 
certain conditions (Balasse & Fery, 1989), including when KME is ingested in the fasted 
state (Cox et al., 2016; Stubbs et al., 2017; Stubbs et al., 2018). However, when co-ingested 
with carbohydrate and/or protein, the glucose-lowering effect of exogenous ketones occurs 
despite similar circulating insulin concentrations in response to carbohydrate and/or protein 
alone at rest (Myette-Côté et al., 2018), during exercise (Cox et al., 2016), and during 
recovery from exercise (Vandoorne et al., 2017). A βHB-mediated glucose-lowering effect is 
likely a result of an attenuation of hepatic gluconeogenesis and increase in hepatic glucose 
uptake (Mikkelsen et al., 2015). The rise in plasma lactate concentrations was attenuated 
during KE compared to carbohydrate ingestion alone, consistent with previous KME work 
(Cox et al., 2016). An attenuation in the exercise-induced rise in plasma lactate was 
previously explained by a reduction in glycolytic flux, sparing of muscle glycogen during 
exercise and an increased contribution of ketone bodies and intramuscular triglycerides to 
energy provision (Cox et al., 2016). Whereas a 50% reduction in the rise in plasma lactate 
was observed during a 60 min pre-load at 75% Wmax and 30 min time-trial in trained cyclists 
(Cox et al., 2016), we observed a reduction ranging from ~10 to 30%. Given the lower 
aerobic fitness in our team sport athletes, the trained cyclists may have had a greater capacity 
to extract ketones from circulation and oxidise them as a substrate, resulting in a larger 
contribution towards total energy production and a greater reduction in glycolytic flux. This 
is because ketone bodies are transported across the skeletal muscle membrane by 
monocarboxylate transporters (MCT), which are most highly expressed in type I muscle 
fibres, and are increased in response to endurance exercise training (Thomas et al., 2012).  
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For that reason, we previously hypothesised that performance benefits of exogenous 
ketones are most likely to be realised in those individuals with high levels of aerobic fitness 
and higher proportions of type I muscle fibres and/or MCT expression (Evans, Cogan and 
Egan, 2017). A lower level of aerobic fitness and training status, and therefore ability to 
oxidise circulating ketones may be one explanation for the lack of performance benefit in the 
present work. That notwithstanding, our performance test was shorter (~2 to 6 min) and 
intermittent in nature, which may be another factor contributing to the contrasting results. 
Another explanation may relate to the proposed benefits of exogenous ketone supplements 
being via their glycogen sparing effect. Given that we employed an optimal carbohydrate-
based fuelling on the day prior to and the day of each trial, our athletes may not have 
experienced glycogen depletion to an extent that the purported glycogen sparing would have 
benefited performance in Part B. In fact, standardized differences in the mean used to assess 
magnitudes of effects between KE and PLA indicate a small effect size for a decrement in 
performance with KE, so it would be remiss not to consider that the effect of exogenous 
ketones in this instance may have been to impair carbohydrate utilisation. 
Nutrition strategies such as high fat feeding, ketogenic diets and exogenous ketone 
ingestion alter substrate utilisation during exercise, which generally results in lower rates of 
carbohydrate utilisation at moderate-to-high exercise intensities (Spencer et al., 2005; Burke, 
2015, Pinckaers et al., 2017). Whether this shift in substrate utilisation reflects a sparing of 
muscle glycogen, which can then be utilised later in an exercise challenge, or instead reflects 
an impairment of muscle glycogen utilisation during such exercise intensities is a salient 
issue for alternative fuelling strategies. The mechanistic basis for reduced carbohydrate 
utilisation in the presence of exogenous ketones is proposed as an attenuation of glycolytic 
flux via inhibition of pyruvate dehydrogenase (PDH) and phosphofructokinase by increases 
in NADH:NAD+, acetyl-CoA:CoA or citrate. A similar mechanism is likely to contribute to 
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the impaired performance during moderate-to-high intensity efforts observed under high fat 
feeding (Havemann et al., 2006; Burke et al., 2017). The attenuation of PDH activity under 
such conditions (Stellingwerff et al., 2006) could be problematic for intermittent activity 
sports that require high intensity efforts, which rely heavily on ATP provision from 
glycolytic pathways, performed on a moderate intensity background. Clearly this is the nature 
of the exercise challenge in the present study, but future work will require direct 
measurement of PDH activity and glycolytic flux in muscle biopsies in order to make 
definitive conclusions about the effects of exogenous ketones on utilisation of muscle 
glycogen in this model. Conversely, we observed no benefit or decrement on 15 m sprint 
times performed at a rate of approximately nine sprints per 15 min block across 75 min of 
intermittent activity. Maximal short duration sprints rely primarily on the ATP-
phosphocreatine (PCr) system and anaerobic glycolysis for energy provision, but as the 
number of repeated sprints increases, the contribution of both decline and the contribution of 
aerobic glycolysis of circulating glucose and muscle glycogen increases over time (Gaitanos 
et al., 1993; Parolin et al., 1999). The lower plasma lactate concentrations in Part A during 
KE suggests a reduction in glycolytic flux, but the reduction ultimately did not impact 
performance in repeated sprints of <3 sec duration. 
 A higher incidence of gastrointestinal (GI) symptoms occurred during KE compared 
to PLA, although this did not affect the HR or RPE responses during exercise. GI symptoms 
are a common side effect of KME and KDE ingestion and more work is needed on the dose 
and timing of both these supplements to mitigate this response. KME ingested as part of meal 
replacement milkshake drink causes a step-wise increase in symptoms with increasing 
dosages (Clarke et al., 2012). Furthermore, ingestion of 500 mg.kg-1 body mass of KDE split 
in two doses caused symptoms in all participants during a cycling time-trial (Leckey et al., 
2017). These symptoms are likely to be a large contributor to the performance decrement in 
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that study given the participants’ nomination of their symptoms as a distraction or 
interference to performance. The incidence of GI symptoms was higher in the present study 
than in previous work with KME (Cox et al., 2016), but the aforementioned commencement 
of exercise in a fed as opposed to fasted state, or this protocol involving running as opposed 
to cycling exercise, may be contributing factors.  
 A novel finding herein is the preservation of executive function during KE compared 
to PLA, measured by the number of incorrect responses to a multi-tasking test. Given that 
team sport athletes are presented with a multitude of decisions throughout match play, 
interventions that preserve or improve cognitive performance could positively influence 
performance outcomes. The primary physiological role of ketogenesis as a survival 
mechanism during low carbohydrate availability is providing a substrate to the brain in the 
presence of diminishing blood glucose concentrations (Owen et al., 1967). Cognitive benefits 
and a neuroprotective role are established for exogenous ketones in non-exercise contexts 
(Ari et al., 2016; Murray et al., 2016; Kovacs et al., 2017; Svart et al., 2018). Notably, in a 
short-term (5 day) feeding study, rats supplemented daily with KME were 38% faster at 
completing a radial maze task, and made more correct decisions before making a mistake 
during the test (Murray et al., 2016). This outcome is consistent with our findings and 
suggests that central effects may be relevant during exercise, although other tests of cognitive 
function, i.e. reaction time and sustained attention tasks, were unaffected. 
 In conclusion, in team sport athletes acute ingestion of a ketone ester elevated plasma 
βHB concentrations, but did not improve performance in a shuttle run to exhaustion 
performed after 75 min of intermittent running. Reductions in plasma glucose and attenuated 
increases plasma lactate during exercise demonstrate the obvious effects of exogenous ketone 
ingestion on carbohydrate metabolism during exercise. However, participants experienced 
incidences of GI symptoms. These results underscore the need for future work to explore 
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possible dose-response effects while minimising any GI distress to athletes. Despite the lack 
of benefit to physical performance, the novel finding of preserved executive function after 
exhausting exercise suggests that there remains a possibility that exogenous ketones could 
enhance sport-specific performance of team sport athletes via other mechanisms. 
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Presented in manuscript format as submitted for review to Medicine and Science in 
Sports and Exercise in February 2019 (Appendix D).  
Evans M, McSwiney F, Brady A, Egan B. No benefit of ingestion of a ketone monoester 
supplement on 10-km running performance (currently under review) 
Abstract 
	
Introduction: Pre-exercise ingestion of exogenous ketones alters the metabolic response to 
exercise, but effects on exercise performance have been equivocal. Methods: On two 
occasions in a double-blind, randomized crossover design, eight endurance-trained runners 
performed 1 h of submaximal exercise at ~65% V̇O2peak immediately followed by a 10-km 
self-paced TT on a motorized treadmill. An 8% carbohydrate-electrolyte solution was 
consumed before and during exercise, either alone (CHO+PLA), or with 573 mL kg-1 of a 
ketone monoester supplement (CHO+KME). Expired air, heart rate (HR), and rating of 
perceived exertion (RPE) were monitored during submaximal exercise. Serial venous blood 
samples were assayed for plasma glucose, lactate and β-hydroxybutyrate concentrations. 
Results: CHO+KME produced plasma β-hydroxybutyrate concentrations of ~1.0 to 1.3 mM 
during exercise (P < 0.001), but plasma glucose and lactate concentrations were similar 
during exercise in both trials. V̇O2, running economy, respiratory exchange ratio, HR and 
RPE did not differ between trials. Performance in the 10-km TT was not different (P = 0.483) 
between CHO+KME (mean = 2402 s; 95% confidence interval [CI] = 2204, 2600 s) and 
CHO+PLA (mean = 2422 s; 95% CI = 2217, 2628 s). Cognitive performance, measured by 
reaction time and a multi-tasking test, did not differ between trials. Conclusion: Compared 
with carbohydrate alone, co-ingestion of KME by endurance-trained athletes elevated plasma 
β-hydroxybutyrate concentrations, but did not improve 10-km running TT or cognitive 
performance.  
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Introduction 
 
The therapeutic and performance potential of exogenous ketone supplements has been 
the subject of increasing interest in recent years (Egan & D'Agostino, 2016; Koutnik et al., 
2018). Metabolic effects the ketone bodies (KB), namely b-hydroxybutyrate (bHB), 
acetoacetate (AcAc), are well-established in many organs, including attenuation of glycolysis, 
hepatic glucose output and adipose tissue lipolysis (Robinson & Williamson 2018), but their 
potential role in modulating substrate utilization has garnered attention for athletic 
performance (Cox et al., 2016; Evans & Egan, 2018). In the fasted state, KB provide up to 10% 
of energy to skeletal muscle during exercise (Balasse & Fery, 1989), and after acute ingestion 
of exogenous ketone supplements, this contribution can increase to 16 to 18% when 
circulating bHB is elevated to the 3 to 4 mM range (Cox et al., 2016). Moreover, this increase 
in bHB oxidation coincides with a reduction in glycolytic flux, as evidenced by an 
attenuation in the exercise-induced rise in plasma lactate and glycolytic intermediates, and an 
increase in intramuscular triglyceride utilization during exercise (Cox et al., 2016).  
 Circulating KB concentrations are <0.1 mM in the postprandial state, whereas 
hyperketonaemia is accepted as KB concentrations exceeding 0.2 mM (Robinson & 
Williamson 1980). Ingestion of a variety of exogenous ketone supplements can acutely 
produce nutritional ketosis (Cox et al., 2016; Evans et al., 2018; Stubbs et al., 2018; Stubbs et 
al., 2017; Rodger et al., 2017; O'Malley et al., 2017; Leckey et al., 2017; Myette-Côté et al., 
2018; Waldman et al., 2017; Vandoorne et al., 2017; Holdsworth et al., 2017; Fischer et al., 
2018; Evans & Egan, 2018), which has been defined as circulating KB concentrations >0.5 
mM (Volek et al., 2015). The most potent of these exogenous ketone supplements is the (R)-
3-hydroxybutyl (R)-3-hydroxybutyrate ketone monoester (KME). When ingested at rest in 
the fasted state, KME produces a dose-dependent increase in circulating bHB concentrations 
of up to 6 mM 20 min after the ingestion of up to 573 mg.kg-1 body mass (Cox et al., 2016; 
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Stubbs et al., 2018). This elevation in bHB concentration coincides with decreases in plasma 
glucose, free fatty acids, triglycerides and ghrelin concentrations (Cox et al., 2016; Stubbs et 
al., 2017; Stubbs et al., 2018 Myette-Côté et al., 2018). Exercise attenuates the rise in bHB 
concentrations, as ingestion of 573 mg.kg-1 body mass KME prior to 45 min cycling at 45% 
and 75% peak power output (Wmax) resulted in circulating bHB of ~4.0 mM and ~3.0 mM, 
respectively. As a consequence of the aforementioned effects on substrate utilization, acute 
ingestion of KME attenuates the rise in plasma glucose and lactate concentrations during 
exercise, whether in an endurance cycling or intermittent running context (Cox et al., 2016; 
Evans & Egan, 2018). 
These metabolic consequences have been proposed to explain the observation that the 
co-ingestion of KME in addition to a carbohydrate-based fuelling strategy improved 
performance in a 30 min maximum distance cycling time-trial by 2% when preceded by 1 h 
of submaximal ‘pre-load’ exercise (Cox et al., 2016). In contrast, high-intensity shuttle 
running capacity (~4 to 6 min) performed after 75 min of intermittent running was not 
improved in team sport athletes with KME co-ingestion compared to carbohydrate alone 
(Evans and Egan, 2018). While the former study considering a ‘sparing’ of muscle glycogen 
to be major factor in the performance benefit (Cox et al., 2016), the latter study speculated 
that the attenuation of glycolytic flux in the presence of elevated circulating bHB may have 
been a factor in the lack of performance benefit in that exercise model (Evans & Egan, 2018). 
Performance in exercise of long duration that incorporates high intensity efforts (i.e. sprint 
finishes, climbs) is largely dependent on carbohydrate utilization (Hawley & Leckey, 2015). 
Therefore, nutrition strategies that could spare muscle glycogen and maintain high intensities 
in the latter parts of races are of interest to scientists and practitioners (Pinckaers et al., 2017). 
However, if glycogen sparing occurs via an attenuation of glycolytic flux that cannot be 
overcome when higher intensity efforts are required, this would instead be likely to impair 
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performance (Hawley & Leckey, 2017). Moreover, the recent observation that acute ingestion 
of KME prior to intermittent exercise in team sport athletes resulted in preserved executive 
function as measured by a decision-making task after volitional exhaustion (Evans & Egan, 
2018), remains to be confirmed in other exercise settings.  
 Therefore, the aim of the present study was to investigate the effects of acute 
ingestion of an exogenous ketone supplement in the form of a commercially-available KME 
on physiological responses, physical and cognitive performance in endurance-trained runners 
in response to 1 h submaximal exercise immediately followed by a 10-km time trial. We 
hypothesise ingestion of KME will have no effect on physical or cognitive performance in 
endurance-trained runners.  
 
Methods 
Participants 
Eight trained, middle and long distance runners (M/F, 7/1; age, 33.5±7.3 y; height, 
1.79±0.07 m; body mass, 68.8±9.7 kg; body fat, 8.0 ± 4.1 %; V̇O2peak, 62.0±5.6 mL kg-1 min-1) 
gave written informed consent to participate after written and verbal explanations of the 
procedures. Ethical approval (permit number: DCUREC2018_039) was obtained from the 
Dublin City University Research Ethics Committee in accordance with the Declaration of 
Helsinki.  
Experimental design  
Participants visited the laboratory for exercise tests on four separate occasions over a 
21 to 28 day period, comprising one baseline, one familiarization and two main experimental 
trials. During their first visit to the lab, each participant’s maximal rate of oxygen 
consumption (V̇O2peak) was determined using an incremental treadmill test to volitional 
exhaustion. The exercise protocol performed in the familarization visit (visit 2) and two main 
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experimental trials (visits 3 and 4) comprised of a pre-load of 1 h of treadmill running at 
65%V̇O2peak followed by a self-paced 10-km time-trial (TT) performance test performed on a 
motorized treadmill (Figure 5.1). A battery of cognitive tests were performed before and after 
the exercise protocol. The main experimental trials were performed in a double-blind, 
placebo-controlled, randomized crossover design. Visits 2, 3 and 4 were identical in terms of 
the pre-test preparation (standardized physical activity and diet for 24 h prior to each visit) 
and the exercise protocol. The visits differed only in the drinks consumed before and during 
exercise, namely an 8% carbohydrate-electrolyte solution, which was co-ingested with either 
a flavored placebo condition (CHO+PLA), or included the (R)-3-hydroxybutyl (R)-3-
hydroxybutyrate ketone monoester (CHO+KME). The primary outcome was endurance 
performance measured by time to complete the self-paced 10-km TT, with secondary 
outcomes including cognitive performance, oxygen consumption (V̇O2), running economy, 
respiratory exchange ratio (RER), heart rate (HR), rating of perceived exertion (RPE), and 
plasma bHB, glucose, and lactate concentrations. 
Assessment of V̇O2peak and submaximal running speeds 
Body mass was measured to the nearest 0.2 kg using a calibrated digital scales (SECA, 
Hamburg, Germany), and height was measured to the nearest 0.01 m using a wall-mounted 
stadiometer (Holtain, Crymych, UK). Body fat was determined by bioelectrical impedance 
analysis (DC-430U Dual Frequency Analyzer; Tanita, Arlington Heights, IL USA). All 
exercise testing and experimental trials were conducted on a motorized treadmill (T200; 
COSMED, Rome Italy). Initially, for the determination of the responses in V̇O2 and blood 
lactate concentration at submaximal running speeds, participants ran for 4 min stages at a 
progressively increasing speeds, interspersed with a 1 min rest interval for determination of 
blood lactate concentrations (Lactate Pro 2; Arkray, Kyoto, Japan , RPE (Borg scale) and HR 
(Polar H7; Polar, Kempele Finland). The first stage was 4 km h-1 slower than the average 
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speed corresponding to each participant’s personal best time for a 10-km race. For each 
subsequent stage, the running speed was increased by 1 km h-1 until the running speed 
exceeded the speed corresponding to their personal best 10-km race speed. After a 10 min 
rest, participants began running at a speed corresponding to the last completed speed of the 
preceding test. Treadmill speed was increased by 2.0 km h-1 every 2 min for two stages, after 
which treadmill gradient was increased by 1.0% every 1 min until volitional fatigue. Expired 
air was collected and analyzed throughout these tests using the Quark RMR metabolic cart 
(COSMED, Rome, Italy). V̇O2, carbon dioxide production (V̇CO2), and RER were calculated 
from an average of breath-by-breath measurements during the last 30 s of each stage during 
the submaximal running stages and the assessment of V̇O2peak. V̇O2peak was considered to 
have been achieved if two of the following criteria were achieved: (1) plateauing of V̇O2 
despite increasing treadmill speed (increase of less than 2.0 mL kg-1 min-1), (2) HR within 5% 
of the age-predicted HRmax (208 – 0.7 x age in years), and (3) an RER ≥1.10.  
Cognitive test battery  
The battery of cognitive tests (CANTAB Cognition, Cambridge, UK) was 
administered via a touch screen tablet lasting ~10 min. An identical test battery was 
administered before and after each trial in visits 2, 3 and 4.  
 During the reaction time (RTI) test, participants select and hold a button at the bottom 
of the screen and five circles are presented above. In each case, a yellow dot appears in one of 
the five circles, and the participants must react as soon as possible, releasing the button at the 
bottom of the screen, and selecting the circle in which the dot appeared. Release time (msec), 
reaction time (msec), and number of errors were recorded.  
 The multi-tasking test (MTT) is a test of executive function that measures the 
participant’s ability to switch attention between stimuli, and ignore task-irrelevant 
information. White arrows are displayed on a black background, with the arrows located on 
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either the left or right side of the screen, and pointing either to the left or to the right. A cue is 
displayed at the same time as the arrows, reading either “SIDE” or “DIRECTION”. When the 
“SIDE” cue is presented, the participant is required to press a button on the left or right of the 
screen corresponding to the side of the screen where the arrow is presented, regardless of the 
direction the arrow is pointing. Conversely, when the “DIRECTION” cue is presented, the 
participants are required to touch a button on the left or right of the screen corresponding to 
the direction the arrow is pointing, regardless of which side of the screen the arrow is 
presented. Reaction time (msec), and number of correct and incorrect responses were 
recorded.  
Pre-trial preparation  
All experimental trials commenced between 0730 and 1130, and were completed 
within a period of 4.0-4.5 h (Figure 5.1). On an individual basis, participants performed their 
second main experimental trial at the same time ±1 h as their first main trial. Pre-trial 
preparation was the same for the familiarization visit and each main experimental trial. 
Participants were asked to abstain from alcohol for 48 h and caffeine for 24 h, and refrain 
from strenuous exercise training on the day prior to each trial. For the day prior to 
experimental trials, participants were provided with a prescribed meal plan that provided 
~2800 kcal (~41 kcal.kg-1) at a macronutrient ratio of 60% carbohydrate (~6.2 g kg-1), 20% 
protein and 20% fat. Participants performed the two main experimental trials separated by 
either 7 or 14 days.  
Main experimental trials 
The protocol for the familiarization and main experimental trials were identical except 
for the drinks consumed before and during exercise (Figure 5.1). Participants arrived to the 
laboratory in a fasted state 2 h prior to the commencement of exercise, and immediately 
consumed a standardized breakfast of quick-cook porridge oats and cereal bars providing 
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~300-400 kcal (~4.4-5.8 kcal.kg-1) and ~1.0 g kg-1 of carbohydrate, and 500 mL of water. 
Participants proceeded to complete the cognitive test battery 45 min after breakfast. 
Thereafter, an indwelling catheter (21G Insyte Autoguard; Becton Dickinson, Franklin Lakes, 
NJ USA) was introduced into an antecubital vein for serial blood sampling at rest (-30 and 0 
min), during submaximal exercise (20, 40 and 60 min) and immediately after the 10-km TT. 
For each trial, a bolus of a given drink was ingested 30 min prior to exercise (drink 1), 
at 20 min intervals during the 1 h of submaximal running (drinks 2 to 4), and at the 5-km 
mark of the 10-km TT (drink 5) (Figure 5.1). The carbohydrate-based fuelling strategy (CHO) 
consisted of a 6.4% carbohydrate-electrolyte solution (Lucozade Sport; Lucozade Ribena 
Suntory Ltd., Uxbridge, UK) with maltodextrin (Cargill Inc,	 Minneapolis, MN USA) added 
to make an 8.0% carbohydrate-electrolyte solution that was provided at a rate of ~1.0 g min-1 
of exercise. During CHO+PLA, CHO was supplemented with denatonium benzoate, malic 
acid and arrow root extract to mimic the bitter taste and mouth-feel of the KME. During 
CHO+KME, CHO was supplemented with 573 mg.kg-1 body mass of a (R)-3-hydroxybutyl 
(R)-3-hydroxybutyrate ketone monoester (HVMNTM Ketone; HVMN, Inc., San Francisco, 
CA USA). The commercially-available ketone ester was mixed directly with the 
carbohydrate-electrolyte solution for ingestion, and the 573 mg.kg-1 body mass dose was 
divided into three boluses at a ratio 50:25:25 ingested at -30 min (drink 1), 20 min (drink 2) 
and 60 min (drink 4), respectively (Figure 5.1). During CHO+PLA, drinks 1, 2 and 4 were 
flavored with the bitter additives to taste match with CHO+KME, and in both trials, drinks 3 
and 5 were provided as the unadulterated 8% carbohydrate-electrolyte solution. All drinks 
were administered in opaque drinks bottles.  
For the exercise protocol, participants first performed a standardized 5 min warm up 
on the motorized treadmill (8 km h-1) followed by self-selected stretching. Participants then 
performed 1 h of treadmill running at a speed corresponding to ~65%V̇O2peak (Table 5.1). 
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Immediately after completion of the 1 h pre-load, participants completed a 10-km TT. The 
pre-load followed by TT protocol was modeled on the previous work demonstrating a benefit 
of KME on cycling TT performance (Cox et al., 2016), and has been similarly applied to 
treadmill running in previous studies (Russell et al., 2004; Scott et al., 2019). Prior to each 
TT, participants were told to complete the distance as fast as possible and they accelerated 
from a standing start by manually-adjusting a mounted control panel on the side of the 
treadmill. Participants were blinded to the speed of the treadmill and the time elapsed at all 
times, but were aware of the distance covered throughout the TT, including the 5-km mark 
when drink 5 was provided. After completing the 10-km TT, participants completed the same 
cognitive test battery as completed prior to exercise. 
 Venous blood samples were collected at 30 min prior to exercise, at 20 min intervals 
during submaximal exercise, and immediately after the 10-km TT. HR and RPE were 
recorded at 20 min intervals during submaximal exercise. Expired air was collected during 
the first 10 min, 25 to 30 min, and 55 to 60 min of the submaximal exercise for the 
monitoring of exercise intensity, and calculation of RER and running economy. Running 
economy is expressed as the volume of oxygen required to run 1 km relative to body mass 
(mL kg-1 km-1) (Barnes & Kilding, 2015). Incidences of gastrointestinal (GI) symptoms were 
recorded by interview after each trial. At the end of visit 4, participants completed an exit 
interview in which they were asked whether they could identify the CHO+KME condition, 
and to identify which experimental trial they believed that they performed their best TT.  
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Figure 5.1 Schematic of the study protocol. 
CHO, carbohydrate electrolyte solution; HR, heart rate; KME, ketone monoester; PLA, placebo; RPE, rating of perceived exertion 
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Blood analysis 
Blood was collected in plastic tubes (2 mL) containing sodium heparin (Plus Blood 
Collection Tubes; Becton Dickinson, Franklin Lakes, NJ USA) for subsequent analysis of 
βHB. A second blood sample was collected in plastic tubes (4 mL) containing sodium 
fluoride (Plus Blood Collection Tubes; Becton Dickinson, Franklin Lakes, NJ USA) for 
subsequent analysis of glucose and lactate. All collection tubes were pre-chilled, and blood 
samples were stored on ice before centrifugation at 3000 g for 10 min at 4ºC, after which 
aliquots of plasma were separated for storage at -80ºC until later analysis. Plasma βHB was 
determined by colormetric assay as per the manufacturer’s instructions (MAK041; Sigma-
Aldrich, Arklow, Ireland). Plasma glucose and lactate were measured using the RX 
DaytonaTM chemical autoanalyser and appropriate reagents as per the manufacturer’s 
instructions (Randox Laboratories, Crumlin, UK: assay codes GL3815 and LC3980, 
respectively).  
Statistical analysis 
Data were evaluated using Prism v8.0 (GraphPad Software, Inc., San Diego, CA USA) 
and are presented as mean [lower, upper 95% confidence interval (CI) of the mean], except 
for the participant characteristics, which are described as mean±SD. A paired samples t-test 
was used to determine differences between trials in time to complete the 10-km TT. The 
smallest worthwhile difference (SWD) was set at 0.2 between-subject SD, which is suggested 
to represent a practically-relevant change in performance in athletes (Hopkins et al., 2009). 
Thus, SWD corresponded to 48 sec, or 2.0%, for 10-km TT performance in this study. Two-
way (time x condition) repeated measures of analysis variance (ANOVA) was used to 
determine differences between the two experimental trials for all variables with serial 
measurements. When a main effect of condition, or an interaction effect between condition 
and time was indicated, post-hoc testing was performed with Bonferroni’s correction with 
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multiplicity-adjusted P values applied to compare CHO+KME to CHO+PLA at the 
respective time points. The data were tested for normality using Shapiro-Wilk test prior to 
proceeding with the parametric tests described. For null hypothesis statistical testing, the 
significance level was set at α = 0.05 for all tests.  
 
Results 
Plasma βHB, glucose and lactate concentrations 
Postprandial plasma concentrations of bHB (mean [95% CI]: CHO+KME, 0.27 [0.22-
0.33] mM; CHO+PLA, 0.28 [0.14-0.43] mM), glucose (CHO+KME, 3.96 [3.22-4.70] mM; 
CHO+PLA, 3.70 [3.06-4.35] mM), and lactate (CHO+KME, 1.04 [0.79-1.29] mM; 
CHO+PLA, 1.02 [0.84-1.20] mM) did not differ between trials (all P > 0.99). A main effect 
of time and condition (both P < 0.001) and a time-condition interaction effect (P < 0.001) 
were observed for plasma bHB concentrations (Figure 5.2A). Ingestion of CHO+KME 
resulted in a rise in plasma bHB concentrations to 0.99 (0.85-1.14) mM at 0 min. bHB 
concentrations peaked at 1.33 (1.13-1.52) mM during submaximal exercise at 40 min, with 
similar concentrations observed at the cessation of the 10-km TT at 1.33 mM (0.95-1.70) mM.  
 A main effect of time (P < 0.001) and condition (P = 0.027) was observed for plasma 
glucose concentrations (Figure 5.2B). Plasma glucose concentrations were lower in 
CHO+KME at 0 min, i.e. 30 min after ingestion of the first bolus of either CHO+KME or 
CHO+PLA (CHO+KME, 3.87 [3.22-4.70] mM; CHO+PLA, 4.52 [3.91-5.13] mM; P = 0.016) 
(Figure 5.2B). Plasma glucose concentrations rose throughout submaximal exercise (Figure 
5.2B) with the highest concentrations observed at cessation of the 10-km TT (CHO+KME, 
6.94 [5.60-8.28] mM; CHO+PLA 7.24 [5.93-8.54] mM), with no difference between trials 
(P > 0.99).  
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 A main effect of time (P < 0.001) was observed for plasma lactate concentrations, but 
were similar between trials at all time points (Figure 5.2C). Peak plasma lactate 
concentrations were observed at cessation of the 10-km TT (CHO+KME, 6.94 [4.15, 9.73] 
mM; CHO+PLA, 7.48 [5.46-9.51] mM; P = 0.738). 
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Figure 5.2 Plasma  bHB (A), glucose (B), and lactate (C) concentrations during ketone 
monoester and placebo trials 
Data are presented as mean values, with error bars representing 95% confidence intervals. *P < 0.05 for 
CHO+KME vs. CHO+PLA; ***P < 0.001 for CHO+KME vs. CHO+PLA. CHO+PLA, placebo; CHO+KME, ketone 
monoester 
	
	
Submaximal exercise 
Running speeds were identical between trials as per the study design. There was no 
difference in %V̇O2peak, V̇O2, running economy, V̇CO2, RER, HR, and RPE between 
CHO+KME and CHO+PLA during the submaximal exercise period (Table 5.1). Main effects 
of time were observed for the decline in RER (P < 0.001), and the increase in RPE (P < 0.001) 
during the submaximal exercise bout (Table 5.1). 
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Table 5.1 Physiological responses to 1 h of treadmill running at ~65% V̇O2peak  with carbohydrate co-ingested with either placebo or a 
ketone monoester 
 
  Time   
 0-10 min 10-30 min 30-60 min P value 
Running speed 
(km h-1) 
12.4 (11.3, 13.5) 12.4 (11.3, 13.5) 12.3 (11.1, 13.5) 
 
V̇O2 
(L min-1) 
   
Time, P = 0.517 
CHO+PLA 2.84 (2.52, 3.16) 2.84 (2.56, 3.12) 2.81 (2.53, 3.09) Condition, P = 0.153 
CHO+KME 2.78 (2.42, 3.13) 2.79 (2.42, 3.13) 2.72 (2.49, 2.95) Interaction, P = 0.700 
%V̇O2peak    Time, P = 0.576 
CHO+PLA 67.0 (62.8, 71.2) 66.9 (64.5, 69.4) 66.2 (63.8, 69.4) Condition, P = 0.170 
CHO+KME 65.3 (60.9, 69.8) 65.8 (62.6, 69.8) 64.1 (63.2, 65.0) Interaction, P = 0.710 
Running economy 
(mL kg-1 km-1) 
   
Time, P = 0.633 
CHO+PLA 202 (184, 219) 203 (185, 220) 202 (185, 219) Condition, P = 0.182 
CHO+KME 196 (181, 212) 199 (181, 217) 196 (179, 213) Interaction, P = 0.779 
V̇CO2 
(L min-1) 
   
Time, P = 0.058 
CHO+PLA 2.67 (2.36, 2.99) 2.60 (2.30, 2.90) 2.55 (2.26, 2.84) Condition, P = 0.470 
CHO+KME 2.63 (2.28, 2.98) 2.58 (2.28, 2.89) 2.50 (2.26, 2.74) Interaction, P = 0.677 
RER    Time, P < 0.001*** 
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CHO+PLA 0.94 (0.92, 0.96) 0.91 (0.89, 0.94) 0.91 (0.88, 0.93) Condition, P = 0.315 
CHO+KME 0.95 (0.92, 0.97) 0.92 (0.89, 0.96) 0.92 (0.89, 0.95) Interaction, P = 0.478 
HR 
(bpm) 
   
Time, P = 0.121 
CHO+PLA 141 (133, 149) 146 (137, 155) 145 (137, 154) Condition, P = 0.359 
CHO+KME 140 (131, 150) 144 (134, 154) 143 (134, 152) Interaction, P = 0.747 
RPE    Time, P < 0.001*** 
CHO+PLA 10 (9, 12) 11 (10, 13) 12 (10, 13) Condition, P = 0.903 
CHO+KME 10 (8, 12) 11 (9, 12) 11 (9, 13) Interaction, P = 0.656 
 
Data are presented as mean (95% CI), n = 8. ***P < 0.001. 
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10-km TT performance 
There was no statistically significant difference in 10-km TT performance between 
trials (CHO+KME, 2402 [2204-2600] s; CHO+PLA, 2422 [2217-2628] s; P = 0.483) (Figure 
5.3A). Compared to CHO+PLA, three participants demonstrated improvements in 
performance with CHO+KME that were greater than the SWD, and one participant 
demonstrated a decrement in performance with CHO+KME that was greater than the SWD 
(Figure 5.3B). The remaining participants’ differences in performance between trials were 
less than the SWD. Running speeds for each 2 km split during the 10-km TT did not differ 
between trials, but did increase progressively throughout the TT (main effect of time, P < 
0.001) (Figure 5.3C).  
 
Cognitive performance 
In the reaction time test (RTI), main effects of time (P = 0.026) and condition (P = 
0.026) were observed for release time, but no interaction effect was present  (P = 0.535), 
whereas an interaction effect was observed for reaction time  (P = 0.014) (Table 5.2). In the 
multi-tasking test (MTT), a main effect of time was observed for response latency (P = 
0.010), correct responses (P = 0.049) and incorrect responses (P = 0.036), but no main effects 
of time, or interaction effects were observed across these parameters (all P > 0.05) (Table 
5.2). Overall, there was no difference in cognitive performance between conditions in either 
the RTI, or MTT assessments (Table 5.2). 
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Figure 5.3 10-km time-trial performance (A), individual differences between CHO+KME compared to CHO+PLA (B), and running 
speeds for each 2 km split during the 10-km time-trials (C) in response to ketone monoester and placebo ingestion 
Data in (A) and (C) are presented as mean values, with error bars representing 95% confidence intervals. The shaded area in (B) represents the range for the smallest worthwhile 
difference in 10-km time-trial performance in this cohort.  CHO+PLA, placebo; CHO+KME, ketone monoester 
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Table 5.2 Cognitive performance in response to ketone monoester and placebo ingestion		
 
Data are presented as mean (95%CI), n=8. Symbols are #P < 0.05 for main effect of Time; §P < 0.05 for main effect of Condition; †P < 0.05 for 
Condition x Time interaction effect; *P < 0.05 for Post vs. Pre; ***P < 0.001 for Post vs. Pre. 
	
 
 
Reaction time test (RTI) 
 
Release time#,§ 
(msec) 
 
Reaction time† 
(msec) 
 Errors 
 Pre Post Post-Pre  Pre Post Post-Pre  Pre Post Post-Pre 
CHO+PLA 417 (373, 461) 401 (356, 446) -16 (-35, 2)  223 (171, 276) 221 (165, 278) -2 (-18, 14)  0.3 (-0.1, 0.6) 0.6 (0.0, 1.2) 0.4 (-0.4, 1.1) 
CHO+KME 430 (383, 477) 409 (368, 450)* -21 (-40, -2)  214 (176, 252) 232 (183, 282)* 18 (2, 34)  0.6 (-0.3, 1.5) 0.5 (0.0, 1.1) -0.1 (-1.3, 1.1) 
            
Multi-tasking test (MTT) 
 
Response latency# 
(msec) 
 Correct responses#  Incorrect responses# 
 Pre Post Post-Pre  Pre Post Post-Pre  Pre Post Post-Pre 
CHO+PLA 599 (500, 698) 561 (447, 674)*** -38 (-58, -18)  159 (157, 160) 157 (155, 159) -2 (-4, 1)  1 (0, 3) 3 (1, 5) 2 (-1, 4) 
CHO+KME 583 (513, 653) 541 (461, 622)*** -41 (-62, -21)  158 (157, 160) 157 (156, 159) -1 (-4, 2)  2 (0, 3) 3 (1, 4) 1 (-2, 4) 
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Gastrointestinal symptoms 
Out of 8 participants, 4 (50%) reported symptoms of GI distress during CHO+PLA 
and comprised 4 (50%), 3 (38%), 1 (13%), 1 (13%), and 1 (13%) incidences of belching, 
flatulence, reflux, urge to defecate, and diarrhoea, respectively. Out of 8 participants, 5 (63%) 
reported symptoms of GI distress during CHO+KME and comprised 3 (38%), 2 (25%), 1 
(13%), 1 (13%), 1 (13%), and 1 (13%) incidences of belching, urge to defecate, cramps, 
reflux, nausea, and stitch, respectively.  
Identification of CHO+KME and best performance trials 
Out of 8 participants, 2 (25%) correctly identified the trial in which they received 
CHO+KME, identifying CHO+KME by taste and a perceived alteration of performance. Six 
(75%) participants declared that they could not differentiate between CHO+PLA and 
CHO+KME. Seven (88%) participants correctly identified the trial in which they performed 
their best 10-km TT.  
 
 
 
Discussion 
 
	 The present study investigated whether the acute ingestion of a commercially-
available ketone monoester supplement altered metabolic responses, physical and cognitive 
performance in endurance-trained runners in response to 1 h of submaximal exercise 
immediately followed by a treadmill-based self-paced 10-km TT. Compared with placebo 
(CHO+PLA), ingestion of the ketone monoester (CHO+KME) elevated plasma β-
hydroxybutyrate to ~1.0 mM at the onset of submaximal exercise, and reached ~1.3 mM at 
the end of the 10-km TT. However, CHO+KME did not alter the metabolic or 
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cardiorespiratory responses to exercise, or demonstrate benefit to physical or cognitive 
performance compared to CHO+PLA ingestion.  
 The present study adds to the growing body of literature investigating the effects on 
exercise performance of elevating ketone body concentrations by exogenous means. The term 
“exogenous ketone supplement” encompasses a range of different forms of supplements, with 
each having differential effects on the metabolic response to exercise, and exercise 
performance. These studies have included the acute ingestion of a (R)-3-hydroxybutyl (R)-3-
hydroxybutyrate ketone monoester (KME) (Cox et al., 2016; Evans & Egan, 2018), and R,S-
1,3-butanediol acetoacetate ketone diester (KDE) (Leckey et al., 2017), racemic ketone salts 
(KS) (Evans et al., 2017; Rodger et al., 2017; O'Malley et al., 2017; Waldman et al., 2018), 
and the ketogenic compound 1,3-butanediol (BD) (Scott et al., 2019; Shaw et al., 2019) prior 
to and/or during an exercise challenge. One of the key metabolic consequences of ingesting 
exogenous ketone supplements is the elevation in circulating βHB, but we speculate that 
exercise performance is unlikely to be affected unless βHB concentrations exceed 1.0 mM 
(Evans, Cogan and Egan, 2017). To date, the only supplement to consistently exceed this 
threshold prior to an exercise challenge is the KME supplement (Cox et al., 2016; Evans & 
Egan, 2018). KS and KDE elevate βHB concentrations into the 0.3 to 0.6 mM range (Evans 
et al., 2017; Rodger et al., 2017; Leckey et al., 2017), and ingestion of BD elevates βHB 
concentrations into the 0.6 to 0.8 mM range (Scott et al., 2019; Shaw et al., 2019). 
Specifically focusing on KME ingestion and exercise studies, ingestion of 573 mg.kg-
1 body mass of KME in the fasted state elevated βHB concentrations to ~2.0 mM 20 min after 
ingestion where it remained throughout 1 h cycling exercise at 75%Wmax and a subsequent 30 
min TT (Cox et al., 2016). In the fed state, ingestion of 750 mg.kg-1 body mass of KME 
elevated βHB concentrations to >1.5 mM after 15 min of exercise, and ~2.6 mM by the end 
of 75 min of intermittent running followed by a short duration shuttle run to exhaustion 
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(Evans & Egan, 2018). In contrast to this previous work, plasma βHB concentrations in the 
present study were elevated to ~1.3 mM during the exercise protocol, which is lower than 
previously observed at the same 573 mg.kg-1 body mass dose (Cox et al., 2016). This 
attenuated rise in plasma βHB concentrations is unsurprising given that ingestion of KME in 
the fasted states consistently elevates circulating βHB to >3.0 mM (Stubbs et al., 2017; 
Stubbs et al., 2018), whereas ingestion of KME in the postprandial state results in circulating 
βHB in the range from ~1.0 to 2.5 mM (Cox et al., 2016; Stubbs et al., 2017; Evans & Egan, 
2018). For instance, ingestion of 395 mg.kg-1 body mass in the fasted state produces peak 
βHB concentrations of ~3.0 mM but only ~2.0 mM in the fed state, a 33% reduction in Cmax 
and coinciding with a 27% reduction in 4 h βHB AUC in resting participants (Stubbs et al., 
2017). Given that our participants were fed a lower initial dose of KME of 287 mg.kg-1 body 
mass, that this ingestion occurred in a postprandial state, and that exercise commenced 30 
min later, it is not surprising that we observed lower βHB concentrations prior to and during 
exercise compared to previous work. 
Although the present protocol achieved acute nutritional ketosis, a benefit to 
endurance performance was not observed. This finding is consistent with a number of studies 
that have failed to find a performance benefit of exogenous ketone supplements in various 
exercise models (Rodger et al., 2017; O'Malley et al., 2017; Leckey et al., 2017; Waldman et 
al., 2017; Evans & Egan, 2018). The variety of exogenous ketones supplements used, the 
large range of changes in circulating βHB produced, and a lack of consistency in the nutrients 
co-ingested and type of exercise challenge performed, make it difficult to make broad 
conclusions on the efficacy of these supplements. However, only one study to date has 
demonstrated a performance benefit with the ingestion of KME, which when co-ingested 
with CHO increased the distance covered in a 30 min cycling TT by ~2% (411 ± 162 m), 
when preceded by 1 h pre-load exercise at 75% Wmax (Cox et al., 2016). The proposed 
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mechanism for this improvement in performance was a shift in the contribution to energy 
provision from substrate utilization of carbohydrate to fat, as demonstrated by reduction in 
glycolytic flux resulting in a ‘sparing’ of muscle glycogen, and a concomitant increase in 
intramuscular triglyceride utilization during exercise (Cox et al., 2016).  
The mechanistic basis whereby elevated ketones reduce carbohydrate utilization 
during exercise is likely an attenuation of glycolytic flux via an inhibition of pyruvate 
dehydrogenase and phosphofructokinase by increases in NADH:NAD+, acetyl-CoA:CoA, or 
citrate. A reduction in glycolytic flux has been proposed to explain the attenuated exercise-
induced rise in plasma lactate observed in previous studies providing KME (Cox et al., 2016; 
Evans & Egan, 2018). This attenuation was ~50% during 60 min at 75%Wmax and 30 min TT 
in trained cyclists (Cox et al., 2016), and ~10% to 30% during 75 min of intermittent running 
in team sport athletes (Evans & Egan, 2018). However, no differences in plasma lactate were 
observed between trials in the present study either during the pre-load or TT periods. The 
submaximal exercise intensity of ~65%V̇O2peak employed was below lactate threshold for all 
participants, and therefore an intensity too low to observe an attenuation, if any, of the 
exercise-induced rise in plasma lactate. However, plasma βHB concentrations were 
elevated >1.0 mM before and at the cessation of the 10-km TT, yet no difference in plasma 
lactate was observed between trials.  
Similarly, while a glucose-lowering effect of KME ingestion is well-documented 
whether ingested alone (Cox et al., 2016; Stubbs et al., 2017; Stubbs et al., 2018), or co-
ingested with carbohydrate or protein (Cox et al., 2016; Stubbs et al., 2017; Myette-Côté et 
al., 2018; Vandoorne et al., 2017; Evans & Egan, 2018), we observed an attenuation in the 
rise in plasma glucose concentrations only at 30 min after ingestion of the first bolus of 
CHO+KME compared to CHO+PLA. This difference in plasma glucose between trials was 
absent during the submaximal exercise period and cessation of the 10-km TT. When effects 
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of KME ingestion on plasma glucose have been observed, the mechanism proposed has been 
an attenuation of hepatic gluconeogenesis and an increase in hepatic glucose uptake (Myette-
Côté et al., 2018). Under certain conditions, elevated ketone body concentrations may have 
an insulinotropic action (Balasse & Fery, 1989) but is not always observed (Nair et al., 1988; 
Mikkelsen et al., 2015). When co-ingested with carbohydrate and/or protein, the effect of 
exogenous ketones to attenuate postprandial glycemia occurs despite similar circulating 
insulin concentrations between conditions (Cox et al., 2016; Vandoorne et al., 2017; Myette-
Côté et al., 2018). 
We propose that the lack of differences between trials for plasma glucose and lactate 
in contrast to previous work suggests that the nature of the exercise challenge, or the degree 
of nutritional ketosis are key determinants of the metabolic effects of exogenous ketone 
supplements during exercise. While plasma βHB concentrations were elevated to ~1.3 mM at 
the cessation of the 10-km TT, concentrations were ~1.2 mM lower than observed in previous 
work demonstrating effects on plasma glucose and lactate during exercise (Evans and Egan, 
2018; Cox et al., 2016), The lower plasma βHB concentrations are a consequence of the 
aforementioned particulars of the dosing and feeding strategy, and future research should be 
cognizant of these issues when designing study protocols. 
  The brain is the primary site of ketone utilization under conditions of low 
carbohydrate availability (Owen et al., 1967). Elevated βHB concentrations are associated 
with a neuroprotective role in non-exercise contexts (Ari et al., 2016; Kovacs et al., 2017; 
Svart et al., 2018), and short-term (5 d) feeding of a diet was supplemented with KME 
improved performance of rats in a radial maze task by 38%, and improved decision-making 
during the test (Murray et al., 2016). Moreover, in our previous work, acute ingestion of 
KME preserved cognitive performance, measured by the number of incorrect responses to a 
multi-tasking test (Evans & Egan, 2018). This test was performed at the cessation of a short 
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duration intermittent run to exhaustion proceeding the Loughborough Intermittent Shuttle 
Test (LIST), a variable intensity running protocol that mimics soccer match-play (Nicholas et 
al., 2000). In contrast to previous results, we observed no difference in cognitive performance 
with the addition of KME in the present study. The specifics of the exercise challenge may 
play a role in these divergent findings. The LIST is a mentally-demanding task that requires 
participants to be aware of current and subsequent running speeds for 75 min. Mental fatigue 
has a negative impact on aspects of cognitive performance, including altered attentional focus 
(Boksem et al., 2005) and slower and less accurate reaction times (Boksem et al., 2006), 
suggesting that the more mentally demanding the task the larger deficit should be evident in 
cognitive performance. In the present study, we observed no decline in cognitive performance 
in either condition. The absence of decline is important to note because in our previous work, 
it was a preservation of cognitive performance with KME, not an absolute improvement 
(Evans and Egan, 2018). These results suggest the exercise challenge presently employed was 
not sufficiently mentally-demanding to negatively impact reaction time or executive function, 
and therefore, potential benefits were unlikely to be observed.  
 Concerns have been raised about the practical use of exogenous ketone supplements 
by athletes due to the high rates of occurrence of GI distress in previous work using BD 
(Shaw et al., 2019), KS (Evans et al., 2017; Fischer et al., 2018), KDE (Leckey et al., 2017), 
and KME (Evans & Egan, 2018). However, in the present study, incidences of GI distress 
were similar between conditions, and this is consistent with previous work using KME (Cox 
et al., 2016). Typically, rates of occurrence of GI distress are higher with exogenous ketone 
ingestion occur at a higher rate with increasing doses (Clarke et al., 2012; Evans et al., 2017; 
Evans & Egan, 2018). Importantly, no participants nominated GI distress as a distraction or 
detriment to performance during CHO+KME trials. 
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 In conclusion, the addition of a commercially-available ketone monoester supplement 
to a carbohydrate-based fuelling strategy prior to and during exercise did not improve 
performance in a self-paced, treadmill-based 10-km TT. Ingestion of the ketone monoester 
attenuated the rise in plasma glucose prior to exercise but concentrations were similar 
between trials thereafter, and no effect on the increase in plasma lactate concentrations during 
the 10-km TT was observed. Moreover, no differences between trials were observed for a 
range of physiological responses, and assessments of cognitive performance. Future research 
should evaluate different dosing strategies and exercise models to elucidate whether a 
threshold of plasma βHB concentration must be exceeded in order to exert performance 
benefits, and in which exercise contexts these benefits, if any, might be realized. 
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Main research findings 
	
 When starting this body of work in winter of 2015, there was a dearth of published 
research on exogenous ketones and performance despite their use in professional sport being 
rumoured in that year (Abraham, 2015). Shortly thereafter, the first published report 
demonstrating pleiotropic effects on exercise metabolism and a meaningful ergogenic effect 
in elite time-trial performance emerged (Cox et al., 2016). Three years later, the area 
continues to grow in scope. The aim of this thesis was therefore to elucidate, if any, the 
metabolic effects of acute exogenous ketone ingestion prior to exercise and their ergogenic 
potential in other exercise contexts. The studies and their key findings are summarised as 
follows: 
Study 1 
	
Ingestion of βHB ketone salts (KetoCaNa, KetoSports, United States) in two boluses 
of 0.38 g.kg-1 body mass prior to exercise elevated plasma bHB concentrations to ~0.4-0.5 
mM. Ingestion of the ketone salts decreased blood glucose by ~10% but had no effect on 
blood lactate concentrations versus a water control. These results agree with other work 
demonstrating a decrease in blood glucose even when bHB concentrations are <1.0 mM 
(O’Malley et al., 2017), but this does not always occur (Waldman et al., 2017; Rodger et al., 
2017).  
Study 2 
	
Ingestion of 750 mg.kg-1 body mass of	 a	 bHB monoester (KME) (KE4, KetoneAid, 
United States) had no effect on 15 m sprint times during 75 min of soccer simulated 
intermittent activity. Intermittent running time to exhaustion may have been impaired with 
bHB monoester ingestion. A novel finding of this work was the preservation of cognitive 
function with bHB monoester ingestion, measured by incorrect decisions during a decision-
making test but no difference was observed in reaction time or sustained attention. This work 
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contrasts with the seminal report on the ergogenic potential of exogenous ketones (Cox et al., 
2016) where an ergogenic effect of a bHB monoester was observed in a 30-min maximum 
distance cycling time trial. However, the metabolic effects of elevated bHB concentrations in 
this study were a decrease in blood glucose and lactate concentrations, which are in 
agreement with other works (Cox et al., 2016; Stubbs et al., 2017; Leckey et al., 2017; 
Myette-Côte et al., 2018). 
Study 3 
	
Ingestion of 573 mg.kg-1 body mass of the (R)-3-hydroxybutyl (R)-3-hydroxybutyrate 
ketone monoester (HVMN Ketone, HVMN, United States) had no effect on a 10-km self-
paced time trial following a 60-min pre-load at 65% V̇O2peak. Cognitive performance 
improved to a similar extent in various measures in both conditions. These data contrast with 
previous results investigating the ergogenic potential of KME in endurance exercise (Cox et 
al., 2016) and in cognitive performance (Evans et al., 2018). We previously observed a 
preservation of cognitive performance with KME ingestion, but this is not to be confused 
with an improvement in cognitive performance. Both conditions in this study improved in 
several measures of cognitive performance in a similar manner. 
 
Metabolic response to ketone salt ingestion during exercise 
Acute ingestion of two servings ketone salts (KS) in the hour prior to exercise 
elevates plasma bHB concentrations to ~0.44 ± 0.27 mM (Evans et al., 2018), while one 
serving KS elevates whole blood bHB concentrations between 0.5-0.8 mM (O'Malley et al., 
2017; Rodger et al., 2017; Waldman et al., 2018), when measured by handheld point-of-care 
monitors. This modest elevation in bHB is accompanied by an ~10% decrease in plasma 
glucose during submaximal exercise (O'Malley et al., 2017; Evans et al., 2017). During 
submaximal exercise, plasma lactate is not affected by acute KS ingestion (Rodger et al., 
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2017; O'Malley et al., 2017; Waldman et al., 2018; Evans et al., 2018). RER findings are 
divergent, both raising (Evans et al., 2018) and lowering (O'Malley et al., 2017) the RER, 
which may be accounted for by the difference in serving size and training status of 
participants. Doubling the recommended dosage of KS was accompanied by a high incidence 
of gastrointestinal distress during exercise, namely nausea, diarrhoea, vomiting and light 
headedness, ostensibly because of the hyperosmotic salt load delivered (Evans et al., 2018). 
 Higher HR values have been observed in response to ketone salt ingestion during 
exercise (Evans et al., 2018) and bHB infusions at rest (Gormsen et al., 2017; Svart et al., 
2018), but this is not always observed during exercise (Waldman et al., 2018). 
 
Metabolic response to ketone ester ingestion during exercise  
In one of a series of experiments, ingestion of 573 mg.kg-1 body mass (R)-3-
hydroxybutyl (R)-3-hydroxybutyrate ketone monoester (KME) prior to 45 min cycling at 40% 
and 75% peak power output elevated bHB concentrations to ~4.0 mM and ~3.0 mM 
respectively and bHB contributed 18% and 16% towards total oxygen consumption. The 
exercise induced rise in plasma lactate was attenuated by ~50% during 1 h cycling at 75% 
Wmax compared to isocaloric carbohydrate ingestion (Cox et al., 2016). Similarly, in study 2 
of this thesis, ingestion of KME resulted in elevated plasma bHB concentrations of ~1.0-3.0 
mM, reduced plasma lactate and glucose concentrations in team sport athletes throughout a 
simulated soccer protocol (Evans & Egan, 2018). In study 3 of this thesis, we observed a 
reduction in plasma glucose 30 min after ingestion of KME, thereafter concentrations were 
similar between KME and placebo conditions throughout a 1 h pre-load at 65% V̇O2peak and 
after a 10-km self-paced treadmill based time trial, but with no differences in plasma lactate 
concentrations. 
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 The glucose-lowering effect of KME and KDE when ingested prior to exercise is 
well-demonstrated (Cox et al., 2016; Leckey et al., 2017; Vandoorne et al., 2017; Myette-
Côté et al., 2018; Evans & Egan, 2018). This effect is most likely explained by reduced 
hepatic gluconeogenesis (Mikkelsen et al., 2015) and occurs independently of differences in 
circulating insulin between conditions where KME is present or absent with carbohydrate or 
carbohydrate-protein ingestion (Vandoorne et al., 2017; Myette-Côté et al., 2018; Vandoorne).  
 KME and KDE ingestion prior to exercise attenuates the exercise-induced increase in 
plasma lactate during endurance and intermittent activity (Cox et al., 2016, Leckey et al., 
2017; Evans & Egan, 2018), but in study 3 on this thesis did not occur during a 60-min pre-
load at 65% V̇O2peak or after the 10 km time-trial in a population of trained endurance runners 
following KME ingestion. These differences are explained by the intensity of the pre-load, 
which was below each runner’s lactate threshold and did not elevate plasma lactate in either 
condition. One of the main proposed benefits of exogenous ketones is a ‘glycogen sparing’ 
mechanism that will confer an advantage during periods of competition that are high intensity 
in nature and carbohydrate-dependent (Pinckaers et al., 2017; Evans et al., 2017). 
Carbohydrate utilisation is reduced during submaximal exercise with KME ingestion in the 
fasted state (Cox et al., 2016), and it remains to be seen whether this sparing of carbohydrate 
can be overcome later in exercise or whether it will impair performance if the exercise 
duration is long enough. When compared to the lack of effect of KS ingestion on plasma 
lactate, bHB concentrations between ~1.0 to 2.0 mM may be required to elicit an attenuation 
in plasma lactate concentrations.  
 
Effect of acute ingestion of a bHB ketone monoester on physical performance 
Ingestion of 573 mk.kg-1 body mass KME improved 30-min max distance cycling 
time trial performance by ~2% (411 ± 162 m), following a 1 h pre-load at 75% Wmax. The 
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drinks consumed in these trials were isocaloric, meaning performance improved despite 
receiving less carbohydrate during the KME trial (Cox et al., 2016). Since then, only two 
reports on the physical performance effects of acute ketone ester ingestion have been 
published (Leckey et al., 2017; Evans & Egan, 2018). Only the latter (study 2 of this thesis) 
utilised a KME and therefore is discussed in detail for contrast with the work of Cox et al. 
(2016). Study 3 of this thesis will add to literature in this area. 
 Ingestion of 750 mg.kg-1 body mass KME ingested 20-min before exercise and at 30-
and 60-min of soccer simulated intermittent activity divided in three aliquots (50:25:25) had 
no effect on 15 m sprint times during a 75 min simulated soccer protocol or subsequent run to 
fatigue time (KME, 229±72 s; PLA 267±96 s; p=0.126; ES=0.45 small) in team sport athletes 
(Evans & Egan, 2018).  
 The divergent findings in relation to performance between study 2 and the original 
KME work (Cox et al., 2016) may be explained by the training level of the participants. KME 
ingestion elevated plasma bHB to >1.5 mM at start of exercise and reached ~2.6 mM at the 
end of exercise, and reduced plasma lactate and glucose concentrations during exercise 
(Evans & Egan, 2018). The concentrations are similar to those achieved in endurance trained 
cyclists, however, KB are transported across the skeletal muscle membrane by 
monocarboxylate transports (MCT). MCT concentrations are highest in type 1 muscle fibres, 
and are increased in response to endurance training (Bonen, 2001; Thomas et al., 2012). This 
would suggest endurance athletes would have a higher capacity to extract KB from the blood 
and oxidise them as a substrate.  
 In trained runners, ingestion of 573 mg.kg-1 body mass KME did not improve 10 km 
treadmill based time trial performance. KME was split into three aliquots (50:25:25) and 
ingested 30 min prior to and at 20 and 40 min of a 1 h pre load at 65% V̇O2peak. These 
findings contrast to the ergogenic effect observed in cyclists with a similar dosing and timing 
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strategy (Cox et al., 2016). This may be accounted for in the different endurance modalities 
employed in the studies (cycling vs. running). On the rationale of an ergogenic benefit due to 
a ‘glycogen sparing’ effect, it is possible that either the intensity of the pre-load was not 
sufficient to elicit an substantial depletion of muscle glycogen, or the duration of the 
performance test (35-45 min) was not long enough to be limited by muscle glycogen 
availability. However, the previous report utilised a 30 min maximal distance cycling time 
trial so this cannot account for the difference between studies. 
 Furthermore, the central tenet is that the combination of fuel sparing and improved 
energetic efficiency during acute nutritional ketosis confers performance benefits (Cox et al. 
2016). Alterations in fuel selection during steady-state exercise have been demonstrated, 
which indicate reduced glycolytic flux, sparing of CHO and increased contribution of IMTG 
and βHB to energy provision (Cox et al., 2016). Whether this sparing of CHO, in fact, 
manifests as impaired CHO utilisation remains to be determined. The mechanistic basis for 
CHO sparing by exogenous ketones is presently proposed as inhibition of glycolytic flux via 
inhibition of PDH and PFK by increases in NADH:NAD+, acetyl-CoA:CoA ratio or citrate.  
In theory, this could be problematic for sports that rely heavily on contributions from 
glycolytic pathways, or a range of sports that are intermittent and/or require periods of high 
intensity ‘bursts’ on a moderate intensity background. However, the use of ‘sparing’ or 
‘impairing’ of glycogen may be a misnomer, as both refer to the downregulation of 
carbohydrate metabolism via the same mechanism. In the current work, glycogen sparing 
refers to a downregulation of carbohydrate metabolism early in exercise, alongside an 
elevation in circulating bHB due to the ingestion of exogenous ketones, which can then be 
utilised later in the exercise challenge. If this downregulation of carbohydrate metabolism 
cannot be overcome later in exercise, resulting in an impairment of carbohydrate oxidation, 
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this would be termed glycogen impairing and likely lead to a performance decrement in 
sporting events that require a high rate of ATP turnover.   
 
Cognitive performance after exercise after ingestion of a bHB ketone monoester 
Cognitive performance after acute exogenous KS or KME ingestion is not well 
described in humans with only two recent reports in the published literature (Waldman et al., 
2018; Evans & Egan, 2018) and study 3 will add to this area. Ingestion of 750 mg.kg-1 body 
mass KME before and during exercise preserved executive function compared to a placebo 
drink, measured by the number of incorrect responses to a multi-tasking test. KME ingestion 
had no effect on reaction time or sustained attention, measured by latency of response and 
correct/incorrect responses. Cognitive tasks were performed immediately after a 75 min 
simulated soccer protocol and subsequent 4-6 min run to exhaustion (Evans & Egan, 2018). 
Following acute ingestion of one serving KS, participants completed a 5-min reaction test 
during their warm up and immediately following 4x15 s anaerobic Wingate sprints on a cycle 
ergometer. No effect on reaction time was observed after the anaerobic activity despite a 
higher fatigue index in the KS condition (KET: 32.3 ± 13.9 W.s-1; PLA: 29.2 ± 12.6 W.s-1), 
however a learning effect is noted by the authors for hits and misses on the same test 
(Waldman et al., 2018). These studies used different forms of exogenous ketones, dosing 
strategies and performance tests. These protocols may not have been long enough to cause 
the aforementioned reduction in whole body energy stores or dehydration to cause substantial 
decline in cognitive function (Tomporowski, 2003), and would seemingly agree that short 
exercise has little impact on cognitive function and exercise lasting <90 min exerts a selective 
influence on cognitive ability.  
 In study 3 of this thesis, in contrast to previous results in study 2, we observed no 
difference in cognitive performance with the addition of KME to carbohydrate compared to 
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placebo ingestion. The specifics of the exercise challenge may play a role in these divergent 
findings. The Loughborough Intermittent Shuttle Test used in study 2 is a mentally-
demanding task that requires participants to be aware of current and subsequent running 
speeds for 75-min. Mental fatigue has a negative impact on aspects of cognitive performance, 
including altered attentional focus (Boksem et al., 2005) and slower and less accurate 
reaction times (Boksem et al., 2006), suggesting that the more mentally demanding the task 
the larger deficit should be evident in cognitive performance. In study 3, we observed no 
decline in cognitive performance in either condition. The absence of decline is important to 
note because in our previous work, it was a preservation of cognitive performance with KME, 
not an absolute improvement (Evans & Egan, 2018). These results suggest the exercise 
challenge employed and the degree of mental challenge are important factors when 
evaluating the effect on cognitive performance 
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Table 6. 1 Summary of the effects of ketogenic supplements on physical and cognitive performance.  
 
Paper	 Exercise	challenge	 Study	design	
Exogenous	
ketone	
supplement	
Dose	of	ketone	
supplement	
	βHB 
concentrations	
Effects	on	
physical	
performance	
Effects	on	
cognitive	
performance	
Cox	et	al.,	
(2016)	
1	h	steady	
state	cycling	
(75%	Wmax)	
	
30	min	
maximal	
distance	
cycling	time	
trial	
βHB 
monoester plus 
carbohydrate 
vs isocaloric 
carbohydrate 
(R)-3-
hydroxybutyrate-
(R)- 1,3-
butanediol 
monoester 
573	mg.kg-1	
body	mass	
(2:1:1)	
2.0-2.5	mM	
Time	trial	
performance	
improved	with	
addition	of	
βHB 
monoester by 
approx. 2% 
(411 ± 162 m) 
N/A	
O’Malley	et	al.,	
(2017)	
3x5	min	cycling		
(30,	60,	90%	
VT)	
	
150	kJ	time	
trial	(approx.	
10km)	
βHB salt vs 
flavour 
matched 
acaloric 
placebo	
βHB	salt	 0.3	g.kg
-1	body	
mass	βHB salt	 0.8	mM	
Time	trial	
performance	
impaired	with	
βHB salt		
	
βHB salt: 711 
± 137 s 
Placebo: 665 ± 
120 s 
N/A	
Rodger	et	al.,	
(2017)	
90	min	cycling	
(80%	VT2)	
	
4	min	maximal	
cycling	
βHB salt vs 
flavour 
matched 
acaloric 
placebo 
βHB	salt 
2	servings	
(11.7	βHB	per	
serving)	
0.6	mM	
No	difference	
in	maximal	or	
average	
wattage	
between	
N/A	
	 137	
performance	
task	
conditions	
Waldman	et	
al.,	(2017)	
Four	maximal	
15	s	cycling	
sprint	trials	(4	
min	active	
recovery)	
βHB salt vs 
flavour 
matched 
acaloric 
placebo 
βHB	salt 1 serving (11.38 g βHB)	 0.5	mM	
Higher fatigue 
index during 
15 s sprints in 
βHB salt 
condition.  
 
No effect of 
condition on 
mean power, 
peak power or 
total work 
performed. 	
No	effect	of	 
βHB salt on	
average	or	
slowest	
response	time	
during	a	
reaction	time	
task		
Leckey	et	al.,	
(2017)	
4x5	min	warm	
up	
	
31.2	km	cycling	
time	trial	
AcAc diester 
vs taste 
matched 
placebo 
R,S-1,3-
butanediol 
acetoacetate 
diester. 
500 mg.kg-1 
body mass split 
in to two 
boluses  
0.4	mM	
Time to 
complete time 
trial approx. 
2% longer with 
AcAc diester 
vs. placebo 
ingestion (58 
s).  
N/A	
Evans	and	
Egan	(2018)	
75	min	
intermittent	
running		
	
Intermittent	
run	to	
exhaustion	
βHB 
monoester plus 
carbohydrate 
vs isocaloric 
carbohydrate 
(R)-3-
hydroxybutyrate-
(R)- 1,3-
butanediol 
monoester 
750 mg.kg-1 
body mass 1.0	-	2.6	mM	
No effect on 15 
m sprint times 
during 75 min 
intermittent 
running 
 
My have 
impaired short 
duration 
intermittent 
No	effect	of	
condition	on	
tests	of	
reaction	time	
or	sustained	
attention.		
	
Addition	of		 
βHB 
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running to 
exhaustion 
monoester may 
have preserved 
decision 
making	
Evans	et	al.,	
(2019)	
1	h	treadmill	
running	(65%	
VO2peak)	
	
Self	paced	
treadmill	
based	10	km	
time	trial	
βHB 
monoester plus 
carbohydrate 
vs isocaloric 
carbohydrate 
(R)-3-
hydroxybutyrate-
(R)- 1,3-
butanediol 
monoester 
573 mg.kg-1 
body mass 1.6	mM	
No effect on 
self paced 10 
km time trial 
performance 
No	effect	of	
condition	on	
tests	of	
reaction	time	
or	decision	
making		
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Emerging issues and future directions for research in exogenous ketone 
supplementation in athletic performance 
	 Considering the recent emergence as exogenous ketone supplements as a method to 
induce acute nutritional ketosis and alter the metabolic response to exercise, more research on 
their effects on physical and cognitive performance needs to be undertaken before any 
statements can be made on the ergogenic potential for athletes and active adults. There 
remains only report of an ergogenic effect of exogenous ketones (Cox et al. 2016). Reports 
on various forms of exogenous ketones have reported either no effect (Rodger et al. 2017, 
Waldman et al. 2017, Evans and Egan. 2018, Study 3) or an impairment in physical 
performance (Leckey et al. 2017, O’Malley et al. 2017).   
  As with any ergogenic aid or nutrition strategy, optimising dosing strategies 
including quantity and timing will be important. Given the saturation kinetics of KB 
oxidation by skeletal muscle and curvilinear relationship between oxidation and plasma 
concentrations, it is likely that there is an optimal range for performance benefits. At present, 
we speculate that this exists between 1 and 3 mM βHB. As with many ergogenic acids, more 
is unlikely to be better and may even be deleterious given the potential for acidosis at higher 
KB concentrations, and aforementioned gastrointestinal distress and other side-effects 
sometimes observed with KS, KME and KDE, so careful consideration should be given to 
these issues. 	
 KME, KDE and KS are proposed as performance-enhancing dietary supplements and 
are available for purchase commercially, with the exception of KDE, which is only available 
for research purposes. Performance-enhancing dietary supplements pose a greater challenge 
than other forms of dietary supplements due to the scarcity of quality research applicable to 
the elite athlete (Maughan et al., 2018). Future studies in exogenous ketone supplementation 
should be cognisant of several of the following important aspects of performance science 
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research to make the largest impact possible (Maughan et al., 2018; Burke & Peeling, 2018). 
Studies should be conducted in double-blinded design where participants are randomised to a 
control or experimental group or in a crossover design where participants receive both 
treatments. Researchers should aim for adequate sample sizes and appropriate participant 
characteristics to gain statistical power, should mimic conditions of real-life events, 
standardise pre-trial preparation across trials (exercise/diet/caffeine ingestion etc.) and 
environmental factors during each trial (temperature, encouragement), use a tested verified 
non-contaminated substance with an appropriate protocol (dosage/timing) and use a reliable 
and valid performance test (Maughan et al., 2018; Burke & Peeling, 2018). Studies 2 and 3 of 
this thesis have aimed to satisfy these recommendations. 
Standardising of reporting methodologies specifically related to exogenous ketone 
supplementation will be important to elucidate that may benefit from supplementation and 
are outlined below.  
 bHB measurement: Verification that a potential performance-enhancing supplement 
was ingested and elicited a biological response should be undertaken in sports performance 
research (Maughan et al., 2018). Ingestion of KS, KME and KDE elevates blood/plasma bHB 
concentrations and should be used to measure responses in experimental and placebo 
conditions. Laboratory assays using reagent and colorimetric assays (Daytona; Sigma Aldrich) 
should be considered the gold standard for measurement of plasma bHB concentrations to 
standardise interpretation of results. Handheld monitors (Precision Neo, etc) measure whole 
blood bHB and overestimated bHB concentrations by ~1.0 mM during a 31.2 km time trial in 
cyclists compared to bHB measured in serum samples (Leckey et al., 2017). If using 
handheld monitors, overestimation should be clearly mentioned and should be reported as 
whole blood bHB concentrations. The use of handheld monitors raises an issue with the 
blinding of a performance study, as they allow immediate measurement of whole blood bHB 
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concentrations. In a performance study utilising crossover design comparing exogenous 
ketones to a carbohydrate fed condition, bHB concentrations will remain at baseline in the 
carbohydrate condition and will be elevated in the ketone condition, de-blinding the study. If 
using a handheld monitor, a researcher who is not involved in the performance testing 
(encouragement etc.) should analyse whole blood samples for bHB concentrations and ensure 
that the participant is not aware of the concentrations in order to ensure that the experiment 
remains blinded.  
 Recovery: KB have an anti-catabolic effect (Thomson & Wu, 1991), attenuating 
leucine oxidation, and increasing MPS by 10% when bHB is elevated to ~ 2.0 mM (Nair et 
al., 1988). Work utilising a practically-relevant glycogen-depleting protocol and optimal 
carbohydrate and protein-based recovery strategies will elucidate whether the addition of 
exogenous ketones confers any benefit to glycogen re-synthesis and MPS. Recovery from 
exercise, in terms of glycogen re-synthesis becomes more important when a short amount of 
time is available between bouts of exercise (i.e. multiple heats). Recently, infusion of ketone 
bodies produced a robust anticatabolic response under an acute inflammatory condition insult 
provided by lipopolysaccharide endotoxin, reducing phenylalanine efflux by 70% in fasting 
conditions over the course of 6 h compared to saline and free fatty acids (Thomsen et al., 
2018). Maintenance of lean mass during calorie restriction and weight loss, which may be 
applicable to weight dependent sports or during periods of intensive training is of interest. To 
our knowledge, there is no work investigating the anticatabolic effects of ketone bodies in 
skeletal muscle in combination with amino acids. However, ingestion of 0.5 mg.kg-1 body 
mass KME provided alongside carbohydrate and protein during a 5 h recovery period from a 
glycogen-depleting protocol resulted in higher mTORC1 activation via downstream 
signalling compared to a placebo carbohydrate and protein drink (Vandoorne et al., 2017). If 
the addition of ketone bodies to amino acids produces a greater net muscle protein balance, 
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either by increasing MPS or reducing muscle protein breakdown, it may represent a novel 
recovery paradigm worth investigating in athletes.  
 Exogenous ketone dose: KME, KDE and KS dosages are reported using a variety of 
methods: mg.kg-1 body mass (Cox et al., 2016; Leckey et al., 2017; Evans et al., 2018), 
mM.kg-1 body mass (Stubbs et al., 2017), kcal.kg-1 (Stubbs et al., 2018) and mL.kg-1 
(Holdsworth et al., 2017; Myette-Côté et al., 2018) and g.kg-1.h-1 (Vandoorne et al., 2017). 
Researchers and practitioners require a standardised reporting method to inform their own 
work and avoid misinterpretations. A standardised measurement of mg.kg-1 body mass total 
supplement is recommended. A salient issue with KS ingestion is the associated 
gastrointestinal distress experienced with higher dosages (Evans et al, 2017). Despite 
receiving double the manufacturers recommended dosage, bHB was elevated to ~0.4-0.5 mM 
during a graded exercise session, which is well below the ~1.0 mM threshold needed to have 
a meaningful contribution to fuel provision and the hypothesised level to enhance 
performance (Cox et al., 2016; Evans et al., 2017). Under fed conditions, KME dose >573 
mg.kg-1 body mass may be required to elevate bHB to 1.0-3.0 mM and elicit an ergogenic 
effect.  
 Substrate oxidation: Traditional equations used to calculate substrate oxidation 
assume negligible contributions from non-carbohydrate and fat sources, including KB (Frayn, 
1983). KME ingestion increases the contribution of bHB to total oxygen consumptions to 16% 
to 18%, calculated using novel and possibly flawed methods of estimation (Cox et al., 2016). 
Therefore, use of traditional methods for calculating substrate oxidation are unsuitable during 
acute nutritional ketosis. Careful interpretation of RER during exercise is needed, as the 
stoichiometry of AcAc, the final step in KB oxidation, is 1.00, similar to that of carbohydrate 
(Frayn, 1983). A recent report on a shift from carbohydrate to fat oxidation during an 
incremental steady state protocol and subsequent time trial using traditional equations likely 
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do not reflect the true substrate oxidation proportions during the exercise challenge (O'Malley 
et al., 2017). Reporting of RER is likely to be all that is valid in reporting indirect calorimetry 
data unless the methods of Frayn (1983) are employed, but these too rely on assumptions that 
might not be valid in the context of acute nutritional ketosis. 
 Product racemity: Commercially-available KS provide a racemic mixture of βHB, i.e. 
containing both the D- and L- enantiomers of βHB (also designated R- and S-, respectively), 
whereas various βHB assays only determine D-βHB concentrations. Ingestion of a 
commercially available KS (KetoForce, KetoSports, United States) elevates L-bHB to ~2.0 
mM (Stubbs et al., 2017). However, L-bHB is not a substrate for mitochondrial BDH a key 
ketolytic enzyme and is not metabolised to AcAc, and is therefore not a substrate for skeletal 
muscle metabolism (Scofield et al., 1982). If possible, purity analysis defined as the D-bHB 
content of the supplement, or L-bHB analysis should be undertaken to account for differences 
in product racemity.  
 Storage of samples: bHB is a very stable metabolite in plasma and whole blood 
samples, allowing for measurement up to 7 days after sample collection when stored at 4 °C, 
or for longer periods when stored at -80 °C (Custer et al., 2001) Degradation of AcAc in 
plasma samples was thought to be rapid, with guidelines suggesting measurement must take 
within 24 h of sample collection or stored for no longer than 3 days at -20 °C. This was based 
on data showing 80% and 30% of AcAc was lost from plasma samples after 3 d storage at 
room temperature and -20 °C, respectively (Price et al., 1977; Stubbs et al., 2018). However, 
degradation of AcAc in plasma is reduced when stored at -80 °C, with only 14% lost over 40 
days of storage (Fritzsche et al., 2001). Moreover, AcAc is stable when de-proteinised with 
perchloric acid and stored at -80 °C for 60 days, and is more stable in plasma than whole 
blood samples. De-proteinisation ensures removal of 3-hydroxutyrate dehydrogenase, 
meaning that AcAc is not being reduced to bHB (McNeil et al., 2014). A comparison 
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between non de-proteinised and de-proteinised samples was not undertaken in this latest 
study (McNeil et al., 2014), but no difference in AcAc concentrations were noted when 
samples were left proteinised and non-de-proteinised prior to analysis in a previous study 
(Galán et al., 2001). Analysis of AcAc concentrations should be undertaken in studies using 
ketogenic supplements as AcAc can be reduced to bHB in collected samples. Samples for 
AcAc analysis should be immediately stored and measurement validity may be improved by 
de-proteinisation with perchloric acid.  
 
 
Concluding remarks 
	
In conclusion, although data are preliminary and somewhat conflicting, acute 
nutritional ketosis achieved by ingestion of exogenous ketone supplements has certainly the 
potential to alter fuel selection and the metabolic response during exercise, but the evidence 
to confer performance benefits remains sparse. Benefits to performance, if any, are most 
likely to be observed in trained individuals who have a greater capacity to uptake and oxidise 
KB during exercise because of their aerobic training base and the consequent ketolytic 
adaptations in skeletal muscle. Additionally, a strong physiological basis, albeit presently 
circumstantial, exists that suggests potential benefits for supporting training adaptation and 
recovery. While much work remains to be performed, particularly in relation to sport-specific 
strategies, this promises to be an exciting topic for scientists, practitioners and athletes alike 
for the coming years. 
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